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The Occupational Safety and Health Act of 1970 emphasizes the need 
for standards to protect the health and provide for the safety of workers 
occupationally exposed to an ever-increasing number of potential hazards. 
The National Institute for Occupational Safety and Health (NIOSH) evaluates 
all available research data and criteria and recommends standards for
occupational exposure. The Secretary of Labor will weigh these
recommendations along with other considerations, such as feasibility and 
means of implementation, in promulgating regulatory standards.
NIOSH will periodically review the recommended standards to ensure 
continuing protection of workers and will make successive reports as new 
research and epidemiologic studies are completed and as sampling and 
analytical methods are developed.
The contributions to this document on nitroglycerin (NG) and ethylene 
glycol dinitrate (EGDN) by NIOSH staff, other Federal agencies or
departments, the review consultants, the reviewers selected by the American 
Industrial Hygiene Association, and by Robert B. O ’Connor, M.D., NIOSH 
consultant in occupational medicine, are gratefully acknowledged.
The views and conclusions expressed in this document, together with 
the recommendations for a standard, are those of NIOSH. They are not 
necessarily those of the consultants, the reviewers selected by 
professional societies, or other Federal agencies. However, all comments, 
whether or not incorporated, have been sent with the criteria document to 
the Occupational Safety and Health Administration for consideration in 
setting the standard. The review consultants and the Federal agencies
which received the document for review appear on pages v and vi.
V J .  Michael Larte, M.D. ly  Acting Director, National Institute 
for Occupational Safety and Health
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I. RECOMMENDATIONS FOR A NITROGLYCERIN:ETHYLENE GLYCOL 
DINITRATE STANDARD
NIOSH recommends that employee exposure to nitroglycerin (NG) or 
ethylene glycol dinitrate (EGDN) in the workplace be controlled by
adherence to the following sections. The recommended standard is designed 
to protect the health and provide for the safety of employees for up to a 
10-hour workshift, 40-hour workweek, throughout a working lifetime.
Compliance with all sections of the recommendation should prevent adverse 
effects of NG or EGDN on the health of employees and provide for their 
safety. Techniques recommended in the standard are valid, reproducible, 
and available to industry and government agencies. Sufficient technology 
exists to permit compliance with the recommended standard. Although NIOSH 
considers the recommended workplace environmental limit to be a safe level
based on current information, the employer should regard it as the upper
boundary of exposure and make every effort to maintain the exposure as low 
as is technically feasible. It should be noted that toxicity can be 
produced as readily through the skin, and therefore the recommended 
environmental limit is protective only if skin contact is prevented. The 
criteria and recommended standard will be subject to review and revision as 
necessary.
These criteria and the recommended standard apply to exposure of 
employees in the workplace to NG (1,2,3-trinitropropanetriol; 
C3H503(N02)3), to EGDN (1,2-dinitroethanediol, C2H402(N02)2), or to
mixtures of these compounds. Workers employed where NG:EGDN explosives are
used may also be exposed to byproducts from explosions of these compounds, 
including oxides of carbon, hydrogen, and nitrogen. Applicable health and 
safety standards for these compounds should also be observed.
Both safety and health hazards are present in work areas where NG or 
EGDN are present, but the criteria and recommended standard in this 
document are concerned primarily with the prevention of adverse effects on 
the health of workers exposed to these compounds. A manual on safe 
practices for nonmilitary explosives and pyrotechnics, including NG and 
EGDN, is being prepared currently by NIOSH.
Like other compounds with nitroester groups, NG and EGDN are potent 
vasodilators. NG has found extensive pharmaceutical use, primarily in the 
treatment of angina pectoris. Both substances are absorbed readily by 
inhalation and through the skin, but the available evidence indicates that 
the greatest danger to employees who directly handle these compounds is 
from skin contact. The health effects of short-term or intermittent 
exposure to NG or EGDN in the workplace include headache, dizziness, 
nausea, palpitations, and decreases in systolic, diastolic, and pulse 
pressures. All these symptoms are associated with vasodilation. Most 
workers do not experience these symptoms after repeated daily exposures to 
NG or EGDN, ie, they develop tolerance. The disappearance of these 
symptoms in workers exposed on successive days of the workweek indicates 
that the vasodilatory activity of NG or EGDN has been counteracted by 
compensatory vasoconstriction. Withdrawal from long-term exposure to NG or 
to NG:EGDN mixtures has been associated with angina pectoris and with 
sudden death in workers, particularly after weekends or holidays. The
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compensatory vasoconstriction in workers who have developed tolerance to 
nitroesters continues in the absence of exposure to a vasodilating agent. 
It has been postulated that this vasoconstriction leads to spasms of the 
coronary arteries and that these spasms are related to the angina pectoris 
and sudden deaths that occur during periods when workers are not exposed to 
nitroesters. Although this mechanism has not been conclusively proven, 
exposed workers may have an increased risk of death from heart disease. 
Skin sensitization (dermatitis) can result from dermal contact with NG or 
EGDN.
"Occupational exposure" is defined as exposure to airborne NG, EGDN, 
or a mixture of these compounds at a concentration above the action level 
or as any dermal contact with these compounds. The "action level" is 
defined as a concentration in the air of the workplace equal to one-half 
the recommended environmental limit for NG, EGDN, or a mixture of these 
compounds (see Section 1). If there is no skin contact, and if exposures 
are below the action level, adherence to the recommended standard will not 
be required except for sections 2, 3, 4(a), 5, 6(a,b,f,h), 7, and 8.
Workers occupationally exposed to NG or EGDN include those who make 
dynamite, propellants, and pharmaceuticals and those who use NG:EGDN 
dynamite in blasting operations. Workers who sell prepackaged 
pharmaceuticals containing NG are not considered to be occupationally 
exposed. "Overexposure" to NG or EGDN is defined as exposure above the 
recommended environmental limit or as any exposure, including dermal 
contact with these substances, resulting in throbbing headache, substantial 
decreases in blood pressure, or other observed effects on health.
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Section 1 - Environmental (Workplace Air)
(a) Concentration
Occupational exposure to NG and EGDN shall be controlled so that 
employees are not exposed to NG, EGDN, or a mixture of these two substances 
at concentrations greater than 0.1 milligram per cubic meter of air (0.1 
mg/cu m) measured as a ceiling concentration during any 20-minute sampling 
period.
(b) Sampling and Analysis
Procedures for the collection and analysis of workroom air samples 
for compliance with the recommended standard shall be as provided in 
Appendix I or by any method shown to be at least equivalent in precision,
sensitivity, accuracy, and safety to those specified.
Section 2 - Medical
Medical surveillance shall be made available as outlined below to all 
workers subject to occupational exposure to NG or EGDN.
(a) Preplacement examinations shall include at least:
(1) Comprehensive medical and work histories with special 
emphasis directed to disorders of the cardiovascular system.
(2) Physical examination giving particular attention to the 
heart and circulatory systems, the central and peripheral nervous systems, 
and the skin. Recording of pulse rate, blood pressures, and 
electrocardiograms (ECG's) at rest and during and after exercise (Master's 
Test) is the minimal requirement.
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(3) A judgment of the worker's ability to use positive 
pressure respirators.
(b) Periodic examinations shall be made available at least 
semiannually and more often if indicated by the responsible physician. 
These examinations shall include at least:
(1) Interim medical and work histories.
(2) Physical examination as outlined in paragraph (a) (2)
above.
(c) During examinations, applicants or employees found to have 
medical conditions, such as cardiovascular disease, that would be directly 
or indirectly aggravated by exposure to NG or EGDN shall be counseled on 
the increased risk of impairment of their health from working with these 
substances.
(d) In the event of an illness known or suspected to be due to NG 
or EGDN, a physical examination as described in paragraph (a) (2) above 
shall be made available.
(e) Employees who may be occupationally exposed to NG or EGDN 
shall be counseled by the physician so that each is aware that headache, 
dizziness, palpitations, and nausea are symptoms of overexposure, that 
these symptoms usually become worse when alcohol is used, and that some of 
these symptoms may disappear with continued exposure as tolerance develops. 
Employees shall be warned that symptoms, such as headache, palpitations, 
and chest pain, can occur, particularly on weekends, on holidays, or at the 
beginning of the workweek, as a result of interruption of exposure to NG or 
EGDN. They shall be advised to consult a physician promptly if they 
experience such symptoms.
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(f) Since a change in pulse rate is an early indicator of NG or 
EGDN exposure, pulse rate, ideally, should be taken and recorded daily.
(g) Pertinent medical records shall be maintained for all 
employees occupationally exposed to NG or EGDN. Such records shall be kept 
for at least 30 years after termination of employment. Records of 
environmental exposures applicable to an employee shall be included in the 
employee's medical records. These records shall be made available to
designated medical representatives of the Secretary of Health, Education, 
and Welfare, of the Secretary of Labor, of the employer, and of the 
employee or former employee.
Section 3 - Labeling and Posting
All labels and warning signs shall be printed both in English and in 
the predominant language of non-English-reading workers. Workers unable to 
read the labels and signs provided shall be informed verbally about 
hazardous areas and the instructions printed on labels and signs.
(a) Containers
Shipping and storage containers of NG, EGDN, or explosives containing 
these substances shall bear the following label in addition to labels 
required by other statutes, regulations, or ordinances:
NITROGLYCERIN (NG)
(and/or)
ETHYLENE GLYCOL DINITRATE (EGDN)
HIGHLY EXPLOSIVE
DANGEROUS TO HEALTH IF INHALED, SWALLOWED, OR 
ABSORBED THROUGH SKIN 
CAUSES HEADACHE, WEAKNESS, AND DIZZINESS
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Avoid contact with eyes, skin, and clothing.
Avoid breathing vapor.
Keep away from heat, sparks, and open flames.
Keep from freezing.
Keep container closed.
Use only with adequate ventilation.
Consult a physician if persistent headaches or chest pains develop.
First aid: In case of skin contact, wash affected area with
soap and water or with a waterless skin cleanser.
(b) Work Areas
Areas where airborne NG or EGDN is likely to be generated or where 
skin contact with these compounds is likely to occur shall be designated 




ETHYLENE GLYCOL DINITRATE (EGDN)
HIGHLY EXPLOSIVE 
SMOKING FORBIDDEN
DANGEROUS TO HEALTH IF INHALED, SWALLOWED, OR ABSORBED THROUGH THE SKIN 
CAUSES HEADACHE, WEAKNESS, AND DIZZINESS
Do not use heat, sparks, or open flame.
Avoid contact with skin, eyes, and clothing.
Consult a physician if persistent headaches or chest pains develop.
If respiratory protection is required in accordance with Section 4, 
the following statement in large letters shall be added to the required 
sign:
RESPIRATORY PROTECTION REQUIRED IN THIS AREA
For buildings in which liquid NG, EGDN, or explosive mixtures of 
these substances are manufactured or processed, limits for the number of
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persons who are authorized to be present and the amount of NG or EGDN that 
may be on the premises shall be posted outside the building.
Section 4 - Personal Protective Equipment and Clothing
(a) Respiratory Protection
Engineering controls shall be used when needed to keep concentrations 
of airborne NG or EGDN at or below the recommended environmental limit. 
Compliance with this limit by the use of respirators is permitted only 
during installation and testing of engineering controls, during performance 
of nonroutine maintenance or repair, or during emergencies. When the use 
of a respirator is permitted, it shall be selected and used in accordance 
with the following requirements:
(1) To determine the type of respirator to be used, the
employer shall measure the concentration of airborne NG or EGDN in the 
workplace initially and thereafter whenever control, process, operation, 
worksite, or climatic changes occur that are likely to increase the 
concentration of these compounds in the air of the workplace.
(2) The employer shall ensure that no employee is exposed
to NG or EGDN at concentrations above the recommended limit because of 
improper respirator selection, fit, use, or maintenance.
(3) The employer shall establish and enforce a respiratory 
protection program. The requirements for such a program are listed in 29 
CFR 1910.134.
(4) The employer shall provide respirators in accordance
with Table 1-1 and shall ensure that the employees use the respirators
properly when they are required. The respiratory protective devices
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provided in conformance with Table 1-1 shall be those approved by NIOSH and 
the Mining Enforcement and Safety Administration (MESA) or its successor, 
as specified under the provisions of 30 CFR 11. Nonsparking parts, such as 
those made of bronze, brass, or plastic, shall be used where steel or iron 
is normally used on any respiratory protective device.
TABLE 1-1
RESPIRATOR SELECTION GUIDE FOR NG AND EGDN
Concentration
Respirator Type Approved 
under Provisions of 30 CFR 11
Less than or equal 
to 10.0 mg/cu m
(1) Supplied-air respirator operated
in continuous-flow mode with half-mask, 
full facepiece, hood, helmet, or suit
(2) Supplied-air respirator with full 
facepiece operated in the positive 
pressure mode
(3) Self-contained breathing apparatus 




(1) Self-contained breathing apparatus 
with full facepiece operated in pres- 
sure-demand or other positive pressure 
mode
(2) Combination Type C supplied-air 
respirator with full facepiece operated 
in pressure-demand mode and auxiliary 
self-contained air supply
Emergency (entry 
into area of unknown 
concentration for 
emergency purposes)
Self-contained breathing apparatus with 
full facepiece operated in pressure- 
demand or other positive pressure mode
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(5) Respirators specified for use in higher concentrations 
of airborne NG or EGDN may be used in atmospheres with lower
concentrations.
(b) Protective Clothing
(1) The employer shall provide a daily change of clean work 
clothing intended to minimize access of dust to the skin of employees in 
areas where NG or EGDN are present. Work clothing shall be changed
immediately when soiled with liquid NG or EGDN.
(2) Rubber or plastic gloves with a cotton lining or plain 
cotton gloves shall be provided for employees who may have skin contact 
with NG or EGDN. The gloves shall be changed at least daily. Cotton
gloves shall be changed immediately if they become contaminated with liquid 
NG or EGDN. Since natural and synthetic rubber are pervious to NG and 
EGDN, unlined gloves made of these materials should not be used.
Section 5 - Informing Employees of Hazards from NG and EGDN
(a) All new and present employees subject to occupational exposure 
to NG or EGDN shall be informed orally and in writing of the hazards, 
relevant signs and symptoms of exposure and withdrawal from exposure, 
appropriate emergency procedures, including first-aid procedures, and the 
proper conditions and precautions conducive to the safe use and handling of 
these compounds. Special care should be exercised to ensure that employees 
unable to read the informational material provided understand the hazards 
of working with the nitroesters, the symptoms of intoxication by these 
materials, and the equipment and procedures that can be used to minimize
the hazard from exposure to these compounds.
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Employees shall be made aware that headache is a warning symptom and that 
tolerance to these compounds and withdrawal symptoms may develop as 
outlined in Section 2(f). This Information shall be readily available to 
all employees involved in the manufacture, use, transport, or storage of 
NG, EGDN, or explosives containing these compounds, and it shall be posted 
in prominent positions within the workplace.
(b) The employer shall institute a continuing education program, 
conducted by persons qualified by experience or training, to ensure that 
all employees have current knowledge of job hazards, proper maintenance and 
cleanup methods, and proper respirator usage. The instructional program 
shall include a description of the general nature of the environmental and 
medical surveillance procedures and of the advantages to the employee of 
participating in these surveillance procedures. As a minimum, instruction 
shall include the information in Appendix II, which shall be on file and 
readily accessible to employees at all places of employment where exposure 
to NG or EGDN may occur.
(c) Information required shall be recorded on the "Material Safety 
Data Sheet" shown in Appendix II, or on a similar form approved by the 
Occupational Safety and Health Administration, US Department of Labor.
Section 6 - Work Practices
(a) Control of Airborne NG or EGDN
Engineering controls, such as process enclosure or non-sparking local 
exhaust ventilation, shall be used when needed to keep exposures to 
airborne NG or EGDN at or below the recommended environmental limit.
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Ventilation systems, if used, shall be designed to prevent accumulation or 
recirculation of NG or EGDN in the workplace environment and to remove them 
effectively from the breathing zone of employees. Exhaust ventilation 
systems discharging to outside air must conform to applicable local, state, 
and Federal air pollution regulations and must not constitute a hazard to 
employees or to the general population. Ventilation systems shall be 
subject to regular preventive maintenance and cleaning to ensure
effectiveness, which shall be verified by airflow measurements taken at
least every 3 months. These engineering control systems shall be
constructed of nonsparking materials.
(b) Ignition Sources and Detonation Hazards
The danger of explosion in buildings where NG or EGDN is manufactured 
or handled shall be minimized by compliance with the following provisions:
(1) Facilities should consist of detached units, with 
explosion-venting systems if possible.
(2) Each unit shall be subdivided by fire- and pressure- 
resistant walls to restrict hazardous areas.
(3) The amount of NG or EGDN present in any building shall 
not exceed the amount being processed at any one time.
(4) To prevent accumulation of explosive dust, equipment 
shall be dust-tight.
(5) All electrical equipment shall have explosion—proof 
fixtures and wiring.
(6) Static electricity shall be minimized by 
humidification, bonding, grounding, and the use of conductive materials.
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(7) Motor-driven portable equipment, internal combustion
engines, and vehicles shall not be used unless they have been approved for 
use in an explosive atmosphere.
(c) Regulated Areas
Access to buildings in which NG or EGDN is manufactured or handled in 
liquid form or in explosive mixtures such as dynamite shall be regulated to 
comply with the following provisions:
(1) Access shall be restricted to authorized persons.
(2) For each such building, a limit shall be established 
for the number of persons who may be present, based on the minimum number 
necessary for efficient performance of the operation. This limit shall be 
posted outside the building. A log of persons entering the building should 
be kept in some secure location outside the building.
(3) Before maintenance or repair work is undertaken in 
these buildings, operations should be shut down and the work area cleaned 
and inspected.
(4) A permit system shall be established for such 
maintenance and repair work. Permits shall be signed by an authorized 
representative of the employer to ensure that necessary precautionary steps 
have been taken.
(d) Confined Spaces
(1) Entry into confined spaces, such as tanks, pits, or 
vessels, that may contain NG or EGDN shall be controlled by a permit 
system. Permits shall be signed by an authorized representative of the 
employer certifying that preventive and protective measures have been 
followed.
13
(2) Confined spaces that have contained NG or EGDN shall be 
cleaned with water and purged with air. They shall be tested for NG or 
EGDN and other contaminants and for oxygen and inspected for compliance 
with these requirements prior to each entry. Adequate ventilation shall be 
maintained while workers are within the confined space.
(3) Employees entering confined spaces shall wear the 
appropriate personal protective equipment and suitable harnesses with 
lifelines tended by an employee outside the confined space who shall also 
be equipped with the appropriate personal protective equipment. The two 
workers shall be in constant communication by some appropriate means and 
shall be under the surveillance of a third person equipped to take any 
action to rescue them if necessary.
(e) Storage and Handling
(1) Buildings used for storage of NG or EGDN shall be 
separated by at least the minimum distances for magazines required by the 
American Table of Distances [1].
(2) Containers of NG or EGDN shall be kept tightly closed 
at all times when not in use and shall be stored in a manner that will 
minimize the risk of spills.
(3) Only properly informed, trained, and equipped personnel 
shall be involved in storing, loading and unloading, or processing liquid 
NG, EGDN, or explosive mixtures containing these compounds.
(4) Storage areas for NG or EGDN shall be clean, dry, and
well ventilated. Storage areas for explosive forms of NG or EGDN shall be
in a structure that is bullet resistant, weather resistant, and ventilated.
Specific requirements for magazines, including those for construction and
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bullet resistance, are listed in the National Fire Codes (Volume 3) [2].
(5) Floors of storage areas shall be swept and washed 
regularly and kept free of dust.
(6) Transporting of NG, EGDN, or explosive mixtures 
containing these compounds must conform to the regulations of the 
Department of Transportation in Title 49 CFR, Parts 171-178 and Title 33 
CFR, Parts 6 and 126 (guidelines for transportation over waterways). Any 
applicable state or local regulations on the transporting or use of such 
explosive materials shall also be adhered to.
(f) General Work Practices
(1) Smoking, matches, open flames, and spark-producing 
devices shall be prohibited in areas where NG or EGDN is handled.
(2) Employers shall ensure that workers do not carry 
smoking materials into regulated areas and should provide smoking areas 
located at a safe distance from NG or EGDN work and storage areas.
(g) Cleanup and Waste Disposal
(1) All equipment shall be cleaned or washed at the end of 
each workshift or when significant accumulation of explosive material on 
equipment occurs.
(2) Small liquid spills shall be wiped up promptly, using
sponges or other suitable absorbent materials. These should be kept 
readily available in a sodium carbonate solution. Large liquid spills
should be washed with water and piped into tanks where the compounds can be 
separated and recovered.
(3) Waste material contaminated with NG or EGDN shall be 
disposed of in a manner not hazardous to employees and conforming to all
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applicable local, state, and Federal regulations.
(4) Clothing grossly contaminated with NG or EGDN shall be
discarded into waste containers kept outside of regulated areas and 
disposed of at the end of each operation.
(h) Emergency Procedures
(1) The employer shall formulate emergency evacuation and
medical procedures and shall ensure that employees are instructed in these 
procedures and that they are posted in all work areas where emergencies 
involving NG or EGDN might occur. Emergency procedures shall include 
prearranged plans for immediate evacuation, transportation, and medical
assistance for affected employees, including alerting designated medical 
treatment facilities of the impending arrival of affected workers.
(2) Necessary emergency equipment, including respirators, 
shall be available in readily accessible locations, and employees shall be 
instructed in its use.
(3) Nonessential employees shall be evacuated from 
hazardous areas during emergencies. Perimeters of these areas shall be 
delineated, posted, and secured. Only personnel trained in emergency 
procedures and protected against the attendant hazards shall shut off 
sources of NG or EGDN, clean up spills, and control and repair leaks in NG 
or EGDN areas.
(4) Showers and washroom facilities shall be provided and 
shall be readily accessible to workers in all areas where skin contact with 
NG or EGDN is likely. If NG or EGDN is spilled on clothing or skin, 
contaminated clothing shall be promptly removed and the skin washed 
thoroughly with soap and water or a waterless skin cleanser.
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(5) The employer shall ensure that all emergency equipment, 
including washing facilities, is in proper working order through regularly 
scheduled inspections and maintenance.
Section 7 - Sanitation
(a) The employer shall develop and maintain a program for plant
sanitation. The requirements for such a program are listed in 29 CFR
1910.141.
(b) Employees occupationally exposed to NG or EGDN shall shower 
and change clothing daily at the end of the workshift.
(c) The employer shall provide appropriate changing and shower
facilities. Requirements for washing and change rooms are listed in 29 CFR
1910 .141 (d and e).
(d) The employer shall be responsible for laundering work clothing 
worn during each workshift and shall ensure that employees do not remove 
work clothing from the premises.
(e) The employer shall ensure that personnel who launder and clean 
clothing or equipment contaminated with NG or EGDN are aware of the 
potential hazards of exposure to NG or EGDN and that the managers of 
commercial laundries understand the need for adequate ventilation of 
laundry areas and for personal protective equipment to prevent overexposure 
of their employees.
(f) Employers shall ensure that employees who handle NG or EGDN
I
wash their hands thoroughly with soap and water or with a waterless 
cleanser before eating, smoking, or using toilet facilities.
(g) The storage, dispensing, preparation, consumption of food and
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beverages, and the carrying of materials such as tobacco and chewing gum, 
within NG or EGDN work areas shall be prohibited.
Section 8 - Monitoring and Recordkeeping
Each employer with a place of employment where NG, EGDN, or 
explosives containing these compounds are manufactured, processed, handled, 
stored, or otherwise used shall determine by an industrial hygiene survey 
whether occupational exposure to NG or EGDN may occur. Records of these 
surveys, including the basis for concluding that there is no occupational
exposure to NG or EGDN, shall be maintained. Surveys shall be repeated at
least annually and within 30 days of any process or engineering change.
(a) Personal Monitoring
If it is determined that there is occupational exposure to NG or 
EGDN, the employer shall institute a program of personal monitoring to 
measure or permit calculation of the exposure of each employee. Source and 
area monitoring may be used to supplement personal monitoring.
(1) In all personal monitoring, samples representative of
the breathing zones of the employees shall be collected.
(2) For each determination of the concentration of NG or
EGDN in workplace air, a sufficient number of samples shall be taken to 
characterize the employees' exposures during each workshift. Variations in 
work and production schedules and in employees' locations and job functions 
shall be considered in choosing sampling times, locations, and frequencies.
(3) Each operation in each work area shall be evaluated at
least every 3 months for conditions that might be conducive to skin contact
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in addition to air sampling, if considered necessary.
(4) If an employee is found to be exposed to NG or EGDN in 
excess of the recommended environmental limit, control measures shall be 
initiated immediately, the exposure of that employee shall be measured at 
least weekly, and the employee shall be notified of the extent of the 
exposure and of the control measures being implemented. Such monitoring 
shall continue until two consecutive determinations, 1 week apart, indicate 
that the employee's exposure no longer exceeds the recommended 
environmental limit. Routine monitoring may then be resumed.
(b) Recordkeeping
Environmental monitoring records shall be retained for at least 30 
years after the employee's last occupational exposure to NG or EGDN. These 
records shall include the dates and times of measurements, job function and 
location of the employee within the worksite, methods of sampling and 
analysis used, types of respiratory protection in use at the time of 
sampling, environmental concentrations found, and identification of the 
exposed employee. Employees shall be able to obtain information on their 
own environmental exposures. Environmental monitoring records shall be 
made available to designated representatives of the Secretary of Labor and 
of the Secretary of Health, Education, and Welfare.
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II. INTRODUCTION
This report presents the criteria and the recommended standard based 
thereon which were prepared to meet the need for preventing impairment of 
health from occupational exposure to nitroglycerin (NG) or ethylene glycol 
dinitrate (EGDN). The criteria document fulfills the responsibility of the 
Secretary of Health, Education, and Welfare under Section 20(a)(3) of the 
Occupational Safety and Health Act of 1970 to "...develop criteria dealing 
with toxic materials and harmful physical agents and substances which will 
describe...exposure levels at which no employee will suffer impaired health 
or functional capacities or diminished life expectancy as a result of his 
work experience."
After reviewing data and consulting with others, NIOSH formalized a 
system for the development of criteria upon which standards can be 
established to protect the health and provide for the safety of employees 
exposed to hazardous chemical and physical agents. Criteria for a 
recommended standard should enable management and labor to develop better 
engineering controls resulting in more healthful work environments, and 
simply complying with the recommended standard should not be regarded as a 
final goal.
These criteria for a standard for NG or EGDN are part of a continuing 
series of criteria developed by NIOSH. The proposed standard applies to 
the processing, manufacture, and use of NG and/or EGDN. The standard was 
not designed for the population-at-large, and any application to situations 
other than occupational exposures is not warranted. The standard is 
intended to (1) protect against the hazards to safety posed by NG or EGDN,
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(2) protect against the toxic effects of exposure to NG or EGDN, (3) be 
measurable by techniques that are valid, reproducible, and available to 
industry and government agencies, and (4) be attainable with existing 
technology.
NG is used to make dynamite, gun powder, and rocket propellants and 
as a therapeutic agent, primarily to alleviate angina pectoris. EGDN is 
used only in the manufacture of dynamite. EGDN is mixed with NG, currently 
in a ratio of about 8:2, to lower the freezing point of the dynamite 
mixture and increase its stability, making it safer to manufacture and use.
The byproducts of explosion of NG or EGDN include the oxides of 
carbon, hydrogen, and nitrogen. In this document, NIOSH recommends a 
standard to control workplace exposure to NG and EGDN but not to byproducts 
of explosion of these compounds. Information on the health effects and 
control of exposure to oxides of carbon and nitrogen may be found in NIOSH 
Criteria and Recommended Standards for Carbon Monoxide, Carbon Dioxide, and 
the Oxides of Nitrogen (Nitrogen Dioxide and Nitric Oxide).
NG and EGDN are absorbed through the lungs and the skin. Absorption 
through the skin is usually the major route of exposure for workers who 
have direct dermal contact with NG or EGDN. Thus, work practices designed 
to limit skin absorption of these compounds should be followed carefully.
The recommended standard for NG, EGDN, or a mixture of these two 
compounds is based on their effects on the cardiovascular system. The 
initial physiologic effect of exposure to these compounds is dilatation of 
the blood vessels, and the initial signs and symptoms of exposure include 
headache, dizziness, nausea, palpitations, and decreases in systolic, 
diastolic, and pulse pressures. These signs and symptoms tend to disappear
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after 3-4 days of repeated exposure, probably as the result of compensatory 
vasoconstriction. After a brief period of withdrawal from exposure, eg, a 
weekend, workers may develop angina pectoris. Some workers exposed to 
NG:EGDN mixtures or to nitroglycerin alone have died suddenly, often on 
Monday or Tuesday mornings, from no apparent cause. The mechanisms 
producing posthiatal precordial distress (angina pectoris) and sudden death 
are not clearly understood, but these effects may be related to spasms of 
the coronary arteries that tend to occur during periods when workers are 
not exposed to vasodilatory actions of these compounds but still have 
compensatory vasoconstrictive mechanisms in operation. A recent 
epidemiologic study also suggests that men who once manufactured NG:EGDN 
dynamite were at increased risk of death from heart disease, even though 
most of them had not worked at the plant for months or years.
Not all workers develop headaches or changes in blood pressure during 
initial exposure to NG or EGDN, but the available data indicate that these 
are usually the first and most consistent effects of initial exposure. 
Compensatory vasoconstriction following prolonged exposure may promote more 
serious effects, including angina pectoris, heart disease, and sudden 
death. The recommended standard for workplace exposure to NG or EGDN is 
designed to prevent significant changes in the diameters of cerebral blood 
vessels during initial exposure, as indicated by the development of 
throbbing headaches or by decreases in blood pressure, thereby preventing 
the development of the compensatory vasoconstrictive mechanisms that may 
eventually result in more serious effects.
Further research is needed in several areas. The concentration below
which exposure to NG or EGDN will not cause significant changes in blood
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vessel diameters, as indicated by throbbing headaches or definite changes 
in blood pressure, is not known. Diagnostic methods that are reliable and 
easy to use are needed to determine whether workers are overexposed to NG 
or EGDN. It appears that workers with prolonged exposure to NG or EGDN can 
develop spasms of the coronary arteries that may lead to angina or to 
sudden death, but further information on the mechanisms responsible for 
these effects should be developed. Epidemiologic studies are needed to 
assess the effect of prolonged exposure to these compounds on the risk of 
developing heart disease or precursors of heart disease. Potential effects 
on reproduction and the potential mutagenicity and carcinogenicity of these 
compounds and their metabolites should be explored more thoroughly.
Additional information on the toxicity of NG and EGDN is provided in 
two other reviews. The available literature was reviewed by Von Oettingen
[3] of the US Public Health Service in 1946. Dacre and Tew [4] reviewed 
literature on the toxicity of NG and EGDN for the Army Medical Research and 
Development Command in 1973.
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III. BIOLOGIC EFFECTS OF EXPOSURE
Nitroglycerin (NG; trinitropropanetriol) is an oily liquid at room 
temperature that is colorless in pure form and pale yellow or pale brown in 
commercial form [5]. The chemical formula for NG is C3H503(N02)3 and the 
molecular weight is 227. It has a bittersweet or burning taste and a 
slightly sweet smell at temperatures above 50 C [5]. Reported measurements 
of the vapor pressure of NG at 20 C range from 0.00012 to 0.011 mmHg [5-7], 
Local overheating of large or confined quantities of NG may cause an 
explosion, although small, unconfined quantities will burn without 
exploding [6]. The two isomeric forms of NG differ in freezing point and 
in crystalline form. The stable isomer of NG freezes at 12.4-13.2 C [5,6] 
to form orthorhombic dipyramidal crystals. The labile isomer forms 
triclinic crystals at 1.9-2.2 C and is converted to the stable isomer after 
some 1-2 weeks of storage [5]. NG is sensitive to impact, and its 
sensitivity increases as the temperature increases [6]. Frozen NG is less 
easily detonated than the liquid form, but it becomes extremely sensitive 
to impact while it is thawing or when it contains minute bubbles of air.
Ethylene glycol dinitrate (EGDN; dinitroethanediol) is a colorless
[6] or yellow [8] liquid at room temperature. The chemical formula for 
EGDN is C2H402(N02)2 and its molecular weight is 152. It freezes at 22.3 
or 22.8 C and measurements of the vapor pressure of EGDN at 20 C range from
0.038 to 0.050 mmHg [5,6]. EGDN is less likely than NG to explode when it 
burns, but the other burning and explosion characteristics of EGDN are 
similar to those of NG. EGDN is less sensitive to heat and to impact than 
NG. Other physical and chemical properties of these compounds are given in
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Table XI-1 [5-9]. Numerous synonyms for NG, EGDN, and NG:EGDN mixtures are 
listed in Table XI-2 [10].
Most of the concentrations of n 6 and EGDN reported in this chapter 
were determined by colorimetric analysis of the amount of inorganic nitrite 
produced after hydrolysis of organic nitroesters. These colorimetric 
methods cannot differentiate between NG and EGDN or any other nitroester. 
However, hydrolysis of 1 mole of NG theoretically releases 3 moles of
nitrite ion, whereas that of 1 mole of EGDN would free 2 moles of that ion.
This means that 1 g of nitrite ion corresponds to 165 g of NG or 1.64 g of
EGDN. Calculations by Einert et al [11] indicate that 1 g of nitrite ion
is equivalent to 2.56 g of NG or 2.60 g of EGDN under usual laboratory
conditions. The amounts of nitroesters calculated from the latter set of 
equivalents are sufficiently close to the theoretical values and to each 
other to render immaterial the nitroester chosen for expression of the
analytical results. For ease of comparison, concentrations expressed by 
the authors in ppm have been converted in this document to mg/cu m, using 
the conversion factor appropriate to the compound stated by the original 
author or authors.
Extent of Exposure
NG was discovered in 1847 by the Italian scientist Ascanio Sobrero,
when he was attempting to produce explosives from sugars and inorganic
acids [12]. He synthesized NG by running dehydrated glycerin into a cooled 
mixture of nitric and sulfuric acids. After Sobrero's discovery, both the 
Italian and the Russian governments became interested in the potential 
military uses of NG, but the inherent danger of spontaneous explosion
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caused the Italians to abandon experimentation. It was not until Alfred 
Nobel invented dynamite in 1867 that practical use was found for this 
compound.
Nobel, who had learned of the explosive properties of NG from Zinin, 
a Russian scientist, used diatomaceous earth to absorb the NG. The 
resulting mixture was a dry, less sensitive material that was safer to 
handle and transport than liquid NG alone [6]. Nobel created "straight" or 
"active dope" dynamite 2 years later by replacing the diatomaceous eatth 
with a mixture of sodium nitrate and an absorbent, combustible material 
such as wood pulp. Gelatin dynamites, mixtures of NG and nitrocellulose 
forming a gel, were invented by Nobel in 1875. Dynamites in this form, 
which are used primarily to blast hard rock, are less sensitive to 
initiation than straight dynamite. By 1879, Nobel had established several 
dynamite plants throughout Europe [12].
EGDN was synthesized by Henry in 1870 but was not used commercially 
until the 1930's [6]. At first, small amounts of EGDN were added to NG 
dynamites and gelatins to lower the freezing points of the mixtures to make 
them safer to use, particularly during the winter months. EGDN is a good 
explosive in its own right and it has gradually become the major component 
of dynamite mixtures. This is the only commercial use for EGDN. The 
EGDN:NG ratio has varied over the years, but currently it is about 8:2 [11] 
or 9:1 [13] .
Although the NG:EGDN dynamites were less likely to explode 
unexpectedly than straight NG dynamites, the available literature indicates 
that the: effects of exposure to NG:EGDN dynamites on health were apparently 
more severe than those associated with exposure to dynamites containing NG
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.re Since the vapor pressure of EGDN is greater than that of NG, the 
ratio of airborne EGDN to NG is much greater than that of the dynamite
mixture itself.
'p the United States, NG is manufactured either by the Biazzi process 
r14 j, which is a continuous, closed process, or by an open batch process 
[13]. The raw materials are glycerin and a mixture of concentrated nitric 
and sulfuric acids [14]. After the glycerin is nitrated, the spent acid is 
removed and the resulting NG is neutralized and washed. Dynamite is formed 
by adding "dope," mixtures that have contained sodium nitrate, sulfur, 
antacids, and carbonaceous combustible material, usually nitrocellulose, to 
the NG. To make NG:EGDN dynamites and gelatins, NG and EGDN are
synthesized together by nitrating a mixture of glycerin and ethylene glycol 
in the presence of sulfuric acid. "Dope" is then added to the NG:EGDN
mixture.
In 1976, about 250 million pounds of dynamite, containing 5-50% 
NG:EGDN, were produced by US manufacturers (Bureau of Mines, written 
communication, November 1977). The use of NG:EGDN dynamite, however, is 
decreasing. At present, only 10% of the blasting agents used in the United 
States are dynamites containing NGrEGDN.
NG is used in gun powder and rocket propellants in addition to its 
use in dynamite [15]. Gun powders are also known as smokeless powders
[13]. Single-base propellants contain nitrocellulose alone, double-base 
propellants contain nitrocellulose and small amounts of NG, and triple-base 
propellants contain nitrocellulose, NG, and other combustible compounds 
[15]. NG is also used for therapeutic purposes, primarily to alleviate 
angina pectoris or to treat other circulatory disorders.
27
NIOSH estimates that about 8,000 persons in the United States are 
exposed to NG alone or to NG:EGDN mixtures. Occupations with potential 
exposure to these compounds are listed in Table XI-3 [16].
The effects on the health of workers exposed to NG and EGDN will be 
stressed in this document. In the workplace, NG and NG:EGDN mixtures are 
absorbed both by inhalation and directly through the skin. The health 
effects of exposure to the explosion byproducts of NG or EGDN, ie, the 
oxides of carbon, hydrogen, and nitrogen are not considered in this 
document. Regulations for the safe manufacture, handling, and use of NG or 
EGDN are listed in Chapter V.
Historical Reports
According to Holmes and DiCarlo [12], the physiologic effects of 
exposure to NG were noted soon after it was first synthesized. Sobrero 
himself tasted a minute amount of the compound and found that it produced 
severe headaches. Hering, Davis, and Jeanes began, according to Holmes and 
Dicarlo [12], in about 1853 to conduct experiments on the effects of NG on 
humans. They dissolved the compound in alcohol, absorbed the solution on 
sugar, and administered it orally to themselves and to others. They found 
that amounts ranging from 1/10 to 1/30 of a drop caused such diverse 
symptoms as headache, facial pain, stimulation of nerves in the neck, 
tremors, a sensation of warmth, and extreme thirst. Although the other 
effects varied, all individuals who ingested the substance developed 
changes in pulse rate and other cardiovascular effects. Hering proposed 
using NG in the treatment of a wide variety of ailments, ranging from 
sunstroke to epilepsy. About 1867, Brunton, a British scientist searching
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for a remedy for angina pectoris, found that amyl nitrite relieved chest 
pains [17]. In 1879, when NG was becoming widely used as the active 
ingredient in dynamite, Murrell [18] reported that it had effects siinildi' 
to those of amyl nitrite on the cardiovascular system.
Early literature mentioning NG as a health hazard focused on toxj.-- 
side effects, overdoses, and accidental poisonings associated primarily 
with its use as a drug [3]. In 1859, Field [19] reported the use of i\G iv 
treat headaches and noted that it relieved them in some patients but ctiuaed 
them in others. Hay [20], a physician studying the mechanism of action of 
NG, reported in 1883 that two drops of a 1% alcoholic solution of thj;: 
compound lowered his blood pressure considerably, produced throbbing uf Ui 
temporal arteries, and caused facial flushing.
The suggestion that NG might be an occupational health hazard f • i d.t
appeared in the US medical literature of the 1890's. In 1890, Darlii ̂ fon
[21] described several cases of illness in miners and tunnel workerfa v!
handled dynamite and inhaled both unexploded NG and its explosion
byproducts. As a physician on an aqueduct project from 188b~ 1 e
Darlington treated 1,300 workers who had complained of headache, aausti,
and dizziness when they worked with dynamite. He attributed the headache*
and nausea to exposure to NG and the dizziness to exposure to byproducts of
explosions and to asphyxiation. The effects were particularly severe whci
a stick of dynamite burned but did not explode, causing some of the No in
the dynamite to vaporize. Darlington distinguished two levels of eiiti: ,
which he termed "acute" and "chronic." He said that the symptoms or'
"acute" illness included loss of consciousness, severe headache, diffn^l
in breathing, weak pulse, and pallor and occurred after exposure to ldi(gu
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amounts of NG. Almost all workers thus affected recovered after passing 
through a phase of drowsiness, languor, excessive perspiration, nausea, and 
vomiting. Symptoms of "chronic" illness included cough, headache, 
indigestion, and central nervous system (CNS) disturbances. These symptoms 
occurred after repeated inhalation of smaller amounts of NG or of larger 
amounts in the presence of ample fresh air. The author also reported that 
similar but milder symptoms were produced by ingestion of very small 
quantities of NG or by skin contact with dynamite.
In 1898, Laws [22] described the effects of exposure to NG on the 
health of workers at a dynamite plant. Since NG was produced in an open 
system, workers were exposed by both inhalation and skin contact. Laws 
noted that the most striking and most frequent symptom was "powder 
headache," of which he said:
All suffered from it who had anything to do with NG in any way.
The head is generally sore; this has to be experienced to be 
appreciated. The workmen's wives, who do the laundry work, 
suffer severely every wash day. Not only the underclothing 
worn by the men, but any clothing, even the bed clothes will 
cause this feeling. In time they become inured, but all 
complain of the ironing. Inhaling the steam from the hot 
clothes makes them very sick [22].
Laws believed that NG affected the vasomotor centers, causing 
dilation of the left side of the heart and of the entire arterial system
[22]. Associated symptoms included flushing, increased pulse rate, 
palpitations, nausea and vomiting, weakness, prostration, and languor. One 
worker developed a rash similar to that caused by contact with poison ivy. 
Laws observed that, after a week of exposure, workers became "accustomed" 
to NG. Their headaches disappeared, but recurred when they returned to 
work after 2 or more days' absence. After the workers developed tolerance
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to NG and no longer experienced headaches and other acute symptoms during 
exposure, they often developed a condition that Laws termed "glonoinism." 
The signs and symptoms included a soft and weak pulse, heart murmurs and 
palpitations, poor appetite, mental sluggishness, and drowsiness during 
work.
Laws [22] reported that mixtures of alcohol and NG were "guaranteed 
to produce a more violent and serious form of intoxication than any other 
combination known to man." He mentioned that some had become addicted to 
"Gibbstown punch," the practice of drinking whiskey while rubbing NG into 
the skin.
The wives of NG dynamite workers often had similar symptoms, although 
in milder forms [22] . In addition, the wives often experienced heavy 
menstrual bleeding and had fewer children, often born prematurely. Infants 
were often cyanotic at birth, were considered to be weaker and less 
vigorous than others, and were thought to be especially susceptible to 
disease. Laws noted that infants could become sick when handled by their 
fathers and indicated that one child had died after being handled. Laws 
also mentioned that sportsmen who used smokeless powder containing NG 
experienced headaches similar to those experienced by dynamite workers.
In 1903, Jennings [23], a British military physician, noted that 
those who ate cordite, a type of dynamite containing 58% NG, and then drank 
beer would often hallucinate and display aberrant behavior. Jennings 
indicated that he experienced hammering and ringing sensations in the ears 
and a "most racking, splitting headache" that lasted 36 hours after he 
sucked on a small piece of cordite for only 2 minutes.
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In 1910, Laws [24] noted that NG workers were "sooner or later 
troubled with dyspnea and tachycardia on exertion," and that there was an 
increase in the "area of heart dullness" in workers employed for many 
years. In this report, Laws indicated that some have a "natural immunity" 
to the effects of NG but that others become "maniacal" when they have this 
headache. Since many dynamite workers had large families, despite the 
tendency of their wives to have fewer successful pregnancies than other 
women, Laws believed that NG was an aphrodisiac. An extensive description 
of the symptoms associated with workplace exposure to NG published by 
Ebright [25] in 1914 is described in Effects on Humans.
The toxic effects of NG and EGDN in animals were studied by Bradbury 
[26] in 1895. He reported that int;ragastric administration of NG or EGDN 
to rabbits caused a rapid decrease in blood pressure and pulse. Haldane et 
al [27] reported in 1897 that the signs associated with subcutaneous (sc) 
administration of NG in mice and rabbits were related to the amount of 
methemoglobin produced,
In 1931, Oltman and Crandall [28] administered NG intravenously (iv) 
to 23 rabbits as a 10% solution in alcohol diluted with physiologic saline 
in doses of 40-70 mg/kg in 5-15 seconds. The initial signs of toxicity 
were immediate respiratory stimulation and slowing of the heart rate. 
Convulsions appeared within 15-20 seconds after injection and were 
initially of the tonic type but later became clonic. Between convulsions, 
the heart rate increased and the respiratory rate decreased. All but two 
of the animals that died from respiratory depression did so within 20 
minutes after NG injection, and the authors stated that recovery was 
assured if an animal survived 5 hpurs. The authors noted that the signs
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that occurred before death were similar to those associated with sudden 
asphyxia, such as that produced by a lethal dose of hydrogen cyanide. They 
concluded that the lethal dose of NG administered iv was about 45 mg/kg in 
rabbits and suggested that a dose-dependent lethal effect was associated 
with asphyxia caused by a decrease in blood pressure or by the formation of 
methemoglobin. Oltman and Crandall were apparently the first to determine 
the lethal dose of NG in animals.
Effects on Humans
Many reports describing occupational exposure to NG and EGDN in 
workers in the explosives and pharmaceutical industries have confirmed the 
clinical effects first noted in the 19th century. Several authors have 
investigated the effects of exposure to these substances on the 
cardiovascular system. Effects that have been reported most frequently 
include, headache, dizziness, nausea, palpitation, angina pectoris, and 
sudden death without any apparent cause. In this document, angina 
pectoris, precordial pain, stenocardia, or posthiatal distress will be 
referred to as angina or as chest pain.
In 1914, Ebright [25] published an extensive description of the 
headaches and other symptoms associated with "acute" exposure to NG and 
reviewed his findings from examinations of about 20 men who manufactured NG 
dynamite. Ebright noted that the throbbing headaches usually began in the 
forehead and moved to the occipital region, where they remained for periods 
ranging from 1 hour to 4 days. Associated symptoms included depression, 
restlessness, and sleeplessness. In some cases, headaches were first 
associated with a sense of exhilaration. The affected workers often
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experienced nausea and vomiting, and, in severe instances, diarrhea. 
Exposures causing these headaches varied from handling large quantities of
I.G to shaking hands with those who had handled the compound. Headaches 
were more frequent and more severe in warm weather than in cool weather. 
The author noted that workers were very sysceptible to headaches when first 
exposed to NG, but that they did not complain of this effect after 3-4 days 
of exposure. Since tolerance to NG might be lost after a couple of days 
without exposure, workers often tried to maintain their tolerance by 
placing some material containing NG underneath their hatbands when they 
were away from work. Alcohol reportedly enhanced the symptoms associated 
with exposure to NG and sometimes precipitated severe headaches in workers 
who had been exposed to NG but had not developed any symptoms.
Ebright [25] examined about 20 dynamite workers to determine whether 
exposure to NG had effects on health other than the headaches and 
associated symptoms reported by the workers. Blood pressure was reported 
to have been within normal limits, and no abnormalities of the heart or 
radial artery were found. The men's complexions were normal, suggesting 
that there had not been appreciable methemoglobin formation, and no glucose 
was found in their urines. At the time of examination, one of the workers 
had a headache from exposure to NG, but no evidence of flushing of the skin 
or relaxation of the radial artery was found. The author concluded that 
examinations of these workers had not revealed any permanent ill effects 
from exposure to NG. The clinical picture of the specific type of headache 
caused by exposure to NG has not changed appreciably since Ebright's 
extensive description. In addition, Ebright [25] like Laws [23], 
considered NG to be an aphrodisiac.
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Since Ebright's work was published, many investigators have studied 
headaches in workers exposed to NG or to NG:EGDN mixtures, but little 
information is available which specifically relates the extent of exposure 
with the development of headaches. In 1966, Hanlon and Fredrick [29] 
briefly reviewed findings from the 1961 Annual Report of the Bureau of 
Industrial Hygiene, Detroit Department of Health, indicating that workers 
who made NG tablets developed headaches and "irritation." Concentrations 
of airborne NG in the breathing zones of the workers ranged from 0.28 to
1.02 mg/cu m. Tablets were manufactured 2-3 times a week rather than 
continuously and, according to the authors, the intermittence of exposure 
prevented the workers from developing tolerance to the vasodilatory effect 
of NG. Concentrations of NG in the urines of these workers were below 0.2 
mg/liter, the limit of sensitivity of the analytical method used. Hanlon 
and Fredrick indicated that the workers no longer complained of headaches 
after changes were made in operations that reduced the concentration of 
airborne NG to 0.09 mg/cu m. Supporting data were not provided, however. 
Bresler [30], Martimor et al [31], and Heimlich (written communication, 
September 1977) have also indicated that workers who make NG 
pharmaceuticals can develop headaches.
In 1946, Schwartz [32] conducted several studies on military 
personnel who handled dynamite sticks and who had experienced intense, 
throbbing headaches, vomiting, and occasional tremors of the arms about 3-4 
hours after starting work. He measured blood pressures, performed blood 
and urine studies, recorded ECG's, and observed the retinal vessels of 10 
workers who had developed headaches. Dilation of the retinal vessels was
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found in all 10 workers, but no other abnormalities except decreases in 
blood pressure were identified.
To determine whether exposure to NG dynamite caused these symptoms, a 
dime-sized patch of dynamite was applied to the left scapular area of 15 
men who had reported for morning sick call with unrelated complaints [32]. 
Another 15 men were patch-tested with "C2," a substance similar to 
trinitrotoluene, in an oily base. Schwartz wanted to control for the 
possible effects of psychogenic factors, and apparently the subjects were 
not informed of the identities of these substances. Fourteen of the 15 men 
treated with dynamite developed severe, throbbing headaches, a feeling of 
warmth in the face, and nausea within 3 hours of application. One subject 
reported seeing scintillating bodies in his right visual field. The 
symptoms increased in severity in some subjects during an unspecified 
period. None of the 15 subjects treated with C2 developed headaches within 
the same 3-hour period.
Schwartz [32] believed that headaches induced by NG were similar to 
those induced by histamine and that both were caused by dilatation of 
intracerebral rather than of extracerebral blood vessels. After testing 
many agents that cause vasoconstriction, he concluded that pretreatment 
with amphetamine sulfate or prostigmine bromide taken orally would minimize 
or prevent NG-induced headaches in workers who handled dynamite.
The headaches characteristic of exposure to such vasodilating agents 
as histamine and NG are thought to be produced by distention of the 
cerebral arteries [33] . The extracranial vessels recover more rapidly from 
the general vasodilatation than do the intracranial vessels, so that each 
systole distends the passive intracranial vessels, producing a severe,
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throbbing headache. The intensity of the headache diminishes as the 
vascular tone of the intracranial vessels is restored.
The development of these headaches appears to be the most 
characteristic symptom of initial exposure to NG or EGDN. Headaches have
also been reported in workers who make NG rocket propellants [34-36], who 
make or handle NG:EGDN dynamite [11,37-46], and who detonate NG:EGDN 
dynamite [47,48, and Bureau of Mines, written communication, November 
1977]. Decreases in systolic, diastolic, and pulse pressures are the 
initial signs of exposure to NG or EGDN.
In 1966, Trainor and Jones [49] reported a study conducted in 
Australia of the relationship of headache and changes in blood pressure 
with concentrations of NG:EGDN vapor from dynamite. The study was
initiated when workers complained of headaches. The magazines were
ventilated by draft vents in the roof and walls, and additional ventilation
could be supplied through the entrance door and three windows. Standard 
operating procedures provided that the buildings should be opened 1 hour 
before the workers entered, but this procedure usually was not followed. A 
preliminary evaluation indicated that concentrations of airborne NGrEGDN in 
six magazines ranged from 0.10 to 0.53 mg/cu m and averaged 0.36 mg/cu m as 
NG. The authors measured the blood pressures of eight men who worked in 
these magazines on a Thursday afternoon during work and on the following 
Monday before work. Seven of the eight men had headaches of varying 
severity when at work. Data were not presented, but the authors reported 
that there were no "significant" differences between the blood pressure 
measurements made on Thursday during work and those made on Monday before 
work. These findings suggest, however, that workers can develop headaches
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when exposed to NG:EGDN vapor at concentrations as low as 0.10 mg/cu m even 
in the absence of skin contact.
Using volunteers, Trainor and Jones [49] assessed the effects of 
exposure to airborne NG:EGDN dynamite on blood pressure and on symptoms 
such as headache or feelings of dullness in the head. Concentrations of 
airborne NG:EGDN in the magazine were measured on Monday morning after 
various quantities of dynamite had been placed on a table the previous 
Friday afternoon. The effects of exposure were assessed at three different 
concentrations of airborne nitroester: 2.0, 0.7, and 0.5 mg/cu m expressed
as NG. Blood pressure was measured before and after a 25-minute exposure, 
or after a shorter period if severe symptoms developed. Pulse pressure 
(systolic minus diastolic pressure) was calculated from the authors' data. 
Changes in the systolic, diastolic, and pulse pressures after exposure were 
determined for each subject, and the statistical significance of these 
changes for each exposure group was determined using a paired t-test. The 
results are shown in Table III-l.
Four volunteer workmen and the two authors were exposed to vapor from 
NG:EGDN dynamite at concentrations of 2.0 mg/cu m as NG (range not 
specified). The maximum allowable concentration in Australia in 1966 was 2 
mg/cu m [49]. Three of the six subjects developed headaches 1-3 minutes 
after entering the magazine. Systolic pressure decreased in five subjects 
and diastolic pressure decreased in four subjects. Blood pressure readings 




susceptible to the headaches associated with exposure to dynamite, although 
both his systolic and diastolic pressures decreased by 10 mmHg after 
exposure. Systolic and diastolic blood pressures were the same before and 
after exposure for one worker, although he developed a slight sensation of 
dullness in his head. The average decrease in blood pressure was 11.0 mmHg 
for systolic pressure, 6.5 mmHg for diastolic pressure, and 4.5 mmHg for 
pulse pressure.
Although it was not explicitly stated in the report, the experiments 
involving exposures at airborne concentrations of 0.5 and 0.7 mg/cu m as NG 
were apparently performed on Mondays, since air concentrations were 
achieved by leaving dynamite on a table in the magazine over the weekend 
[49]. By Monday morning, the volunteer workmen had probably lost most of 
the tolerance to NG:EGDN that they had acquired during the previous week. 
The responses of those not exposed to NG:EGDN in the workplace might be 
greater than the responses of dynamite workers. For instance, the blood 
pressure of one of the authors decreased from 150/90 to 120/70 within 3 
minutes of exposure to the dynamite mixture at 2.0 mg/cu m expressed as NG. 
The author's systolic pressure decreased by 30 mmHg, compared with the 
group average of 12.5 mmHg, and his diastolic pressure decreased by 20 
mmHg, compared with the group average of 1.4 mmHg.
Although such symptoms are difficult to evaluate objectively, the 
authors [49] concluded that the headaches were "marked," "slight,"' and 
"mild" at concentrations of 2.0, 0.7, and 0.5 mg/cu m expressed as NG,
respectively. The mean systolic, diastolic, and pulse pressures for each 
group decreased after exposure at the three concentrations, but the large 
standard deviations indicated that there was considerable variation in the
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response of individuals. Only the mean difference between pulse pressures 
measured before and after exposure appeared to be dose-related.
This study [49] showed that, in most workers, initial exposure to 
NGrEGDN vapor from dynamite is consistently associated with headache or 
similar symptoms and with decreases in systolic, diastolic, and pulse 
pressures. These signs and symptoms can be considered to be indicative of 
changes in blood flow associated with vasodilation. The study conclusively 
shows that exposure to NGrEGDN vapor at an average concentration of 0.5 
mg/cu m as NG, even in the absence of direct skin contact, is associated 
with the development of headache and decreases in blood pressure. From 
their preliminary study, inhalation of airborne NGrEGDN at concentrations 
as low as 0.1 mg/cu m as NG may have been associated with the development 
of headaches.
Decreases in systolic, diastolic, and pulse pressures during initial 
exposure are suggestive of vasodilation, and increases ill diastolic 
pressure from the levels during initial exposure are indicative of 
compensatory vasoconstriction. However, other factors, including activity 
level, use of stimulant beverages such as coffee or tea, and underlying 
diseases can affect measurments of blood pressure in workers exposed to NG 
or EGDN.
The monitoring of blood pressure in dynamite workers began in the US 
in 1937 [50], and scoring procedures similar to those developed by Foulger 
[51,52] have often been used. Workers were usually removed from exposure 
if their scores indicated that their blood pressures were not within normal 
limits, ie, if the extent of compensatory vasoconstriction during exposure
to NG or EGDN was not sufficient to maintain normal blood pressure. Some
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US dynamite manufacturers are currently measuring the blood pressures of 
workers exposed to NG:EGDN [13].
Although most of the monitoring data has not been published, a few 
authors [11,46,53,54] have reported blood pressure measurments in dynamite 
workers. Einert et al [11] measured the blood pressures before and after 
work and found that, during each workshift, systolic pressures decreased, 
diastolic pressures increased, and pulse pressures decreased in dynamite 
workers. However, Hasegawa et al [53] did not find any significant 
differences in the systolic, diastolic, or pulse pressures of 29 NG:EGDN 
dynamite workers compared with those of 8 controls. The results of these 
studies are discussed in further detail in Epidemiologic Studies.
In 1957, Forssman et al [54] reported findings from medical 
examinations of 276 workers (174 men and 102 women) employed at three 
dynamite plants in Sweden. At the first plant, EGDN was mixed with NG only 
during the winter months; the ratio of EGDN:NG was 1:1 at the other two 
plants throughout the year. Concentrations of airborne NG:EGDN from 
various operations were measured at all three plants. The samples were 
taken at face level as close to the work areas as possible, and the results 
were expressed in mg/cu m as NG. Using a colorimetric method, airborne
concentrations ranged from undetectable in the packing and the washing and 
drying operations at the first plant to 11 mg/cu m as NG in the 
"gelatinating" operation at the second plant. Average airborne
concentrations were 2.3 mg/cu m as NG at the first plant (10 operations),
3.7 mg/cu m at the second plant (7 operations), 3.4 mg/cu m at the third 
plant vi-t operation: . , and 3.1 mg/cu .r. L'or all three plants combined.
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Information on the potential for dermal absorption of NG:EGDN was not 
provided.
Blood pressure was measured for each of the 276 workers at the 
beginning of a workweek, after a holiday, and at the end of the week [54]. 
Twenty-four per cent of the men and 30% of the women were less than 30
years old, 54% of the men and 60% of the women were 30-49 years old, and
22% of the men and 10% of the women were 50 or more years old. Information
on duration of employment was not available for the third plant. At the
other two, the average length of employment was about 6 years for men and 
about 5 years for women.
The authors [54] reported average blood pressure readings in each of 
the three age groups at each of the three plants. Since airborne 
concentrations of NG jEGDN at the three plants were in the same range, the 
data for each age group at the three plants were averaged by NIOSH, 
weighted by the number of workers in each group, so that blood pressure 
measurements could be compared easily. At the beginning of the week,
average blood pressure measurements for the 174 men were 123 mmHg for 
systolic pressure, 75 mmHg for diastolic pressure, and 47 mmHg for pulse 
pressure. At the end of the week, average blood pressure measurements for 
these workers had increased to 129 mmHg for systolic pressure, 79 mmHg for 
diastolic pressure, and 51 mmHg for pulse pressure. For the 102 women, 
average blood pressure measurements at the beginning of the week were 145 
mmHg for systolic pressure, 77 mmHg for diastolic pressure, and 47 mmHg for 
pulse pressure. At the end of the week, average blood pressure 
measurements for these women were 132 mmHg for systolic pressure, 82 mmHg
for diastolic pressure, and 55 mmHg for pulse pressure.
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Forssman et al [54] stated that initial exposure to NG or to EGDN was 
associated with rapid decreases in both systolic and diastolic blood 
pressures. They also believed that long-term exposure to EGDN tended to 
raise diastolic pressure and reduce systolic pressure but that long-term 
exposure to NG had no known effects on blood pressure. References were not 
cited, however. During the week, average diastolic and pulse pressures 
increased in both men and women, but systolic pressure decreased by an 
average of 13 mmHg in women, whereas that in men increased by an average of 
6 mmHg. The increase in diastolic pressure in both men and women suggests, 
however, that there is some compensatory vasoconstriction during exposure 
to these compounds. Information was not provided on the circumstances 
during which the workers' blood pressures were measured, but if physical 
activity is required by the job, particularly for the men's jobs, the 
measurements taken after a week of work probably reflect a combination of 
the effect of exposure to NG:EGDN and compensatory vasoconstriction as well 
as differences in level of activity and other factors.
Forssman et al [54] reported that 31 of the 276 dynamite workers 
(11%) had "light" ECG changes which were associated with increased blood 
pressure, or "moderate" changes which were associated with organic heart 
disease, but they did not attribute these changes to exposure to NG:EGDN. 
The extent or degree of these changes was not specified. Pulse rates and 
respiratory rates were measured as indicators of physical capacity. 
Fifteen workers had readings indicative of "reduced capacity", but the 
authors reported that 14 of these 15 (93%) also had symptoms (not
specified) that could have contributed to reductions in physical capacity.
They also indicated that the absence records of workers exposed to NG:EGDN
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were generally similar to those of workers who were not exposed.
Forssman et al [54] concluded that permanent symptoms of impaired 
health that could be attributed to exposure to "nitrocompounds" were not
found in medical examinations of this group of dynamite workers. With the
exception of the blood pressure measurements, the authors reported their 
conclusions without citing supporting data.
A comparison of pulse pressure measurements in workers employed at an 
NG:EGDN dynamite plant in Tamaqua, Pennsylvania, was reported by Keogh et 
al [46] in 1977. The 46 workers, all volunteers, were divided by the 
authors into four exposure groups based on the jobs they performed when the 
study was conducted. The cleanup crew was in the heavy exposure group, 
mixing and packing workers were in the moderate exposure group, locomotive
operators and laundry workers were in the minimal exposure group, and
nitrocellulose and dope house workers were in the no exposure group. The 
pulse pressures of workers determined after work on Friday and before work 
on a Tuesday after a long weekend are shown in Table III-2 [46] .
All the workers had been engaged in strenuous physical activity 
before pulse pressures were determined on Friday, but they had been at rest 
before the determinations on Tuesday [46]. On Friday after work, average 
pulse pressures were lower in workers in the minimal, moderate, and heavy 
exposure groups than in those in the no exposure group. On the following 
Tuesday, after 3 days without exposure, average pulse pressures of the 
three exposed groups were somewhat higher than that of the unexposed group. 
In workers not exposed to NG:EGDN, the average pulse pressure was 6 mmHg 
higher (20%) on Friday after work than on Tuesday before work, suggesting 
that physical activity in the absence of exposure to NG:EGDN can cause an
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TABLE III-2
PULSE PRESSURES* IN NG:EGDN DYNAMITE WORKERS
Difference
Exposure Workers Pulse Pressure (mmHg) Friday-Tuesday
Av Friday after Tuesday before
No. Age Exposure Exposure
(Mean) (SD) (Mean) (SD)
Heavy 5 39 28 23 36 10 -8
Moderate 22 36 30 8 35 10 -5
Minimal 4 38 33 12 35 12 -2
None 2 36 39 10 33 14 +6
*Determined while workers were standing 
Adapted from Keogh et al [46]
increase in pulse pressure. In contrast, average pulse pressures were 
lower on Friday after work than on Tuesday before work in those with 
minimal, moderate, or heavy exposure to NG:EGDN. Measurements of pulse 
rates would have been useful in determining whether differences in pulse 
pressures were affected by differences in level of activity. A 
quantitative index of exposure was not available, but in the three exposure 
groups, decreases in average pulse pressures at the end of work on Friday 
below the presumably normal pulse pressures determined on Tuesday before 
work appear to be related to the estimated intensities of the exposures. 
These findings suggest that the vasodilating activity of NG:EGDN causes 
decreases in pulse pressures of exposed workers even during activity that
would normally be associated with increases in pulse pressure.
In another study, Keogh et al [46] attempted to identify an adequate 
biologic index of exposure to NG:EGDN. Blood pressure, pulse rate, pulse 
wave changes in the fingertips, heart chamber volume, and concentrations of 
NG and EGDN in the blood and on the skin surface were measured in volunteer 
workers after work on Friday and before work on Monday. The analysis of 
this information, however, is not yet complete.
Kubota [55], in 1975, reviewed findings from studies on workers
exposed to NGrEGDN at a dynamite plant in Japan. He indicated that the
amount of EGDN absorbed through bare hands was about twice the amount
absorbed through rubber gloves. The study design, however, was not
presented. Kubota noted that the surface of "sticky" dynamite contained a
surface activating agent that accelerated EGDN absorption through the skin,
but the agent was not identified. The author listed the methods that he
considered to be useful for the early detection of EGDN poisoning, based on
a study during 1963 of workers at a Japanese dynamite plant. Postural
hypotension, a decrease in blood pressure of more than 10 mmHg upon
standing, was found in about 15% (12 of 81) of the workers exposed to
NG:EGDN and in about 4% (2 of 50) of the unexposed workers. Of the 22
former dynamite workers with a history of "EGDN poisoning," 32% (7) also
had postural hypotension. Kubota also indicated that another useful
indicator of early intoxication by NGrEGDN was found in the concentrations
of fatty acids in the workers' sera: decreases in those of free fatty
acids and of linoleic acid and an increase in that of oleic acid. Liver
function disorders were apparently more common in workers with a history of
EGDN poisoning but, again, details were not reported. Kubota's findings
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suggest that the effects of exposure to NG:EGDN dynamite are not completely 
reversed when exposure is terminated.
Laws [24] noted in 1910 that some dynamite workers employed for many 
years developed an enlarged "area of heart dullness." The first reports of 
what have become known as "Monday morning angina or sudden death" were 
published in the 1950's [37,56]. In 1952, Symanski [56] described three
cases of sudden death without any apparent cause in men who made or filled
cartridges with NG:EGDN dynamite in the Saar (West Germany). One worker 
was 42 and the other two were 50 years old at the time of death. All died 
suddenly on Monday or Tuesday morning. Distension of the cerebral blood 
vessels was the only autopsy finding in the two cases examined shortly 
after death. In the third case, no evidence of heart disease, cerebral 
hemorrhage, or hypertensive disease was found in an autopsy performed 1
year later on the exhumed body. Symanski [56] concluded that the deaths 
were associated primarily with exposure to EGDN although he suggested that 
alcohol ingestion or physical exertion over the weekend may have been 
contributing factors.
Symanski [56] learned through personal communication that 6-8 
dynamite workers from Scotland and 1 from West Germany had died suddenly 
and that 37 sudden deaths had occurred in dynamite workers in the United 
States between 1927 and 1936. Apparently these deaths were more frequent 
in the United States in 1935-1936 than in earlier years [56] . The workers 
who died had presumably developed tolerance to NG:EGDN, since they had not 
complained of headaches. The deaths seemed to occur shortly after slight 
physical exertion, and some of the workers had complained of weakness
shortly before death. All 37 dynamite workers in the United States
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apparently died suddenly from heart attacks, most of which occurred during 
summers. Symanski [56] did not learn of any sudden deaths in US dynamite 
workers that occurred after it had become the practice to circulate fresh 
air in the breathing zone of workers in the homogenizing and cartridge- 
filling areas. According to a personal communication from Naoum cited by 
Symanski [56] , this procedure apparently helped to keep the concentration 
of NG:EGDN in the mixing and cartridge-filling areas below 2 mg/cu m, as 
measured by a colorimetric method using sulfuric acid.
Symanski's report [56] was the first to mention that sudden deaths 
had occurred in dynamite workers in the United States, yet further details 
on the circumstances of these deaths have apparently not been published. 
In an oral deposition taken in 1975 [50], Foulger said that Symanski's
report of 37 sudden deaths in US dynamite workers was only a rumor,
although he indicated that an unspecified number of sudden deaths in this 
group had occurred when they were away from work.
In 1954, Barsotti [37] described symptoms of angina in 14 workers who
manufactured NGrEGDN dynamite in Italy. Medical histories and interviews 
with workers were used to identify workers with symptoms and to 
characterize these symptoms. Seven of the 14 workers had frequent and 
severe attacks of angina, and the other 7 had had mild and occasional 
attacks. These symptoms were more severe in the summer than in the winter 
months. In most instances, the workers suddenly developed angina on Sunday 
night or Monday morning, about 48-60 hours after their last workplace 
exposure to the dynamite mixture. The pain usually began in the chest and 
spread to the left side of the neck. Associated palpitations and 
difficulty in breathing were sometimes so severe that the workers were
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immobilized. The attacks usually lasted for several minutes; shorter, less 
severe episodes often continued to occur for several hours and for up to 3- 
4 days in severe cases. The workers experienced relief from mild attacks 
immediately after they returned to the same workplace. Angina attacks were 
equally prevalent in men and women and were reported only in workers over 
40 years old.
Barsotti [37] noted that other symptoms, including severe headache, 
weakness, loss of appetite, hot flashes, palpitations, and intolerance to 
alcohol, occurred more frequently and were more severe when dynamite 
workers were exposed during production of dynamite containing NG and EGDN 
than when they were exposed to dynamite containing NG alone. Medical 
examinations indicated that bradycardia and hypotension also were more 
frequent and severe when workers were exposed to the NG:EGDN mixture. 
There was no evidence of production of methemoglobin or Heinz bodies, and 
no ECG changes were found regardless of the time of examination.
The types of work engaged in by some of the workers who developed 
angina were described. Two worked in the nitration operation, one in 
solidification, two in forming, and two in cartridging [37]. Barsotti 
indicated that the ventilation in work areas was being increased in an 
attempt to keep the concentration of airborne NG:EGDN below 2 mg/cu m and 
that the plants were eliminating EGDN from the dynamite mixture during the 
summer months. Environmental concentrations of NG:EGDN were not given. 
The author reported that the frequency and severity of angina attacks and 
other symptoms in workers progressively declined and then nearly 
disappeared after ventilation was increased and the use of EGDN was
restricted to the cooler months, but supporting data were not provided.
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Barsotti [37] believed that exposure to EGDN aggravated the symptoms, 
such as headache, associated with exposure to NG, and that angina and 
similar symptoms were associated with exposure to and withdrawal from EGDN 
alone. He based these inferences on the observation that angina was first 
reported in dynamite workers after the practice of adding EGDN to the 
mixture began in the 1930's. Barsotti suggested that angina was a symptom 
of deficiency in blood flow caused by reflex vasospasms in the heart 
mediated by the CNS during a period when the worker was not exposed to the 
vasodilating effect of EGDN.
In 1963, Bille and Sivertssen [57] reported the circumstances of the 
death of a 34-year-old man who had been employed for 6 years in a Norwegian 
dynamite plant, where his most recent duty had been to mix NG and EGDN by 
hand with other substances, such as nitrocellulose. A mixture of 40% NG 
and 60% EGDN was used in the winter, and the reverse mixture was used in 
the summer. The authors reported that air samples taken during recent 
years revealed concentrations of airborne explosives, expressed as NG, of 
0.3-1.4 mg/cu m in the winter and 1.4-3.8 mg/cu m in the summer. The 
authors noted that these concentrations were well below the MAC in Norway 
at that time (4.7 mg/cu m). The extent of skin exposure was not 
determined.
The worker, a very heavy smoker, complained of chest pains for 3 
weeks in January 1959, but no other signs or symptoms were detected in a 
medical examination [57]. Later in the same year, during a 60-hour 
vacation period, he went outside after smoking a few cigarettes and eating 
breakfast, but returned immediately because he was feeling ill. He
developed chest pains and died within 10 minutes of returning to the house.
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An autopsy revealed enlarged lungs with the alveoli containing bloody 
edema fluid [57]. The heart was flabby, blood vessels were dilated, and 
the coronary arteries were atherosclerotic to varying degrees. The 
worker's death was considered to have been job-related, although heavy 
smoking was regarded as a contributory factor. This is one of the few
reports describing sudden deaths in workers exposed to NG or EGDN in which
information on airborne concentrations of these compounds is included.
In 1963, Carmichael and Lieben [58] investigated six deaths at one 
dynamite plant, four at a second plant, and three at a third plant. These
deaths occurred between 1956 and 1961 in a group of some 125 workers
employed in NG:EGDN dynamite mixing or cartridge-filling operations at 
plants in Pennsylvania. The authors summarized the available occupational, 
clinical, and autopsy information on these cases and compared the estimated 
death rates in dynamite workers with expected values for all coronary 
artery diseases combined and for sudden unexpected death. They also 
discussed several theories of the toxicity of EGDN and NG.
From 1957 through 1960, 6 deaths occurred among 75 workers employed 
in the nitrating, mixing, and packing and shoveling operations at one 
plant. Four of the six workers died suddenly, one a few hours after the 
initial heart attack and one 8 days after an attack. In all cases, 
coronary artery disease was considered the cause of death. All but one of 
the workers in the plant were under 55, and the six workers who died were 
between 32 and 50 years old. The authors estimated that the expected 
number of deaths from coronary artery disease (ICD No. 420.1, including 
coronary artery disease, sclerosis, and myocardial infarction) for the 75
dynamite workers was 0.084/year, based on Pennsylvania statistics for 1957-
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60, and 0.1/year, based on statistics for the county in which the plant was 
located. Thus, the risk of death from coronary artery disease among the 75 
dynamite workers was 15-18 times greater than expected in the 4-year 
period.
Carmichael and Lieben [58] also compared the risk of sudden death 
from heart disease in these workers with estimates available for men aged 
30-62 from the Framingham (Massachusetts) Heart Study [59] . The incidence 
of sudden death in Framingham men was 10.5/1,000 for a 6-year period. At 
one of the dynamite plants in Pennsylvania, 5 of 65 men aged 30-62 died 
suddenly within 4 years. Compared with the Framingham men, these dynamite 
workers were about 11 times as likely to die suddenly from heart disease. 
Carmichael and Lieben acknowledged that these estimates were crude but 
thought that the estimates did give some indication of the extent of the 
increase in deaths from heart disease in dynamite workers at one plant in 
Pennsylvania.
Complete information was not available for any of the six workers 
from the first plant who died suddenly [58] . Autopsy information was given
for five workers, and some information about work histories and clinical
findings was given for all six workers. Five of the six who died suddenly 
had packed dynamite into cartridges by hand for periods ranging from 3 to 
more than 13 years. The five died on a Saturday morning, a Sunday evening,
a Monday morning, or a morning after a holiday. Three of the five had not
complained of chest pain, one had complained for 10 years, and one had had 
chest pains shortly before his death. Blood pressure measurements were 
variable, but they generally showed decreased systolic and diastolic 
pressures and increased pulse rates after workshifts. ECG recordings were
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described for four of the five handpackers. The recordings were considered 
to be normal for three of the workers; an inverted T wave (V3 and V4 leads) 
was noted in the recording of the fourth worker, in whom a healed infarct
was found at the autopsy. Autopsies of four of the five handpackers showed
that all organs except the heart were normal. Sclerosis of the coronary 
arteries was moderate to severe, and the vessels were often thickened with 
hyaline or connective tissue. A thrombus was found in the coronary artery 
of one worker, and an atherosclerotic plaque that almost completely
occluded a coronary artery was found in another worker, but no anatomic
anomalies or accumulation of lipids that could cause sudden death were 
found in the other two workers.
The sixth death reported from the first dynamite plant was that of a 
man in his mid-40's who had been employed in the mix house and who was 
admitted to the hospital on Sunday evening with severe epigastric pain 
[58]. Acute myocardial infarction was diagnosed and he died 8 days later. 
Moderately severe coronary arteriosclerosis, a thrombus of the right 
coronary artery, and an arteriosclerotic occlusion of the left coronary 
artery were found at autopsy. The man reportedly drank large amounts of 
alcohol.
In a small plant in Pennsylvania employing fewer than 25 people, 4 
men who had worked as dynamite packers for 1 year or more died suddenly 
during a period of 5 years [58]. The authors stated that the 
concentrations of airborne "nitrates" in the areas where cartridges were 
filled by hand were elevated, but the concentrations were not given. 
Review of the plant personnel records indicated that many workers had left
the plant after less than 2 months' employment, apparently because they had
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developed severe headaches. The four workers who died suddenly at this 
plant were 34-43 years old. Three of these had experienced chest pain 
before death. One of the workers had worked as a dynamite cartridge-filler 
for 3 years and had passed a comprehensive physical examination 2 weeks 
before his death at age 37. The cause of death was diagnosed as acute 
myocardial infarction secondary to coronary occlusion. The walls of the 
coronary arteries were thickened, and arteriosclerotic plaques almost 
completely occluded the lumen in some areas. A previous infarction was 
indicated by the extensive replacement of myocardial tissue with fibrous 
tissue.
The authors [58] were able to provide even less complete information 
on workers from the third plant, where four workers had died suddenly on 
Monday mornings over a 12-year period. At autopsy, a worker who died at 
the age of 32 was found to have had severe sclerosis of the coronary 
arteries. The authors reviewed the medical records from one of the plants 
(unspecified) and found that many workers had complained of indigestion, 
chest pain, and shortness of breath, although indications of cardiac 
ischemia had rarely been found in their ECG's. Blood pressure 
measurements, apparently made at regular intervals, indicated that there 
was no consistent rise in diastolic pressure, although pulse pressure 
measurements had decreased considerably from preemployment measurements in 
many exposed workers.
Information given by Carmichael and Lieben [58] indicated that there 
were many similarities between the cases of sudden death in workers at 
these three dynamite plants. All the workers died suddenly at a relatively 
early age during a period of up to 48 hours when they were not exposed to
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NG or EGDN in the workplace. In most of the autopsies, the walls of the 
coronary arteries were found to be thickened with fibrous and hyalinized 
connective tissue, and the lumina were restricted with moderate to severe 
arteriosclerosis. However, the arteriosclerosis appeared to be limited to 
the coronary vessels. The cause of death appeared to be acute myocardial 
infarction, but in only a few cases was there evidence that an occlusion 
had occurred shortly before death. About half the workers had experienced 
angina or similar symptoms before death, but at least two of them had not 
reported having any pain.
The authors [58] were unable to determine the toxic mechanism that
caused sudden deaths in dynamite workers, but they suggested two theories. 
One possibility was that the deaths were associated with a spasm in a 
coronary artery that occurred when the worker was not exposed to the
vasodilatory effects of the dynamite mixture. The other was that death was 
related to peripheral vasodilatation consequent to reexposure to
nitroesters after withdrawal from repeated exposures on workdays. The
expansion of the peripheral circulatory bed in conjunction with sclerosis 
of the coronary arteries would require the heart, through barostatic 
reflexes, to pump extra blood, a requirement it could not meet because of
deficient venous return and insufficient supply of oxygen to its own
muscles. If the subsequent peripheral hypoxemia resulted in release of 
catecholamines from the adrenals and chromaffin tissue, these 
sympathomimetic amines would tend to further increase demands on the heart 
without increasing either the venous return or the intramural supply of
oxygen. Carmichael and Lieben indicated that they favored the second
theory, since they had found little pathologic evidence of coronary
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vasospasm in the autopsied workers. It is unlikely, however, that a spasm 
of a coronary artery would result in findings that could be identified in 
an autopsy. It is possible that both mechanisms were associated with these 
sudden deaths.
According to Carmichael and Lieben [58], Hueper [60,61] had suggested 
that the nutrient arterioles in the heart might have been damaged by 
repeated dilation and constriction, promoting the deposition of hyaline 
connective tissue. This tissue could then have resulted in sclerosis that 
could not be distinguished at autopsy from arteriosclerosis associated with 
other factors. However, these data do not indicate whether 
arteriosclerosis was more or less severe in the hearts of the dynamite 
workers than in those of others, since the coronary arteries from these 
autopsies were not compared with those from autopsies of unexposed men of 
similar age.
In conversations with medical personnel from other US explosives 
manufacturers, Carmichael and Lieben [58] learned that sudden deaths had 
occurred in US dynamite workers some 20-25 years previously, but that they 
could not be directly attributed to exposure to either NG or EGDN. 
Apparently on the basis of these conversations, the authors indicated that 
there had been a nearly tenfold increase in sudden deaths in workers since 
EGDN had been introduced into the dynamite manufacturing process. 
Therefore, they implicated EGDN as the agent responsible for angina and for 
sudden deaths in dynamite workers. Carmichael and Lieben were the first to 
describe cases of sudden death in workers employed in the manufacture of 
NG:EGDN dynamite in the United States.
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Yamagawa [62] reported in 1965 that eight workers aged 35-51 who had 
been employed at a NG:EGDN dynamite plant in Japan for 12-26 years had died 
suddenly without any apparent cause. Six of the eight died on Sunday or 
Monday. An unspecified number of workers had angina and numbness in the 
fingers. Both symptoms disappeared when the workers changed jobs, 
suggesting that at least some effects of exposure to NG:EGDN are 
reversible.
Lund et al [63], in 1968, described nine cases of toxic effects in 
workers after they were withdrawn from exposure to NG. The exposures 
occurred at an explosives factory in Sweden during 8 years when workers 
were handling NG directly. Although the workers wore protective clothing 
and gloves, the authors indicated that some NG might have been absorbed 
through the skin.
A 35-year-old worker who died had been exposed to NG for 9 years 
[63] . He had consulted a physician about 5 months before his death about 
severe attacks of chest pain. These attacks occurred on Sundays, during 
either the evening or the night, but disappeared shortly after he returned 
to work on Monday. Physical examination and an ECG recording at that time 
revealed no abnormalities. At a routine physical examination 1 month 
later, the patient indicated that the chest pains had not returned. He 
died 4 months later on a day after a national holiday. Myocardial 
infarction was the clinical diagnosis of the cause of death, but an autopsy 
did not reveal any signs of atherosclerosis in the coronary arteries or any 
other pathologic condition except lung congestion. It was learned later 
that the worker nad experienced chest pains before his death.
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Eight cases of nonfatal symptoms associated with withdrawal from 
exposure to NG were described in this report [63]. Seven of the subjects 
were men aged 38-55 who had worked with NG for 2-27 years; one of these men 
had also been exposed to EGDN, but only for 24 hours. The eighth subject 
was a 45-year-old woman who had worked with NG for 11 years. In most of 
these cases, the workers suffered from headaches and chest pains that 
developed 30-65 hours after their last contact with NG, in several cases 
when the employees returned to work on Monday. Physical examination of 
these workers did not reveal any pathologic conditions, and ECG recordings 
contained no abnormalities. None of the workers reported having continued 
chest pains after they were no longer exposed to NG in the workplace.
Lund et al [63] concluded that withdrawal from exposure to NG was the 
cause of the chest pains in all these workers, since they could find no 
other reason for their occurrence. This was the first report to indicate 
that workers exposed to NG alone as well as to NGrEGDN mixtures could 
experience angina or die suddenly without any apparent cause. The authors 
suggested that the symptoms associated with withdrawal from NG were 
qualitatively similar to those associated with withdrawal from EGDN. They 
also suggested that angina would probably occur less frequently in dynamite 
workers exposed to NG alone than in those exposed to NG:EGDN mixtures, 
since they believed that both the vapor pressure and the toxicity of NG 
were lower than those of EGDN.
In 1977, the US Army Environmental Hygiene Agency (AEHA) provided 
NIOSH with information on work practices, engineering controls, and 
environmental concentrations of NG at 11 installations [35]. This 
information, apparently collated from industrial hygiene surveys conducted
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by the AEHA, is reviewed in Chapter IV. The AEHA also provided some 
information on the health of workers at two of the installations.
At "Installation H," about 120 workers engaged in the manufacture of 
double-base rocket propellant were exposed to airborne NG at concentrations 
ranging from 1.3-2.0 mg/cu m for 4-8 hours a day [35]. Workers were 
provided with neoprene gloves or cloth gloves with leather palms. The 
report indicated that workers complained of occasional headaches, but no 
further details were provided.
The 1977 AEHA report [35] included a summary of an industrial hygiene 
survey and a review of medical records conducted in 1971 at a plant listed 
as "Installation K." A 1971 report from the AEHA [36] indicated that 
Installation K was the Badger Army Ammunition Plant in Baraboo, Wisconsin. 
Double-base rocket and small arms propellants containing NG were 
manufactured at this plant, which had operated during World War II and the 
Korean War and had been reopened in 1966 to make ammunition for the Vietnam 
War. The plant is no longer in operation.
There was concern, beginning in 1968, that exposure to NG might be 
affecting the health of some workers. The AEHA was asked to perform this 
study after the appearance of magazine and newspaper reports of chest pain 
in workers exposed to NG. A total of 8,836 workers were employed at the 
Badger plant at the time of the AEHA survey in 1971 [36]. Of these, 266 
workers (136 men and 130 women) were employed in areas where there was a 
potential for exposure to NG.
The AEHA first reviewed the medical records of 40 workers from this 
plant alleged to have had illnesses or diseases associated with exposure to
NG between January 1968 and August 1971 [36]. The AEHA decided that there
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was no potential for exposure to NG in the jobs of 7 of the 40 workers. A 
table in the report indicates that three of these seven people worked in 
the smokeless powder or the nitrocellulose (nitrocotton) areas where there 
probably was little or no exposure to NG, but the other four operated 
transport carts or were supervisors in areas where NG was present.
The AEHA found that 5 of the 40 workers (13%) alleged to have had 
conditions related to exposure to NG had not reported having heart problems 
or other illnesses to the plant medical department [36]. Four workers had 
reported rashes and four others, all employed in the roll and press area, 
had reported headaches but no other symptoms. The AEHA concluded that 12 
of the 40 (30%) had "heart conditions," based on ECG evidence of myocardial 
infarction or coronary occlusion, or on complaints of angina, burning in
the chest, or chest pain. Eight of the 40 workers (20%) were considered to
have had "chest pains", which were described as coronary spasms, gas pains, 
or dull pains in the chest. The criteria used to distinguish "chest pains" 
from "heart conditions" were not discussed.
Seven of the 40 workers (18%) employed at the plant had died between 
January 1968 and August 1971 [36]. In 1968, a 49-year-old man who had 
worked in the paste area died on a Tuesday, and a 40-year-old woman who had 
worked in the roll and press area died on a Monday. The cause of death was 
not listed in the plant medical records of either worker. The AEHA 
classified both of these deaths as "sudden." A 60-year-old man who worked 
in the roll and press area died on a Thursday and a man (age not specified) 
who was a supervisor in the rocket area died on a Monday. No cause of
death was listed for either worker, but both of them were considered to
have had heart conditions when they were first employed at the plant. The
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AEHA had stated that there was no potential for chronic exposure to NG for 
supervisors in the rocket area, although it had indicated that supervisors 
in rocket manufacturing areas would occasionally handle propellant paste or 
chips with their bare hands.
The fifth worker, a 50-year-old man who was also a supervisor in the 
rocket area, died on a Thursday. Again, no cause of death was listed, but 
he was considered to have had a "heart condition," since "minimal" ECG 
changes had been found previously in a periodic examination. The sixth 
worker, a 53-year-old woman employed in the roll and press area, died on a 
Thursday in 1969. No cause of death was given, although she had been 
referred to a private physician on the morning of her death. The AEHA 
indicated that she also had a previous heart condition, since she had 
complained of "shortness of breath" and "burning in the chest." The 
seventh worker, a 40-year-old woman employed in the finishing area, died in 
1968. The death was attributed to a cause other than cardiovascular 
disease (not specified). The AEHA concluded that only two of the seven 
deaths that occurred in workers employed at the Badger plant should be 
classified as "sudden," but their criteria may have been too stringent.
Concentrations of airborne NG in the Badger plant were measured in 
August 1971 [36]. The rocket propellant manufactured at that time
contained 50% nitrocellulose, 35% NG, 10% diethylphthalate, 2% 2-
nitrodiphenylamine, 1.5% lead 2-ethyl hexanoate, 1.3% lead salicylate, and 
a trace of candelilla wax. The small-arms propellant contained 84% 
nitrocellulose, 10% NG, and 6% other compounds. A total of 118 samples 
were taken: 84 breathing-zone samples and 34 area samples. Concentrations
of NG were measured by a colorimetric method described by Yagoda and
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Goldman [64] . The average and highest concentrations of airborne NG were 
0.5 and 1.7 mg/cu m in the NG manufacturing area (8 breathing-zone samples, 
no area samples), 2.7 and 12.5 mg/cu m in the rocket paste manufacturing 
area (30 breathing-zone samples, 2 area samples), 1.7 and 9.2 mg/cu m in 
the rocket roll and press area (31 breathing-zone samples, 26 area 
samples), and 1.6 and 7.1 mg/cu m in the rocket finish area (14 breathing- 
zone samples, 7 area samples). The lowest concentrations of NG measured in 
all four areas were said to have been below the unspecified limit of 
sensitivity of the analytical method used. These findings suggest that the 
average concentrations of airborne NG were lowest in the NG manufacturing 
area (0.5 mg/cu m), higher in the rocket roll and press and the rocket 
finish areas (1.6-1.7 mg/cu m), and highest in the rocket paste 
manufacturing area (2.7 mg/cu m).
The AEHA interviewed 83 of the 266 workers (31%) employed in these 
four areas at the Badger plant in August 1971 [36]. In addition, the plant 
medical records of these 83 workers from September 1966 to August 1971 were 
reviewed. Details of the methods used to select workers, conduct 
interviews, and analyze results were not provided. The results of the 
survey are shown in Table III-3.
In general, headaches, chest pain, and ECG changes appeared to be 
more prevalent in workers employed in the rocket paste, roll and press, and 
finishing areas than in those employed in the NG manufacturing area. 
Headaches were reported most frequently on hot, humid days, particularly 
late in the afternoon [36] . A few workers reported having headaches after 
a weekend away from work, but most of those who reported headaches
complained when they returned to work after an absence of a week or more.
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TABLE III-3
SIGNS AND SYMPTOMS IN WORKERS WHO MADE 
ROCKET PROPELLANT CONTAINING NG*
Rocket Paste
NG Manufacturing,
Manufacturing Roll and Press,
Area and Finishing
Men Women Men Women
No. % No. % No. % No. %
Signs and Symptoms
Headaches 3 27 - 8 22 12 33
Chest Pain 1 9 - 0 - 5 14
ECG Changes 0 - - 5 14 5 14
Hypertension** 0 - - 3 8 7 19
Rash 0 - - 7 19 4 11
Number of Workers 11 - 36 36
Average Concentra­








♦Information from interviews in August 1971 and from 
medical records (September 1966-August 1971) of work­
ers at Badger plant in Baraboo, Wisconsin 
**Hypertension diagnosed if systolic pressure was greater 
than 160 mmHg, diastolic pressure was greater than 90 
mmHg, or both. (Three had a history of hypertension, four had 
hypertension on examination.)
Adapted from a report of the Army Environmental 
Hygiene Agency [36]
Based on three to five blood pressure readings, the AEHA concluded that 
there were no consistent changes in blood pressure or pulse rate, although
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the data were not included in the report. The AEHA concluded that 
"withdrawal from chronic NG exposure could precipitate chest pain and in 
some instances sudden death." The report stated that the findings from 
this study were not sufficient to show, however, that workplace exposure to 
NG can cause, or contribute to, the development of coronary artery disease.
The AEHA survey of the health of workers exposed to NG at the Badger
plant [36] is difficult to evaluate, since the criteria used to select
workers, classify signs and symptoms, and analyze the findings were not 
explicitly stated. However, this study and that in 1968 by Lund et al [63] 
suggest that there is an association between chest pain or sudden death and
withdrawal from workplace exposure to NG in the absence of EGDN. The plant
medical records of seven deceased workers were reviewed, but the AEHA 
considered that only two of these were cases of "sudden death." One of 
these two workers who died suddenly was employed in the rocket paste area, 
where the average concentration of airborne NG was 2.7 mg/cu m and the 
highest was 12.5 mg/cu m. The other worked in the rocket roll and paste 
area, where the average concentration of airborne NG was 1.7 mg/cu m and 
the highest was 7.1 mg/cu m. Both people died during the early part of the 
week, one on Monday and the other on Tuesday. Only one of the other five 
deaths occurred during these 2 days. The AEHA study found that sudden 
deaths have occurred after reexposure following a weekend of no exposure in 
workers exposed to NG in the range of the current Federal standard of 2 
mg/cu m.
In 1972, Lange et al [34] reported on 9 cases of nonatheromatous 
heart disease in a group of about 200 workers exposed to NG at a munitions
plant in Wisconsin. This was probably the Badger Army Ammunitions Plant in
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Baraboo. Rocket propellant containing nitrocellulose and 37% NG was 
produced at the plant. The authors estimated that about 200 workers, about 
160 female process workers and 40 male supervisory or maintenance workers, 
were subject to exposure to NG between 1967 and 1971. Rubber gloves and 
protective aprons were provided, but apparently there were instances in 
which NG contacted the skin directly. Although the work areas were
ventilated, many workers developed headaches, weakness, dizziness, and 
nausea soon after beginning the workshift. Lange et al indicated that a 
"significant" fraction of those hired quit working at the plant during the 
first few weeks, but that those who continued to work developed tolerance 
to NG and took measures to maintain this tolerance.
Lange et al [34] described cases of heart disease in eight women and 
one man between 35 and 54 years of age who had been employed at the plant 
for 11-48 months. All had experienced angina during the weekend or on
Monday morning and two had died suddenly. A 40-year-old woman who had 
worked with the NGrnitrocellulose mixture for 11 months died early on a 
Monday morning about 62 hours after her last workplace exposure. A routine 
ECG, taken 5 days before her death, was normal. Death was preceded by
angina, shortness of breath, pallor, excessive perspiration, hypotension, 
and bradycardia. A clinical diagnosis of coronary occlusion with 
myocardial infarction was made, but an autopsy was not performed.
The second case was that of a 54-year-old man who died suddenly in 
November 1971 [34] . He had been employed at the munitions plant for 4 
years but had not returned to work after having an acute myocardial
infarction 6 months before his death. About 1.5 years earlier, arterial 
hypertension and a pattern of incomplete left bundle branch block had been
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noted, although they had not been found at the time of first employment. 
The worker experienced diffuse chest pain on a Sunday evening about 6 
months before his death. An ECG taken the following Tuesday showed 
evidence of an acute myocardial infarction in the anterior wall with a left 
bundle branch block. After recovery, the worker remained asymptomatic but 
did not return to work. Coronary angiography and cardiac catheterization 1 
month before his death indicated that the coronary arteries were normal and 
that the left ventricle was normal in size and shape. However, ventricular 
function was altered and left ventricular end-diastolic pressure was 
elevated (15 mmHg). He died suddenly while unloading a small boat from a 
trailer. An autopsy was not performed.
A 52-year-old woman who had been employed at the munitions plant for 
28 months began to experience angina on Monday mornings that was relieved 
by returning to work [34] . An ECG taken after one of these episodes 
indicated that she had had an acute myocardial infarction in the anterior 
wall. She was unable to tolerate mild physical activity for about a year 
and subsequently experienced severe exercise intolerance and recurrent 
episodes of cardiac irregularity. Coronary angiography and cardiac 
catheterization showed that the coronary arteries were normal except for a 
slight irregularity in the midportion of the right artery, ventricular 
function in response to exercise was abnormal, left ventricular end- 
diastolic pressure was increased, and there was intermittent atrial 
fibrillation. She was unable to return to work.
A 51-year-old woman employed at the munitions plant for 4 years was 
evaluated clinically for ischemic heart disease [34]. After working for 
about 8 months, she began to have nonexertional chest pain on weekends or
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on Monday mornings that was relieved by returning to work. At first, chest 
pains occurred after she had been away from work for extended periods, eg, 
5 days, rather than after a weekend. After episodes of severe chest pain 
on a Sunday and Monday, clinical examination indicated that she had 
recently had a myocardial infarction in the anterior wall. She had no 
symptoms during a 3-month convalescent period, but the chest pains recurred 
on weekends after she had returned to work. For about 2.5 years, she took 
one to three tablets of NG sublingually on weekends to relieve the chest 
pains. A physical examination conducted on a day during which she had 
worked disclosed no abnormalities, but she experienced chest pain in the 
hospital 48 and 60 hours after leaving work. Coronary angiography 
conducted while she had chest pain showed severe spasms of the coronary 
arteries. The area of the arteriospasm was diffuse, irregular, and 
relatively small, but there was significant obstruction. The chest pain 
was relieved by NG taken sublingually. Within 4-6 minutes after the 
patient took NG, the walls of the coronary arteries became smooth and free 
of irregularities and the lumens had increased in diameter. The resting 
cardiac output was normal, but the left ventricle was moderately dilated, 
the left ventricular ejection fraction was slightly reduced, and the left 
ventricular end-diastolic pressure was elevated (18 mmHg). The patient was 
discharged and returned to work 2 days later. Clinical examination was 
apparently normal on the following weekend after about 20 hours of 
workplace exposure to NG during a 3-day period. On Friday evening after 
work, reduced digital pulsations that became normal after administration of 
NG were found by plethysmography. This case is important because it was 
the first to provide evidence that the chest pain associated with
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intermittent withdrawal from exposure to NG in dynamite workers may be 
related to spasms of the coronary arteries.
Lange et al [34] also described the cases of five other women exposed 
to NG who experienced nonexertional chest pain on weekends or on Monday 
mornings. Three of them had ECG evidence of an ischemic episode or a 
myocardial infarction after an episode of severe chest pain. Most workers 
no longer experienced chest pain after they terminated employment, although 
residual effects, including exercise intolerance, impaired left ventricular 
function, intraventricular conduction defects, and atrial fibrillation, 
often remained.
The report by Lange et al [34] indicated that at least 9 of 
approximately 200 workers (5%) exposed to NG at a munitions plant in 
Wisconsin that operated for 5 years developed nonexertional chest pain that 
occurred on weekends or on Monday mornings. Epidemiologic data are not 
available for comparison, but the finding of chest pain indicative of 
ischemic heart disease in relatively young women without significant 
arteriosclerosis is quite striking. Barsotti [37] believed that angina and 
sudden death in dynamite workers were associated with exposure to EGDN but 
not to NG. However, reports by Lund et al [63], by the AEHA [36], and by 
Lange et al [34] have shown that these effects can occur in workers exposed 
to NG alone.
It is important to note that, according to the report by Lange et al 
[34], sudden death can occur in workers who did not have premonitory 
symptoms other than angina. An angiographic study of one worker indicated 
that the chest pain associated with withdrawal from exposure to NG was 
related to spasms of the coronary arteries. This suggested mechanism is
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plausible, but it may not be the only one responsible for chest pain in 
workers exposed to NG or to NG:EGDN mixtures.
On the basis of these symptoms, Lange et al [34] proposed that the 
duration of compensatory vasoconstriction is longer than the vasodilatory 
effect of NG. They suggested that when workers are no longer exposed, 
compensatory vasoconstriction is not opposed by the vasodilatory effect of 
NG, and coronary insufficiency or acute myocardial infarction can result. 
They suggested that the vasoconstrictor response subsides after 96-120 
hours. This is a plausible interpretation of the findings of this and 
other case reports, but it is clear that further research is needed to 
determine the actual effects of exposure to, and withdrawal from, NG and 
EGDN.
In 1975, Klock [48] described a case of nonocclusive coronary artery 
disease in a 38-year-old man employed as an explosives foreman in a mine in 
the United States. The worker said he consumed 10-20 aspirins and 10-15 
cups of coffee and smoked 2 packs of cigarettes a day. There was no family 
history of heart disease. He had been working with NG:EGDN dynamite sticks 
and NG gel daily for 10 years and had experienced nausea, chronic headache, 
and palpitations since he had begun to work with explosives. His daily 
exposures were interrupted in December 1972. In early January 1973, he had 
a severe attack of angina with nausea and sweating. Several weeks later, 
the attacks began to occur once or twice a week, usually on the weekends or 
on Monday mornings, but always while he was resting. His work was 
interrupted only briefly and he was able to lift heavy objects and exercise 
vigorously. The pain was relieved by taking NG sublingually, by entering
the powder magazine, and occasionally by exercising.
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The results of a clinical examination of the worker a few months 
after the attacks of angina began were considered to have been normal 
except for low blood pressure (100/50) and pulse rate (50 beats/minute) 
[48]. ECG's recorded during rest and during exercise were normal, with no 
ST segment changes before or after exercise. Selective right and left 
coronary arteriograms and left ventricular angiograms were obtained. No 
circulatory abnormalities were found in the left coronary arteriogram, but 
the worker developed chest pain just before injection of contrast material 
into the right coronary artery. A spasm of the midportion of the right 
coronary artery was detected, but it disappeared, along with the pain, 
after he took NG sublingually. No changes were found in the ECG's taken 
during arteriography or during the six attacks of angina that occurred 
within 3 hours after the procedure. Again, NG taken sublingually relieved 
the angina; clinical chemistry studies performed and ECG's recorded shortly 
after the attacks were found to be within normal limits, indicating that he 
had not recently had a myocardial infarction. One year later, after the 
worker had changed jobs, the attacks were less severe and had decreased in 
frequency to one or two a month, and he was able to lead an active and 
unrestricted life.
Klock [48] indicated that this worker was exposed to stick and gel 
forms of dynamite that contained contained both NG and EGDN. Although the 
attacks of angina probably were associated mostly with exposure to an 
NGrEGDN mixture containing a higher proportion of EGDN than of NG, they 
were relieved by taking NG sublingually. This report indicated that, in a 
young and otherwise healthy worker withdrawn from exposure to NG or EGDN,
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angina can be caused by muscle spasms in coronary arteries that are not 
occluded by atherosclerotic plaques or thrombi.
In 1967, Morikawa et al [65] published the results of a study in 
which they used plethysmography to assess the effects of exposure to 
"ethylene nitrate" (NG:EGDN) on pulse waves in the fingertips of workers at 
a dynamite plant in Japan. In accordance with government regulations, the 
dynamite mixture contained less than 40% of the NG:EGDN mixture. About 200 
men and women, with an average age of 40, were studied; most had been 
working at the dynamite plant for at least 10 years. Workers in areas of 
the factory where exposure to NG or EGDN was possible were examined once a 
month for 8 months. There was a control group consisting of an unspecified 
number of workers not exposed to dynamite, but whether it was matched to 
the exposed group for age, sex, and other variables was not stated.
Concentrations of airborne nitroesters (NG and EGDN) were measured at 
each of the selected work areas several times during the study [65]. Room 
air was sampled for nitroesters with a midget impinger and analyzed by a 
colorimetric method. The mean concentrations of airborne nitroesters, 
calculated as EGDN, ranged from 0.12 to 0.41 mg/cu m.
The effects of exposure on the pulse waves were graded by the authors 
as slight, moderate, or severe [65], but their criteria for these grades 
were not stated. Of 1,271 recordings of pulse waves, 143 (11%) were 
classified as abnormal. Of these, 117 (82%) were characterized as slightly 
changed and 26 (18%) as moderately altered. By comparison, no abnormal
pulse waves were found in 175 examinations conducted on the control group. 
When the apparently affected workers were reexamined the next morning 
before work, the pulse waves had returned to normal.
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No correlation was found between airborne concentrations of 
nitroesters, expressed as EGDN, and the percentage of workers with abnormal 
pulse waves, although both indices varied from one work area to another 
[65]. The authors did find that abnormal pulse waves were associated with 
certain kinds of work. The highest percentages of abnormal pulse waves 
were found in areas where workers wore surgical rubber gloves without 
liners or where workers handled unwrapped dynamite, even though those in 
the latter group wore cotton-lined rubber gloves with a nylon covering. 
Workers who used similar gloves to handle wrapped dynamite only 
occasionally had abnormal pulse waves. These data indicated that EGDN can 
penetrate rubber, nylon, and cotton. This conclusion was supported by the 
observation of abnormal pulse waves and a decrease in the systolic blood 
pressure in a nonexposed worker who wore for 3 hours a pair of rubber 
gloves that had been used just previously in a dynamite workshop.
The authors [65] believed that the abnormal results of 
plethysmographic examinations were a very sensitive indicator of exposure 
to nitroesters. However, the usefulness of plethysmography as used by 
Morikawa et al as a medical surveillance tool is limited at present because 
criteria for objectively grading the effects of exposure on pulse waves 
have not been described fully. In addition, the relationship between the 
degree of change in pulse waves and impairment of health has not yet been 
established. However, the use of fingertip plethysmography as a means to 
evaluate the cardiovascular response to nitroesters merits further 
evaluation.
Foulger [52] attempted to relate the percentage of dynamite workers 
with abnormal blood pressure measurements with the types of gloves used in
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six dynamite plants. The criteria for classifying readings as abnormal 
were not specified. The percentages of workers with abnormal blood 
pressure readings were 33% in the first plant, where canvas gloves were 
changed every 2 hours; 42% in the second plant, where they were changed 
every 2 hours, and some gloves were discarded after use; 59% in the third, 
where gloves were changed when "dirty"; 76% in the fourth plant, where 
rubber-coated canvas gloves were worn and were reused after laundering; 80% 
in the fifth plant, where the rubber-coated canvas gloves that were used 
retained NG:EGDN after laundering; and 87% in the sixth plant, where the 
amount of NG:EGDN remaining in the rubber-coated canvas gloves was 
sufficient to cause headaches in unexposed persons who wore them. 
Foulger's findings tend to support the premise that NG:EGDN is retained by 
the rubber used in protective gloves and is not removed adequately by 
laundering.
Results from examinations given to workers exposed to NG:EGDN have 
been reported by many authors [41,42,44,45]. In 1959, Maccherini and 
Camarri [41] reported that nearly all of 265 dynamite workers complained of 
having had headaches, palpitations, nausea, and sensations of heat in the 
face and limbs when they first started work at the plant. These symptoms 
gradually subsided, disappearing after a few weeks of work. About 15% of 
the workers continued to experience them occasionally while they were at 
work. The authors found that 52% of the dynamite workers (137 of 265) but 
none of the 25 office workers were hypotensive in comparison with a large 
industrial population not exposed to dynamite. In most instances, systolic 
and diastolic pressures were reduced, but pulse pressures were within the 
normal range. The authors indicated that dynamite workers were hypotensive
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during working hours only and that hypotension occurred more frequently in 
those who had direct contact with dynamite than in others at the plant. 
ECG's recorded during working hours were normal in all but one worker, who 
had a previous history of cardiac ischemia. Chest X-rays of the 265 
dynamite workers and 25 office workers revealed aortic arteriosclerosis 
with moderate enlargement of the left ventricle in seven dynamite workers 
and two office workers. Slight leukopenia was found in 27 dynamite workers 
(10%), and slight normochromic anemia was found in 60 of them (23%), but 
methemoglobin or Heinz bodies were not found in the red blood cells of 
either dynamite or office workers.
Of the 70 workers who handled dynamite frequently, 10 (14%)
complained of attacks of angina after 40-60 hours away from work [41]. 
These 10 had been employed at the plant for 8-15 years and were 40-50 years 
old. A few of the ECG's taken during or shortly after the attacks of 
angina in these workers showed moderate lengthening of the PR interval. Of 
the 70 workers, 9 had slight imbalances between plasma albumin and globulin 
levels and 3 had elevated serum cholesterol levels. Information on 
concentrations of airborne NG:EGDN or on the extent of skin contact with 
dynamite was not reported, but the study suggests that, with the exception 
of blood pressure measurements, clinical signs are less indicative of the 
effects of NG:EGDN exposure than are symptoms.
Rubino et al [43] reported the effects of exposure to NG:EGDN on 20 
dynamite workers (15 men, 5 women, aged 20-53). The workers, employed for 
an average of 7 years, were engaged in mixing, rinsing, machining, loading 
cartridges, wrapping, and shipping dynamite. Concentrations of airborne
NG:EGDN ranged from 6 to 14 mg/cu m in work areas. Fifteen of the workers
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reported headaches, 10 nausea and vomiting, 7 chest pain, 4 heart 
palpitations, 4 peripheral circulatory disorders and paresthesia (altered 
sensation), 5 labored breathing related to stress, 2 fainting, 1 cyanosis, 
and 1 weakness. The authors noted that most of these symptoms were present 
at the time of examination and interview, and that chest pain, when 
present, persisted during exposure-free periods. Systolic and diastolic 
blood pressures increased between Friday evening and Monday morning in six 
workers and remained unchanged in three of them. The authors found that 
alterations in ECG's indicative of cardiac ischemia were demonstrably 
present for six workers, the presence or absence of ECG changes was 
questionable for nine workers, and that five workers were unaffected.
In 1965, Hanova [44] reported the results of ECG’s recorded from 13 
NG:EGDN dynamite workers who had experienced angina. Concentrations of 
airborne NG:EGDN were not given, but the author indicated that they were 2- 
5 times the admissible concentration (not stated) in Czechoslovakia. ECG's 
recorded during rest, after exercise, and after oral administration of 0.5 
mg of NG, revealed no alterations in the QRS complex or in the PQ and QT 
intervals. There were, however, changes in the ST segment at rest in 7 of 
the 13 workers, a depression in 6 and an elevation in 1. Depression of the 
ST segment became more pronounced after exercise but diminished after 
administration of NG. There also were alterations in the shape and height 
of the T wave in several workers. Respiratory arrhythmia was detected in 
all 13 workers. Hanova concluded that, since ECG changes occurred 
primarily during the repolarization segments (ST and T), they were probably 
caused by hypoxia, changes in metabolism, tachycardia, or nervous
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conditions. The author also suggested that the occurrence of angina in the 
employees while not at work was caused by reflex spasms of the coronary 
arteries.
In 1966, Orlando et al [45] reported the effects of exposure to 
NG:EGDN on 31 dynamite workers, 25-40 years old, who had blended and mixed 
dynamite powder for an average of 10 years. ECG's were recorded on Monday 
morning before work and again during a general examination, but other 
details of the examination were not reported. Some of the workers had 
complained of frontal headache, chest pain, or difficulty in breathing, but 
none of the symptoms was reported to have interfered with normal work 
activity. Sixteen (52%) of the 31 workers examined had normal ECG's, 9 
(29%) had normal tracings with atrioventricular (AV) conduction within what 
the authors considered the lower limits of normal, and the remaining 6 
(19%) had first degree AV blocks. Thus, 15 (48%) of the 31 workers had at 
least marginal disturbances in AV conduction. The authors presumed that in 
the workplace, the less volatile NG was less toxic than the highly volatile 
EGDN, and they therefore concluded that workplace exposure to EGDN could 
alter AV conduction. The authors believed that chronic exposure to NG:EGDN 
dynamite could enhance adrenalin-induced arrhythmias of the heart.
Rubino et al [43], Hanova [44], and Orlando et al [45] reported that 
exposure to NGtEGDN dynamite may be associated with changes in ECG 
recordings in some workers. Their findings indicate, however, that ECG
recordings are not the most sensitive indicators of the effects on health 
of exposure to NG:EGDN.
In 1967, Bartalini et al [38] reported that, between 1955 and 1965,
the severity of symptoms had decreased in NGrEGDN dynamite workers at a
77
plant in Italy. The dynamite mixture contained 67% EGDN and 33% NG in 1955 
and 50% EGDN and 50% NG in 1965; the mean airborne concentrations expressed 
as EGDN were about 1.7 mg/cu m in 1955 and 1.2 mg/cu m in 1965. Of the 36 
workers studied in 1955, 8 had attacks of angina, usually during the 
afternoons on nonworking days, 12 had Raynaud's phenomenon in the fingers 
after exposure to cold, and 31 had other symptoms including headache, 
nausea, vomiting, palpitations, and dizziness, particularly on Mondays 
during hot, damp weather or when alcohol was consumed. Work practices were 
improved so that less of the NGrEGDN mixture was absorbed through the skin 
and workers with symptoms were transferred to jobs in which they were not 
exposed to NGrEGDN. Preplacement and periodic medical examinations were 
conducted and the criteria for allowing employees to work in the dynamite 
area, although not specified, were apparently made more stringent. None of 
the 65 workers employed in 1965 had attacks of angina, although 7 had 
Raynaud's phenomena in the fingers and 50 had other symptoms, such as 
headache or nausea. It appears that reductions in both airborne and dermal 
exposures to NGrEGDN, the transfer of workers with symptoms, and more 
stringent evaluation of findings from preplacement and periodic medical 
examinations contributed to the decrease in the frequency and severity of 
symptoms in workers at the dynamite plant, although the relative importance 
of these factors cannot be determined from this study. The authors 
suggested that Raynaud's phenomenon and the symptoms of transient ischemia 
in the limbs that usually occurred at night, such as sensations of pricking 
with pins or needles or heaviness and transitory inability to move the 
fingers, were related to alterations in arteriolar tone caused by prolonged 
cutaneous exposure to NGrEGDN.
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In 1965, Prerovska and Teisinger [42] described signs and symptoms 
associated with exposure to NG:EGDN mixtures in workers at a dynamite plant 
in Czechoslovakia. The authors indicated that concentrations of the 
airborne mixture were much greater than 5 mg/cu m, but the sampling and 
analytical methods used were not described. Between 1958 and 1961, four 
workers, 29-47 years old and employed for 5-7 years, died suddenly after a 
day away from work; three of them had previous histories of angina. 
Autopsies of the four workers revealed sclerosis of the coronary arteries 
and aorta ranging from slight to severe, but none had evidence of a recent 
infarct. Of the 37 workers who were interviewed at the plant, most of whom 
were roll-mill operators, nearly all complained of headaches, particularly 
when returning to work after a weekend. Some had angina, usually on days 
when they were not at work, some had collapsed, and a few had fainted. 
Intolerance to alcohol was noted by some workers, and there were a few 
instances of paresthesia.
Clinical findings were reviewed for 20 workers in whom chronic EGDN 
intoxication was diagnosed [42]. In all of them, decreases in blood 
pressure of more than 10 mmHg were found and methemoglobin levels were 
about 5%. Almost all 20 had serum cholesterol levels of about 220 mg%, 
which the authors considered to be the upper limit of the normal range. 
When workers with a diagnosis of chronic EGDN intoxication were transferred 
to other operations, the frequency of angina attacks decreased in these 
workers and there were no further instances of collapse or sudden death. 
The workers who were not transferred continued to have headaches, 
intolerance to alcohol, and angina, and there were a few instances of 
collapse. However, the ECG's and concentrations of serum cholesterol
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(about 190 mg%) and of other lipids were considered to be within the normal 
range. According to the plant physician, gastric ulcers seemed to occur 
more frequently in workers exposed to EGDN than in the general population. 
It is possible, however, that the development of gastric ulcers is related 
to hazards to safety in dynamite plants rather than to exposure to NG:EGDN 
mixtures. Unlike Maccherini and Camarri [41], Prerovska and Teisinger [42] 
found that serum cholesterol levels were elevated in NG:EGDN dynamite 
workers. A more rigorous study is needed to determine whether NG or EGDN 
actually elevates the concentration of cholesterol in the serum in exposed 
workers.
Lanfranchi and Beraud [40] reported that workers at an NGtEGDN
dynamite plant in France had changes in ECG recordings and symptoms similar
to those reported by other authors. Four workers had died suddenly without
any apparent cause, three on Mondays and one on a Thursday. They also 
found that one worker, a 26-year-old chemist employed at the plant for 2 
years, had attacks of angina at regular intervals and had Raynaud's 
phenomenon in his arms and legs. These symptoms seemed to be unusually 
severe for a young man who probably had been exposed only intermittently to 
NG:EGDN and who had been employed at the plant for a relatively short 
period.
In 1969, Jacob and Maroun [39] reported a case of peripheral
neuropathy in a 49-year-old man who had been handling "organic nitrate" 
dynamite. Twenty-five years earlier, he had developed severe headaches and 
nausea while handling dynamite sticks with his bare hands. He was not 
exposed to dynamite again until 1967, when he developed headaches and 
nausea, which usually lasted for 2-3 hours. During one episode, he
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partially lost his vision either before or during the headache, but his 
vision returned to normal after a few minutes. Without actually touching 
the dynamite, he once developed a headache from merely opening the safe in 
which it was stored. About 2-3 weeks after he had last handled dynamite, 
he developed pain and swelling in his feet with slight edema at the ankles 
and small hemorrhages on the skin of the lower leg. The pain and swelling 
continued, and within a month, numbness had spread to the lower front part 
of the left leg and more small hemorrhages had appeared on both ankles. A 
muscle biopsy 3 months later showed that the muscle fibers were normal, but 
that the media of one small arteriole was necrotic, and that many white 
blood cells of types indicative of both acute and chronic inflammation were 
on and around the vessel walls. Treatment with corticosteroids helped to 
reduce the swelling, but the numbness persisted. The authors concluded 
that the peripheral neuropathy was related to nerve damage secondary to 
inflammation of the arteries. This case is probably one of high individual 
susceptibility. Although sufficient information on which to base 
conclusions was not reported, the case of Raynaud's phenomenon in the 26- 
year-old worker reported by Jacob and Maroun [39] may also have been an 
instance of high individual susceptibility to NGrEGDN. Paresthesia and 
Raynaud's phenomenon have been reported by a few other authors [38,42,62], 
Bartalini et al [38] suggested and the findings of Jacob and Maroun [39] 
also suggest that nerve damage in the extremities in workers who absorb 
NGrEGDN through the skin may be secondary to ischemia caused by 
compensatory vasoconstriction or by vasospasms in the peripheral blood 
vessels.
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In 1959, Planques et al [66] reported a case of skin and nervous
allergic reactions induced by dermal exposure to dynamite. A 41-year-old
man had worked for 4 months with vibratory pneumatic equipment in a lead 
mine and had come into contact with numerous compounds including NG:EGDN 
dynamite. He developed plaques, blisters, and scabs on his hand although 
no other abnormalitites were found in an examination and complained of 
severe dysesthesia with a sensation of burning in the fingertips. After 2 
months of treatment with lotions containing dyes and antibiotics, the 
dermatitis disappeared, but the dysesthesia, although somewhat improved, 
was still present. The dermatitis had first occurred when the worker had 
handled pneumatic equipment and dynamite, but the authors found that the 
dysesthesia was not related to vibration. Patch tests were performed on 
the worker and on an unspecified number of control subjects with four types 
of dynamite that the affected worker had handled. The tests were negative 
in the control subjects but highly positive in the worker. To determine 
the ingredients of dynamite specifically involved, NG, EGDN, and guncotton 
were applied to the skin on the backs of the worker and the control
subjects. NG caused dermatologic reactions and dysesthesia on the hands of
the worker but did not affect the control subjects. The authors concluded 
that NG was responsible for the two types of symptoms developed by the 
worker and that it acted as both an irritant and a sensitizer
A case of sensitivity to both NG and pentaerythritol tetranitrate 
(PETN) in a man who took these drugs to alleviate angina was reported by 
Ryan [67] in 1972. The patient developed an extensive rash and edema in 
the ankles and wrists that disappeared when treatment with these drugs was 
discontinued. The rash recurred when he used NG again. The author
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concluded that both NG and PETN caused skin sensitization. He speculated 
that the "trinitrate grouping" in both of these compounds behaved as a 
hapten that elicited the immunologic response, although evidence supporting 
this idea was not provided. The possibility that cross-sensitivity also 
had a role in causing the rash was suggested by the authors as well.
A few reports [21-23,31] suggest that workplace exposure to NG can 
affect behavior. Darlington [21] indicated in 1890 that some mine and 
tunnel workers who handled dynamite and were exposed to vapor of NG from 
unexploded dynamite had disturbances of the CNS, although the types of 
disturbances were not specified. Laws [22] noted in 1898 that dynamite 
workers were especially likely to become violent after drinking relatively 
small amounts of alcohol. Jennings [23] reported in 1903 that those who
sucked on dynamite and then drank beer would often hallucinate and display
aberrant behavior. In a more recent report, Martimor et al [31], in 1958, 
described behavioral disorders in a 40-year-old man who made NG-containing 
pharmaceuticals. He had experienced episodes of mental disorder when he 
was 7 and 20 years old. He frequently had skin rashes, but no longer had 
headaches at work after developing tolerance to NG. After 2 years of work, 
he complained of loss of appetite, insomnia, headaches, nervousness,
gastrointestinal pain, vomiting, and weakness so severe that he had to stay 
in bed. Within a month, he was in a depressed state, his memory was
affected, and he was delirious and hallucinating. He eventually committed 
suicide.
The authors suggested that, although the mental disorders could not 
be definitely linked to workplace exposure, the pattern of the disease
indicated that the patient was particularly susceptible to the effects of
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NG. It seems more likely, however, that the headaches caused by exposure 
to NG could have acted as a nonspecific stress that contributed to an 
episode of mental disorder in a patient with a previous history of these 
episodes. This case, then, does not provide evidence that NG acts directly 
on the CNS to cause mental disorders.
In 1975, Matsushita and Tadokoro [68] reported findings from EEG 
examinations of nine workers at a NG:EGDN dynamite plant in Japan. The 
workers were also given physical examinations. The authors indicated tha^, 
for several years, concentrations of airborne EGDN in the dynamite 
workrooms had been below 1.24 mg/cu m. About 3 years before the 
examinations, four of the workers, men aged 36-49, had been transferred out 
of dynamite workrooms after they had experienced attacks of angina. The 
other five workers, four women and one man, aged 22-42, were selected 
randomly from a group of workers who had been employed in the dynamite area 
for "many years" and who indicated that they had not experienced angina. 
There was no group of individuals who had never been exposed to EGDN 
dynamite.
Findings from the clinical examinations of eight of the nine workers 
were not unusual. Of the four former dynamite workers, two had no 
symptoms, one had palpitations and one had altered sensations in the upper 
limbs. All five of the workers employed in the dynamite area had symptoms, 
including palpitations (two), headache (two), a heavy feeling in the head 
(two), fatigue (one), lack of appetite (one), stiffness in the shoulder 
(one), and backache (one) .
The workers were told not to take any medication for at least one
week before the EEG examinations [68]. To minimize the effects of acute
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EGDN exposure, the authors recorded EEG's in workers who had been away from 
their jobs for at least 2 days. Recordings were made while the subjects 
were at rest, while they were asleep, after they had hyperventilated for 3 
minutes, and after iv administration of bemegride, an analeptic.
The authors [68] reported that EEG's were "abnormal" in five workers, 
"slightly abnormal" in two, and "almost normal" in two. There were no 
apparent differences between EEG's of workers formerly and currently 
employed in the dynamite area. The authors indicated that the disturbances 
in the EEG pattern were slight and characterized by fast, diffuse activity.
Matsushita and Tadokoro [68] concluded that seven of the nine workers 
had abnormal EEG's and that chronic EGDN exposure seemed to influence 
cerebral activity. The authors did not consider any of the recordings to 
be normal. These findings are difficult to evaluate because the EEG 
recordings were not described in sufficient detail and because a control 
group of individuals who had never been exposed to NG:EGDN dynamite was not 
included in the study. More rigorous studies with well-defined criteria 
for the evaluation of EEG's are needed to determine whether exposure to 
EGDN can affect cerebral activity.
In a 1966 report on the health of workers from the same NG:EGDN 
dynamite plant in Czechoslovakia studied by Prerovska and Teisinger [42], 
Styblova [69] found that about a third of the workers had depression and 
sleep disturbances and that some roll-mill operators also had excessive 
hunger. Of 85 mine workers exposed to NGrEGDN explosives, the author found 
that 11 had histories of loss of consciousness for unknown reasons; in 2 
workers, these episodes resembled epileptic attacks. The attacks of 
unconsciousness were first attributed to head injuries, but 10 of the 11
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workers continued to have attacks after they were no longer exposed. 
Fifteen other mine workers also had neurologic symptoms, including tetanus­
like spasms in the fingers with altered sensation in the skin around the 
mouth, dizziness, and weakness in the lower extremities. One of the 15 
developed aphasia and slight paralysis on one side, but these symptoms 
disappeared after 3 days.
Styblova [69] indicated that symptoms such as depression, sleep 
disturbances, and excessive hunger could be related to the stress of 
working in a plant where fires and explosions occurred frequently. The 
author believed, however, that neurologic symptoms were associated with the 
toxic effects of dynamite on some part of the brain and that these effects 
may have been potentiated in mine workers by exposure to carbon monoxide 
after a detonation in the mine. The study is not reported in sufficient 
detail, however, and the author did not present data to support her 
hypothesis. This study and other isolated reports of neurologic 
disturbances in workers exposed to NG or EGDN are merely suggestive. They 
indicate, however, that further study is warranted to determine whether 
these compounds may affect the nervous system.
Experimental studies using in vivo and in vitro techniques have 
investigated the rate of absorption of EGDN through the skin and its 
metabolic fate. Gross et al [70], in 1960, published the results of a 
study of the initial rate of percutaneous absorption of EGDN in humans. 
Six men each had about 100 mg of an explosive mixture containing about 22% 
EGDN applied to 1 sq cm on the outer sides of their left forearms. An 
occlusive bandage was placed over the entire preparation for 7 hours, after 
which time the remaining material was scraped from the skin. By
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determining the amount of EGDN remaining on the skin, the authors estimated 
that an average of 3 mg of EGDN (13.7% of the amount applied) was absorbed 
by each subject during the 7-hour test period [70]. Evaporation was 
controlled somewhat, but part of the decrease in the amount of EGDN 
remaining on the skin may have been the result of evaporation rather than 
absorption.
In 1966, Williams et al [71] determined the rate of disappearance of 
EGDN from human blood in vitro. Concentrations of EGDN were measured by 
gas chromatography with an electron-capture dectector. One-half the EGDN 
disappeared in 20 hours from a human blood sample that had originally 
contained 0.18 ppm EGDN, in 10 hours from a sample that had contained 0.08 
ppm EGDN, and in about 2 hours from a sample that had contained 0.04 ppm 
EGDN. Since the rate of disappearance was more rapid when EGDN 
concentrations were lower, the authors suggested that EGDN concentrations 
in human urine and blood be measured as soon as possible after the samples 
are taken.
The authors [71] also measured EGDN concentrations in the blood and 
urine of two controls and five workers from an unspecified area of the 
dynamite plant where exposure was reportedly greatest. Blood samples were 
taken from a peripheral vein a few minutes after work and all blood and 
urine samples were analyzed within 30 minutes. Blood samples from the five 
workers contained EGDN at 0.01, 0.04, 0.05, 0.06, and 0.07 ppm (average 
0.046 ppm), The corresponding urine samples contained EGDN at 0.03, 0.02, 
0.08, 0.04, and 0.02 ppm (average 0.038 ppm). Calculations by NIOSH 
indicate that the concentrations of EGDN in blood and urine are not well 
correlated (r=0.07). Blood and urine samples collected 16 hours after work
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from the same five workers and from two controls contained no EGDN.
To determine the rate of EGDN disappearance from human skin, 5 mg of 
EGDN was spread over a 4-sq-cm area of a palm [71]. The rate of 
disappearance reflects both the rate of absorption through the skin and the 
rate of evaporation from the surface of the skin. After 3 minutes, the 
palm was washed with soap and water; 5 mg of skin was removed with a 
scalpel and found to contain 30 ng of EGDN/mg of skin. After 1 hour, the 
concentration of EGDN in the skin was 3.5 ng/mg, and after 1.5 hours 
following a second washing, it was 2 ng/mg. The authors concluded that the 
usual cleaning methods with soap and water would not remove all the EGDN 
from the skin. It is also possible that EGDN would be absorbed more
rapidly through areas of the skin less thick than the palm.
In a study reported by Sundell et al in 1975 [72] and by Gotell in 
1976 [73], blood EGDN concentrations were compared with airborne EGDN 
concentrations and with various job categories for NG:EGDN dynamite 
workers. The half-life of EGDN in red blood cells taken from exposed 
workers and from controls was also investigated. To correlate blood and 
airborne EGDN concentrations, blood EGDN concentrations were measured by 
gas chromatography in an unspecified number of volunteers exposed to 
airborne EGDN at concentrations of 1.2, 6, and 7.8 mg/cu m [73]. The
volunteers did not handle EGDN directly, although some airborne EGDN may 
have been absorbed through the skin. Blood EGDN concentrations, which 
ranged from 0.9 to 8.0 ng/ml, were highly correlated with airborne EGDN 
concentrations (R=0.95) in volunteers. Based on this finding, Gotell 
estimated that a maximum blood EGDN concentration of 2 ng/ml would
correspond with an 8-hour TWA exposure to EGDN of 1 mg/cu m. Gotell [73]
also suggested that a maximal blood concentration of NG of 4 ng/ml would 
correspond to an 8-hour TWA exposure to NG of 2 mg/cu m. The derivation of 
these estimates was not provided, however.
Concentrations of EGDN in the blood of 333 dynamite workers exposed 
to airborne EGDN at concentrations ranging from less than 0.5 to 10 mg/cu m 
were also measured [72] . The procedures used to select workers and to 
collect blood samples were not discussed. The results are shown in Table 
III-4.
No significant differences were found between any of the 
concentrations, suggesting that, for these workers, EGDN absorbed through 
the skin probably influenced blood EGDN concentrations more than exposure 
to airborne EGDN did [72]. The association of blood EGDN concentrations 
with job classification in 278 dynamite workers was also studied. In a 
review of this study, Gotell [73] indicated that the blood samples were 
taken at random intervals during the workshift. The results are shown in 
Table III-5.
The finding that blood EGDN concentrations were 10 times higher in 
cartridge makers than in other dynamite workers suggests that the amount of 
EGDN absorbed through the skin by workers who handle dynamite is 
substantial [72] . This study emphasizes that airborne EGDN concentration 
is not an accurate indicator of the extent of exposure to EGDN when the 
compound is handled directly, so that large quantities are absorbed through 
the skin.
The authors also studied the half-life of EGDN in vitro [72] . Red 
blood cells were taken from 26 men and 30 women employed in the dynamite
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TABLE III-4
CONCENTRATIONS OF EGDN IN WORKPLACE AIR AND 






Workers Concentrations of Blood EGDN (ng/ml)
Mean** SD Range
<0.5 192 43 121 <1-920
>0.5-1.0 93 55 123 <1-675
>1.0- 2.0 22 99 250 1-1,160
>2.0-10.0 26 88 138 2-450
*Blood samples taken after 3-5 hr of work 
**;>o significant differences found between the
Adapted from Sunde11 et al |72]
T A B L E  I I I - 5
means
CONCENTRATIONS OF EGDN IN THE








28 4 4 0.5-16
Nitrifying Workers 24 8 11 0.5-39
Knead-house Workers 44 8 8 1-30
Carc::. jge makers 182 89 176 1-1,160
*Blood samples taken during the workday 
Aaapte.d lion* judeil ec al [72]
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industry for more than 2 years and from 22 men and 28 women who were not 
exposed to EGDN in the workplace. The details of the procedure were not 
reported. The half-life of EGDN in vitro was 0.8 hour for male dynamite 
workers, 0.4 hour for male controls, 0.7 hour for female dynamite workers, 
and 0.6 hour for female controls. The half-life was signficantly longer in 
male dynamite workers than in male controls, but it was not significantly 
different in female dynamite workers and controls. The half-life was also 
significantly longer in female controls than in male controls. The authórs 
did not suggest why the half-life of EGDN in human red blood cells in vitro 
might be different in men and women or in dynamite workers and controls, 
although this finding suggests that prolonged exposure to EGDN may increase 
the half-life of EGDN. Thus, if dynamite workers and controls were exposed 
to EGDN at the same concentration, blood EGDN concentrations would be 
greater in male and possibly in female dynamite workers than in controls.
Although the details of these experiments [72] were not reported, one 
of the experiments indicated that airborne and blood EGDN concentrations 
were correlated in the absence of skin contact. However, the finding that 
workers who handled dynamite, eg, cartridge makers, had greater blood EGDN 
concentrations than those exposed primarily by inhalation suggests that 
skin absorption was a major route of exposure to EGDN in the workplace.
In 1977, Blumenthal et al [74] compared NG concentrations in the
plasma of one healthy volunteer after sublingual (0.3 mg), oral (2.4 mg and
6.5 mg), and topical (equivalent to 16 mg) administrations with associated
changes in pulse rate and mean arterial pressure. The authors used gas
chromatography with an electron-capture detector to measure concentrations
of plasma NG as low as 0.1 ng/ml. Thus, an apparently satisfactory
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analytical method seems to be available to determine concentrations of NG 
in the blood plasma that are associated with exposure to NG by inhalation 
as well as by skin absorption and to relate these concentrations to changes 
in blood flow.
Plasma NG concentrations did not rise above 0.1 ng/ml until
approximately 20 minutes after topical application of the NG-containing 
ointment [74]. A peak concentration of 0.25 ng/ml was reached at about 22 
minutes and the concentration was about 0.2 ng/ml 60 minutes after 
application of the ointment. Mean arterial pressure began to decrease 
gradually from the preadministration level shortly after the ointment was
applied. The effect was maximal after 45 minutes, when mean arterial
pressure had decreased by 20%. Sixty minutes after administration, .mean 
arterial pressure was about 10% less than the preadministration level. The 
change in pulse rate was maximal, a 12% increase over the preadministration 
level, after 20 minutes, although no consistent effect on pulse rate was 
noted before 20 minutes had elapsed. During the 20-60 minutes after 
administration, the pulse rate was increased by an average of about 5%, but 
returned to normal within 60 minutes.
These preliminary findings [74] indicate that plasma NG
concentrations below 0.1 ng/ml, the limit of sensitivity for the assay, are 
associated with decreases in mean arterial pressure. Since results are 
available for only one healthy volunteer, further tests are needed before 
the technique can be considered to be an appropriate assay for the biologic 
monitoring of exposed workers.
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Epidemiologic Studies
A study of deaths from ischemic heart and cerebrovascular diseases in 
a parish in Sweden in which there was a dynamite plant was reported by 
Hogstedt and Axelson [75] in 1977. Noraberg, a parish of about 8,000 
people, had mining, forestry, agricultural, engineering, and service 
industries in addition to a plant where NG:EGDN dynamite was manufactured. 
The parish register of deaths and burials was reviewed to identify deaths 
that had occurred between January 1955 and October 1975. A total of 408 
men aged 36-70 had died during the study period. However, the deaths of 55 
men were excluded from the study because the authors believed that these 
deaths could bias the results. Ten of the 55 excluded men, 7 of them 
dynamite workers, had died in explosions, 20 had died of diabetes or 
"primary debilitas," diseases that the authors thought would have caused 
the workers to have been excluded from dynamite operations, and the 
underlying cause of death could not be determined for the other 25 men.
From plant employment records beginning in 1921, Hogstedt and Axelson
[75] found that 31 of the remaining 353 men (9%) who died had worked in 
dynamite operations for at least 1 year. Of these, 68% (21) had died of 
ischemic heart or cerebrovascular disease (ICD No. 410-412, 427-428, and
430-438). In contrast, only 46% of the deaths (148 of 322) in men from the 
parish who had not worked at the dynamite plant were from ischemic heart or 
cerebrovascular disease. The difference between the percentages of deaths 
from these diseases in dynamite workers and in other men is statistically 
significant (P<0.05). Only 3 of the 21 deaths in dynamite workers were 
from cerebrovascular disease. For dynamite workers and other men who died 
between the ages of 36 and 50, the percentages of deaths from ischemic
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heart or cerebrovascular disease were similar, 25% in dynamite workers (2 
of 8 deaths) and 27% in other men (12 of 44 deaths). However, in men who 
died between the ages of 51 and 70, 83% of the deaths in dynamite workers 
(19 of 23) but only 49% of the deaths in other men (135 of 278) were from 
ischemic heart or cerebrovascular disease. Again, the difference between 
the percentages is statistically significant (P<0.05). Of the 21 dynamite 
workers who died of ischemic heart or cerebrovascular disease, 4 (19%) had 
worked at the plant for 1-20 years and 17 (81%) had worked there for over
20 years. None of the deaths in men who had worked at the dynamite plant
for more than 20 years was from a cause other than ischemic heart or
cerebrovascular disease. At the time of their death from ischemic heart or
cerebrovascular disease, 3 of the 21 dynamite workers were still employed 
at the plant but the other 18 had not worked at the plant for months or 
years. The difference between the percentages of deaths from ischemic 
heart or cerebrovascular disease in dynamite workers and in other men as 
well as the clustering of deaths from these causes in men who had worked at 
the dynamite plant for more than 20 years strongly suggest that those 
exposed to NG:EGDN in the workplace were more likely to die from diseases 
of the circulatory system than those who were not exposed. It is important 
to note that although most of the dynamite workers who died of diseases of 
the circulatory system had worked at the plant for a long time, they had 
not worked there for months or years before death.
Studies discussed in Effects on Humans indicate that workers exposed 
to NG or EGDN can develop chest pains or die suddenly, particularly after a 
brief period of withdrawal from exposure, eg, a weekend. This study [75] 
suggests that people who had been dynamite workers for a long time but were
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no longer exposed to NG or EGDN in the workplace were also more likely to 
die from circulatory diseases than those who had never been exposed. It 
appears, then, that the effects of long-term workplace exposure to NG or 
EGDN on the circulatory system may not be reversed completely after
exposure is discontinued, and that these changes can result in severe 
effects on the health of former dynamite workers.
Einert et al [11] in a 1963 report of a study of dynamite workers in 
California, estimated their extents of exposure to NGrEGDN by inhalation 
and by skin absorption and attempted to relate this to findings obtained
from clinical examinations of the workers. The dynamite produced at the
plant consisted of up to 80% EGDN and at least 20% NG. Air was sampled 
with midget impingers charged with ethyl alcohol, and the samples were 
analyzed using a colorimetric method. Air samples were taken in the
breathing zones of workers throughout the plant. Concentrations of NG:EGDN 
ranged from 0.03 to 4.35 mg/cu m as EGDN, depending on the worksite. 
Because EGDN has a greater vapor pressure than NG, the exposure to airborne 
NG was considered by the authors to be negligible compared with that to 
EGDN. Einert et al considered EGDN exposure levels "low" when the TWA 
concentration of airborne EGDN was less than 0.25 mg/cu m, "moderate" when 
TWA concentrations were between 0.25 and 0.75 mg/cu m, and "much" when they 
were over 0.75 mg/cu m. Exposure tests were conducted to estimate the 
amount of NG and EGDN that came in contact with employees' hands. Thin 
cotton gloves that had been cleaned specially and dried were worn by 
workers during 2- or 4-hour exposures. The used gloves were analyzed for 
total nitrites. Amounts of NG and EGDN recovered from the gloves varied
from less than 0.1 mg to 1.0 mg for 4-hour exposures. Exposures of skin to
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EGDN were based on the amount of EGDN recovered from glove linings, and 
were considered "low" if they were less than 0.25 mg, "moderate" if they 
were between 0.25 and 0.75 mg, and "much" when they exceeded 0.75 mg in an 
8-hour period.
To relate these concentrations of NG and EGDN to medical findings, 
the authors [11] studied 38 workers exposed to dynamite and 20 unexposed 
workers with a similar distribution of ages and years of employment. Each 
worker was interviewed to elicit medical, personal, and occupational 
histories. Following initial medical examination, the 58 workers were 
examined before and after each workshift. Blood pressure, pulse rate, and 
respiration rate were determined, and information was obtained on the 
actual job performed during the shift, the amount of sleep before work, 
ingestion of food, coffee, tea, or any medication taken before or during 
work, and any symptoms experienced by the worker. These examinations were 
repeated on 8 different days, the first set of data for each man being 
discarded. A total of 349 paired preshift and postshift examinations was 
obtained, each representing one workshift or "manshift."
Einert et al [11] included in their analysis all "unusual" findings 
that occurred in 1% or more of the workshifts. Findings were considered 
unusual when they were beyond the following "normal" limits: pulse rate
65-84 beats/minute after work; systolic blood pressure of 140 mmHg or more 
before work; diastolic blood pressure of 64-85 mmHg after work; and pulse 
pressure of 30-60 mmHg after work. Changes during the workshift of 8 or 
more beats/minute for pulse rate or of 10 mmHg or more for systolic, 
diastolic, or pulse pressure were considered to be unusual findings.
Complaints of headache, dizziness, or nausea were also classified as
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unusual findings. The prevalences of these findings were compared on the 
basis of exposure during the workshift (fully exposed, intermittently 
exposed, or unexposed), but also on the basis of age and years of 
employment, as well as that of other factors, such as smoking history, 
eating before work, drinking stimulant beverages, such as coffee or tea, 
before or during work, amount of sleep, and air temperature during the 
workshift.
Einert et al [11] found that the workers were generally healthy. 
Using exposure estimates based on job titles, the investigators assumed 
that 102 of the workshifts measured had no exposure, 61 had intermittent 
exposure, and 186 had full-time exposure to NG:EGDN dynamite. From these 
figures, they calculated that the group of exposed workers showed an 
increase in pulse rate during work, averaging 5.7 beats/minute for fully 
exposed workers and 1.8 beats/minute for intermittently exposed workers, 
whereas the mean pulse rate for the group of unexposed workers decreased by 
0.4 beats/minute. These findings, however, were considered to be within 
the normal limits established by the authors. All groups showed decreases 
in systolic blood pressure (averaging 12.7, 3.9, and 3.7 mmHg for fully 
exposed, intermittently exposed, and unexposed workers, respectively) and 
in pulse pressure (13.8, 7.9, and 4.6 mmHg for the same groups).
Complaints of headache were reported for only 4.0% of the unexposed 
workshifts but for 14.7% of the intermittently exposed group and for 49.8% 
of the group with full-time dynamite exposure.
Subsequent analyses of the data were not based on these preliminary 
exposure classifications because evaluation of actual exposures showed that 
only 86 workshifts were free of exposure, while 223 workshifts had varying
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degrees of exposure that could be estimated [11]. Exposures could not be 
evaluated for 40 of the 349 workshifts, but these were added to the group 
of exposed workshifts. Comparison of these groups showed that several 
unusual findings occurred more than twice as frequently in the 263 exposed 
workshifts as in the 86 unexposed shifts. These were: (1) unusually high
pulse rate after work (27.8% for all the exposed shifts versus 4.7% for 
unexposed shifts); (2) unusually low pulse pressure after work (20.6% 
versus none); (3) complaint of headache (39.2% versus 4.7%); (4) unusual 
rise in pulse rate during work (39.2% versus 15.1%); (5) unusual drop in 
systolic blood pressure (48.3% versus 24.4%); (6) unusual rise in diastolic 
blood pressure (17.2% versus 7.0%); and (7) unusual drop in pulse pressure 
(56.3% versus 23.2%).
Comparing the unusual findings by age groups for all 349 shifts, the 
authors [11] found three trends with increasing age. Using age categories 
of up to 35, 36-45, 46-55, 56 and over, they observed that, with increasing 
age, there were decreasing percentages of increased pulse rates, increased 
diastolic blood pressures, and decreased pulse pressures. Subdividing the 
349 shifts by years of employment (1-5, 6-15, 16-25, 26 and over), the
authors found that the percentage with pulse rates below 65 beats/minute 
after work increased, and the percentage of workers with unusual increases 
in pulse rate during work decreased with longer employment. Nonsmokers had 
lowered postshift pulse rates in a higher percentage of workshifts than the 
total group (24.0% versus 14.3%), but they also had a higher percentage of 
unusual increases in pulse rate during work (45.3% versus 33.2%). Workers 
who did not drink tea or coffee before work had higher percentages than the 
total workshift population for all unusual findings except high pulse rate
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after work. Findings in workers who did not eat before work varied in the 
opposite direction. Comparison of unusual findings on 2 "hot" days 
(maximum effective temperatures, 76F and 78F) and 2 "cold" days (maximum 
effective temperatures, 58 F and 63 F) revealed little difference 
associated with the ambient temperature in either the exposed or the 
unexposed group. Although no consistent relationship with dose could be 
demonstrated, the medical findings were influenced by both airborne and 
skin contact exposures. All findings except low pulse rate after work 
tended to increase with the extent of exposure by inhalation. Within any 
single inhalation exposure category, most of the unusual medical findings 
tended to increase with increasing exposure to dynamite through the skin of 
the hands.
To evaluate whether the medical findings could be used as a measure 
of excessive exposure, the authors [11] attempted to use four of these 
findings as indicators: pulse rate increases of 8 or more beats/minute,
decreases in systolic pressure of 10 mmHg or more, similar decreases in 
pulse pressure, and complaints of headache. A significant difference 
(P<0.05) between the incidences of these findings in 21 exposed and 18 
unexposed workers was found. In 86 unexposed shifts (18 men), the 4 
findings never occurred simultaneously, but all four occurred together in 
21.6% of 88 shifts (21 men) with "much" exposure through the hands and in 
43.7% of 16 shifts with much exposure by inhalation. The authors concluded 
that these results provided some assurance that their four criteria 
constituted a reasonable means for detecting exposure to EGDN.
To determine whether the workers needed medication containing NG to 
maintain tolerance to "organic nitrates" when they were away from work, the
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authors [11] compared the percentages of workshifts in which there were 
complaints of headaches before and after three weekends. Headaches were 
not reported any more frequently on Monday than on Friday. The authors saw 
no reason, therefore, to provide medication to continue tolerance to 
"organic nitrates" on weekends or during vacations.
Einert et al [11] concluded that the amount of skin absorption was an 
important consideration in evaluating workplace exposures to NG and EGDN. 
They suggested that a glove test, such as that employed in this study, be 
used to estimate skin exposures, but they added that refinement of this 
method was needed. They concluded that requiring the use of plastic gloves 
with cotton liners and conducting simple clinical tests such as 
measurements of pulse rate and blood pressure before and after the 
workshift would be of value in protecting the health of workers exposed to 
NG:EGDN.
In 1962, Hasegawa et al [53] reported on the concentrations of 
airborne NG:EGDN dynamite, expressed as EGDN, and its effect on workers at 
a plant in Japan. Data from medical examinations of 29 workers who had no 
symptoms, selected "impartially" from about 600 men and women, were 
presented. The control group consisted of eight clerical workers and four 
of the authors. The average age was 24.1 years for both the dynamite 
workers (range 15-37 years) and the control group (range 20-29 years), but 
the numbers of men and women in each group were not reported. EGDN workers 
had been employed for an average of 7.0 years (range 0.5-16 years) in 
various areas, including the powder dynamite packing house, the gelatin 
dynamite packing house, the extruding house, and the cartridging house. 
Concentrations of airborne nitroesters in these four areas ranged from 1.37
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to 2.43 mg/cu m expressed as EGDN, with the highest concentration being 
reported in the cartridge house. Neither the number of measurements made 
nor the sampling method used was disclosed by the authors.
Blood samples were collected from the 29 dynamite workers and their 
blood pressures were measured after 2 hours of work [53]. Erythrocyte 
counts, resistance to hemolysis, methemoglobin concentration, catalase 
activity, oxygen affinity, and the concentration of nitrate in the blood 
were measured. Blood EGDN concentrations were measured in three workers. 
For 9 of the dynamite workers, all measurements except blood pressure and 
erythrocyte count were taken on both Friday and Monday; the other 20 were 
examined only once. The same measurements were made on the eight clerical 
workers but not on the four authors.
For the 29 dynamite workers and 8 controls, the means and standard 
deviations for blood pressure and other measurements were calculated, based 
on the authors' data [53]. They are shown in Table III-6.
Average systolic, diastolic, and pulse pressure measurements were 
nearly the same in dynamite workers and controls [53]. The authors also 
found that there were no statistically significant differences between 
blood pressure measurements taken on Mondays and those taken on Fridays in 
nine dynamite workers. Catalase activity, apparently measured in red blood 
cells, was about 28% less in dynamite workers than in controls, but the 
difference was not statistically significant. Catalase activity decreased 
by 3% between Monday and Friday in the nine dynamite workers in whom it was 
measured. The number of erythrocytes was about 5% less in dynamite workers 
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Mean SD Mean SD
Blood Pressure (mmHg)
Systolic 109 2 111 4
Diastolic 68 2 69 3
Pulse 41 2 42 4
Other
Nitrate (jug/ml) 1.49 0.05 1.22 0.02**
Catalase Activity (%) 74 3.2 101 1.9**
No. Erythrocytes (X 10,000) 424 6.7 450 21
Methemoglobin (%) 3.1 0.34 - -
Hemolytic Resistance (%) 0.384 0.006 0.373 0.01
Oxygen Affinity (PC 1/2) 15 3 16 0.3
♦Exposure concentration^.37-2.43 mg/cu m
**No.=4 for blood nitrates; No.=12 for catalase activity and 
oxygen affinity
Adapted from Hasegawa et al [53]
The percentage of methemoglobin decreased by about 1.5% between Friday and 
Monday in dynamite workers. The authors claimed that methemoglobin values 
were normal in dynamite workers, but control values were not provided. 
Oxygen affinity, measured as the partial pressure of oxygen at which 50% of
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the hemoglobin is saturated with oxygen (PC 1/2) , was about 1 mmHg lower in 
dynamite workers than in controls, and it decreased between Friday and 
Monday in dynamite workers. Resistance of red blood cells to hemolysis, 
expressed as the concentration of a sodium chloride solution at which 
hemoglobin escapes from 50% of the blood cells suspended in the solution, 
decreased in dynamite workers from an average of 0.403% on Friday to 0.363% 
on Monday, but was nearly the same in dynamite workers and controls.
Concentrations of EDGN, measured in the blood of three workers, were 
1.0, 1.3, and 1.1 jug/ml [53]. Citing animal studies that indicated that 
EGDN is rapidly metabolized to nitrates, the authors suggested that blood 
nitrate concentrations were an adequate indicator of EGDN absorption. In 
workers under 25 years of age, the average blood nitrate concentration was 
3.3 Mg/ml (SD=0.11) for those employed less than 5 years, and 1.42 ¿ug/ml 
(SD=0.17) for those employed more than 5 years. Blood nitrate 
concentrations averaged 1.49 jug/ml (SD=0.19) in EDGN workers over 25 years 
of age and employed 5 years or more and 1.22 Mg/ml (SD=0.04) in the four 
authors, all of whom were over 25. Workers employed in the extruding
process had the highest blood nitrate concentrations, averaging 1.71 iug/ml. 
Blood nitrate concentrations decreased an average of 0.43 ng/ml between 
Friday and Monday in EGDN workers, although the mean blood nitrate 
concentrations measured on Monday were still greater in EGDN workers 
(mean=1.30 |ig/ml, SD=0.04) than in the controls (mean=1.22 ;ug/ml, SD=0.02).
The study by Hasegawa et al [53] suggests that exposure to airborne 
concentrations of 1.37 to 2.43 mg/cu m expressed as EGDN was associated
with elevated blood nitrate concentrations in workers. Certain
characteristics of the blood in dynamite workers, such as catalase
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activity, hemolytic resistance, and number of erythrocytes, differed from 
control values, although the authors did not discuss any correlation of 
these findings with impairment of health. Interpretation of these findings 
is difficult since the number of workers in the study was small, the 
workers were not chosen randomly, and the selection and matching of 
controls were inadequate, particularly for a cross-sectional study. The 
study does suggest, however, that exposure to nitroesters at concentrations 
of 1.37-2.43 mg/cu m can affect the composition of the blood of workers 
even though they may not have any symptoms.
Animal Toxicity
The effects of exposure to NG and EGDN by inhalation and dermal 
absorption have been investigated in experiments on animals. Other routes 
of exposure have also been used in studies designed to investigate the 
development of tolerance and to identify metabolic pathways and products 
resulting from exposure to these compounds. A few investigators have 
studied the carcinogenic and mutagenic potentials of NG and EGDN in 
animals.
(a) Inhalation
In 1942, Gross et al [76] evaluated the effects of inhaling EGDN and 
NG on cats (sex and age not stated) exposed for 8 hours/day, 5 days/week, 
except Saturdays, Sundays, and holidays, for as long as 1,000 days. A 
regulated flow of air at 36 C was passed over weighed amounts of each 
compound in a Petri dish. The air was then cooled to room temperature and 
passed into the exposure chamber. The concentrations of airborne EGDN and
NG in the chambers were measured daily, and the authors reported that the
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values were consistent from day to day. One cat each was exposed to EGDN 
at concentrations of 13, 134, and 140 mg/cu m for 1,000, 1,000, and 273
days. Two cats were exposed to EGDN at a concentration of 170 mg/cu m for 
8 hours/day, 5 days/week, one for 102 days and the other for 97 days. 
Three cats were exposed to NG at approximately 0.005 mg/liter (5 mg/cu m), 
one cat each for 31, 68, or 156 days. The authors indicated that they
could not measure accurately concentrations in the chambers, but they 
calculated an approximate value of 5 mg/cu m.
The cat exposed to EGDN at a concentration of 13 mg/cu m for 1,000
days showed few effects [76]. Erythrocyte counts decreased during days 30- 
120 but then returned to the initial values. Heinz bodies were detected 
occasionally, but the blood was considered to be normal otherwise.
Methemoglobin was not detected. The cat was killed 2 months after the
exposure ended. No abnormalities were found at necropsy.
Another cat exposed to EGDN at 134 mg/cu m for 1,000 days was found 
to have anemia, an increased leukocyte count, Heinz bodies, and up to 29% 
of total hemoglobin converted to methemoglobin. During two interruptions 
in the experiment totaling 45 days, erythrocytes and hemoglobin values 
returned to normal. At necropsy, 2 months after the end of the exposure 
period, the authors found evidence of fatty degeneration of the heart, 
liver, and kidneys and pigmentation of the liver and spleen.
The cat exposed to EGDN at concentrations of 140 mg/cu m died after 
273 days, and the two exposed at 170 mg/cu m died after 102 and 97 days
[76]. All three had normoblastic anemia and decreased appetite, and their 
deaths were preceded by clonic and tonic seizures. Autopsy findings were 
severe anemia, hemorrages in the internal organs, and marked renal damage.
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Exposure to airborne NG at a concentration of about 5 mg/cu m for 31 
and 156 days produced slight to moderate anemia in two cats, but neither 
methemoglobin nor Heinz bodies were detected. One cat exposed for 68 days 
to NG at 5 mg/cu m showed moderate lymphocytosis.
Absorption of EGDN vapor by test animals was measured in an 
experiment described by Frimmer et al [77] in 1960. Radioactive r e ­
labeled EGDN was evaporated into a chamber in which a fan was used to 
circulate the air. Concentrations of airborne 14C-EGDN in the chambers 
ranged from 133 to 428 mg/cu m. (The saturation concentration of EGDN at 
room temperature and standard pressure is about 400 mg/cu m.) Fifteen 
Wistar rats and 1 guinea pig were anesthetized with 1.25 g/kg of urethane 
and connected to the chamber by rubber tubing attached to tracheal 
cannulae. Potassium hydroxide was used to remove carbon dioxide from the 
chamber and constant pressure was maintained by adding oxygen. To 
determine the amount of EGDN absorbed by the animals in 10 minutes, the 
authors measured EGDN concentrations in the chamber before the animals were 
attached and again 10 minutes later. The rats absorbed an average of 20% 
of the EGDN they breathed (range 10-34%), and the guinea pig absorbed 27%.
In 1956, Stein [78] studied the effects of exposure to airborne EGDN 
on mice, rats, and guinea pigs. Thirty white mice of unspecified age, 
strain, and sex were exposed to EGDN at a concentration of 800 mg/cu m for 
8 hours/day, 6 days/week, for 10 weeks. The mice were observed for a total 
of 24 weeks, and an unstated number of the animals that died during the 
experiment were examined for macroscopic and microscopic changes.
During tht5 first 4 weeks of EGDN administration, mice shewed 
progressive signs of lethargy, Heinz body formation, cyanosis, and
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exhaustion [78]. By the end of the 7th week of exposure, three mice had 
died after having spasms. Examination of the surviving mice revealed 
intensive Heinz body formation, reticulocyte increases, hemolytic
phenomena, skin erosion, and thin coats. Three more mice had died by week
10, when exposure was terminated. By this time spasms had become less
frequent, but skin damage continued to increase. By the 15th week after
initial exposure, half (15) of the animals had died. Only 10 were alive 
after 20 weeks, and 7 animals were alive at the end of the experiment (24 
weeks). Surviving animals showed no external effects of EGDN exposure. 
Dead animals randomly chosen for dissection during the experiment showed no 
pathologic changes in the heart, lungs, or brain.
Stein [78] concluded that exposed mice died from hemolytic anemia, 
Heinz body formation, and hemoglobinemia. Since spasms often occurred just 
before death, the author speculated that the proximate cause of death was 
probably cerebral hypoxia caused by circulatory and respiratory paralysis. 
Ulceration of the skin was attributed to the effects of EGDN on tissue 
metabolism rather than to direct dermal contact.
In Stein's other experiments [78], mice were exposed to EGDN at a 
concentration of 300 mg/cu m for 14 days, and rats, mice, and guinea pigs 
were exposed at concentrations varying from 500 to 1,500 mg/cu m for from 3 
weeks to 3 months. The details of these experiments are sketchy, but the 
animals were observed to be sleepy and to have Heinz body formation, 
increased reticulocyte counts, and anemia. The severity of these signs 
increased with the length of exposure.
Stein [78] concluded that mice were more sensitive to the effects of 
EGDN than rats or guinea pigs. However, all three species were able to
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tolerate exposure to EGDN at relatively high concentrations without 
developing the circulatory changes that have occurred in workers exposed to 
EGDN from NG:EGDN dynamite. The animals died only after severe blood 
changes had occurred, including hemolytic anemia, Heinz body formation, and 
methemoglobinemia. The effects on circulation in man occurred at lower 
concentrations of EGDN than those associated with blood changes such as 
methemoglobinemia and Heinz body formation in animals.
(b) Dermal Absorption
Gross et al [76] reported on the effects of absorption of EGDN and NG 
through the skin of animals in 1942. Seven cats were exposed to NG and an 
unspecified number to EGDN by application of 4-cm x 6-cm gauze sponges to 
the shaved skin on the cats’ backs. The sponges were saturated with NG or
EGDN, but the amount of these substances on the sponges was not reported.
An unspecified number of rabbits was also exposed dermally to EGDN,
apparently using the same method. The sponges were held in place by 
occlusive bandages for up to 96 hours in EGDN-exposed animals and for up to 
10 days in NG-exposed animals. Blood samples were taken at various times 
after the exposures ended.
One of the cats exposed to EGDN died of severe methemoglobinemia 
after less than 5 hours of exposure [76]. The others survived exposures of 
96 hours or longer. One survivor, exposed to EGDN for 7 hours, developed 
anemia after 3 days and then Heinz bodies and methemoglobin appeared in the 
blood. This animal died 7 days after exposure ended. Another cat, exposed 
for 70 hours, survived but developed anemia and Heinz bodies and had 
methemoglobin values of up to 4 g/100 ml. The anemia was most severe 10
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days after exposure to EGDN. No blood changes were found in rabbits 
dermally exposed to NG for 24 hours.
Only one of seven cats dermally exposed to NG died [76]. A sponge 
saturated with NG was held in place on the cat for 7 days. After a 2-day 
interval, a fresh sponge was applied to the same cat for 3 days, and the 
animal died 10 days after the experiment ended. The only findings reported 
from the autopsy were hemorrhages in the heart muscle. There were no 
unusual findings in a cat exposed for 5 days, and skin irritation was the 
only finding in a cat exposed for 9 days. The skin of nearly all the cats 
was irritated by the NG-soaked sponges. In a cat with an open wound caused 
by irritation from a sponge, erythrocyte and hemoglobin counts decreased, 
and Heinz body formation increased, more rapidly than in cats with intact 
skins that were exposed to NG. The authors concluded that EGDN was 
absorbed through the skin more rapidly than NG and that EGDN, therefore, 
caused more severe toxic effects more quickly.
Gross et al [70] reported in 1960 on the rate of dermal absorption by 
rats of EGDN in a gelatinous mixture and in an "explosive soft paste." The 
authors also studied the rate of EGDN absorption from human skin; these 
findings are reported in Effects on Humans. A gelatinous mixture 
containing 93% EGDN and 7% nitrocellulose was applied to 1 sq cm of 
depilated skin on the backs of 308 male Wistar rats weighing 200-300 g and 
was covered with an occlusive bandage. The amounts of EGDN applied ranged 
from 100 to 600 mg/sq m in 100 mg/sq m increments. The animals were 
divided into 36 groups, with at least 6 animals in each group receiving 
similar doses. An unspecified number of depilated control animals were
bandaged in the same manner as these animals, but no EGDN was applied.
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Each animal was caged alone during the experiment. A similar study was 
conducted using a soft paste consisting of 22.0% EGDN, 6.0% dinitrotoluene, 
5.0% trinitrotoluene, 0.9% nitrocellulose, 1.0% sawdust, 64.9% sodium 
chloride, and 0.2% iron oxide [70]. Eighty-four male rats, divided into 14 
groups of 6, received skin applications of 200, 400, or 800 mg of the
paste.
The bandages on the test animals with the two preparations were 
opened at intervals, starting 12 hours and ending 8 days after application. 
When a bandage was removed, the remaining gel or paste was completely 
removed and analyzed for EGDN by a colorimetric method. A separate 
experiment indicated that not more than 1% of the applied EGDN was released 
from the bandages by evaporation.
In the rats treated with 100 mg of the gel containing 93% EGDN, half 
of the EGDN was absorbed after 1 day and all of it was absorbed after 8 
days [70]. Larger quantities of EGDN required more time for complete 
absorption. The initial rate of absomtion of EGDN from the gel was 
approximately 10 mg/sq cm/hour. EGDN was absorbed more slowly from the 
soft paste containing 22% EGDN, with an initial absorption rate of 
approximately 6.5 mg/sq cm/hour. The authors pointed out, however, that 
the difference between the absorption of EGDN from the two preparations was 
not proportional to the difference in EGDN concentrations. Since the 
concentration of EGDN was only 22% in the soft paste, compared with 93% in 
the gel, the authors concluded that EGDN was absorbed more rapidly from the 
soft paste form. However, because of the consistency of the soft paste and 
the lower concentration of EGDN in it, application of amounts equivalent to 
those in the gel was not feasible.
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In the experiment with the gel, many animals died from the toxic 
effects of EGDN during the first days, when absorption was most rapid [70]. 
Mortality increased with higher doses. Within 12 hours after application, 
1 of 41 (2%) rats receiving 100 mg/kg died; none of 36 died at 200 mg/kg, 8 
of 45 (18%) died at 300 mg/kg, 17 of 78 (22%) died at 400 mg/kg, 9 of 47
(19%) died at 500 mg/kg, and 18 of 61 (30%) died at 600 mg/kg. Heinz
bodies and methemoglobin concentrations of up to 30% of the total blood 
pigments were found in the blood of one of the rats that died from the 
toxic effects of an unspecified concentration of EGDN. None of the rats
treated with soft paste containing EGDN and none of the control rats died
during the experiment, although both groups had poor appetites and lost
weight. Gross et al concluded that, under the same experimental
conditions, 3-4 times less EGDN was absorbed through human skin than 
through rat skin.
Gross et al [79] also reported in 1960 on the amount and rate of 
dermal absorption by rats of NG from two different formulations. Wistar 
rats weighing an average of 243 g were treated with the same "gel and soft 
paste" mixtures used in the previous study, but with NG replacing EGDN. 
The gel (93% nitroglycerin) and soft paste (22% NG) preparations were 
applied to 1 sq cm of depilated skin on the back of each rat and were 
covered with a dressing as described in the preceding study [70] . The gel 
preparation was applied in amounts of 100, 200, 400, and 800 mg, and the 
soft paste was applied in amounts of 100, 200, and 400 mg; both
preparations were applied to 24 rats at each concentration. The dressings 
were left in place for 4 days over the gel preparation and for 8 days over 
the soft paste preparation. The amounts of NG left in the residues at the
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ends of these periods were determined by weight for the gel formulation and 
by the colorimetric method of Bandelin and Pankratz [80], following 
extraction with alcohol, for the soft paste formulation.
Because similar results were obtained from gravimetric and 
spectrophotometric determinations of NG lost from the gel form, mean values 
determined by each method [79] were calculated for six rats. The authors 
reported that 56.8 ± 7.4 mg and 86.8 ± 13 mg of NG were absorbed from the 
100- and the 800-mg compresses of NG gel, respectively, during the 4-day 
experimental period. The rate of absorption of NG was reported to have 
been 0.85 mg/sq cm/hour and was independent of the amount applied to the 
skin. This rate of absorption was about 1/12 that found in the earlier 
study [70] for EGDN (10 mg/sq cm/hour).
The initial rate of absorption of NG from the soft paste containing 
22% of that ester was 0.63 mg/sq cm/hour, or 75% of the rate of absorption 
from gel containing 93% NG (0.85 mg/sq cm/hour) [79]. None of the rats 
died from the action of either NG-containing substance applied to the skin.
(c) Tolerance
Bogaert and De Schaepdryver [81] studied the development of tolerance 
to NG in dogs in 1968. Dogs weighing 6-12 kg were anesthetized with 
pentobarbital (30 mg/kg) and were then given increasing iv doses of NG 
(0.1-100 ij.g/kg) while their arterial blood pressures were continuously 
monitored. Before the anesthetic was administered, six dogs were each 
given a total of 1 mg/kg of NG during 3 days by sc injection, and six dogs 
were each given 1 mg/kg of NG by sc injection 20 times/day for 4 days. 
Fifteen control dogs received the iv injections without pretreatment with 
NG.
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The blood pressure responses in pretreated dogs given iv doses of 3 
or more y.g/kg of NG were significantly less than those in controls (P<0.05) 
[81]. In dogs pretreated with 20 mg/kg/day of NG for 4 days, the dose 
needed to produce a 25 mmHg decrease in blood pressure (ED 25-mmHg) was 
242.7 Mg/kg (SE=27.9), while for six controls it was 12.2 /ig/kg (SE=3) . 
The results indicated that dogs apparently developed tolerance to NG, 
although no explanation was provided for the mechanism of action.
To determine whether short-term exposure to NG had a lasting effect 
on tolerance, the ED 25-mmHg was determined 7 days after the initial blood 
pressure measurement for three dogs that had been pretreated with 20 mg/kg 
of NG for 4 days [81]. Tolerance to NG was less marked: the mean ED 25-mm
Hg at this stage was 74.1 ^g/kg.
Bogaert and De Schaepdryver [81] also investigated the possibility 
that cross-tolerance to NG was produced by exposure to another nitroester. 
Two dogs were given 3 mg of PETN orally 4 times/day for 1 week, and three 
dogs were given 80 mg of the long-acting PETN orally 2 times/day for 10 
days. Following PETN pretreatment, the dogs were anesthetized and given 
0.1-100 jug/kg iv injections of NG while their blood pressures were 
monitored. The pretreated dogs responded to NG no differently than did 
those that were not pretreated, indicating that cross-tolerance between NG 
and PETN had not developed.
Bogaert [82] also reported on the development of tolerance to NG in 
rabbits. In one experiment, 28 rabbits were divided into 4 groups of 
unequal size; 3 of these were given various doses of NG. Ten control 
rabbits were not pretreated. Five rabbits were given sc injections of 1
mg/kg of NG every 30 minutes, 12 hours/day for 3-5 days, ending 12-16 hours
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before the experimental regimen was begun. Eight rabbits received similar 
pretreatment ending 3 hours before the final test began, and five rabbits 
were pretreated with NG only on the day on which the final test began.
The rabbits were anesthetized with urethane, apparently before the 
final pretreatment dose, and arterial blood pressures were recorded [82]. 
Various doses of NG and bradykinin (a vasodilator) were then administered 
iv separately, and the decreases in blood pressure were recorded. To 
quantify the tolerance produced by pretreatment with NG, the authors 
calculated the doses of NG and bradykinin needed to produce a decrease of 
25 mmHg in blood pressure (ED 25-mmHg) from dose-response curves. 
Tolerance was judged by comparing the ratio of the ED 25-mmHg for NG in the 
pretreated animals to that in the controls with the similar ratio for 
bradykinin in the various groups. A high ratio indicated that tolerance 
had developed.
Rabbits pretreated with NG for 3-5 days required larger doses of NG 
to cause a 25 mmHg decrease in blood pressure than did rabbits that 
received no pretreatment or pretreatment only on the final day [82]. The 
effect was most noticeable in rabbits that received sc injections of NG up 
to 3 hours before it was administered iv. The ratio of the ED 25-mmHg for 
NG to that for bradykinin in this group (424, SE=100) was significantly
higher (P<0.05) than it was in the controls (42, SE=13).
Bogaert [82] also examined the response to NG of vascular smooth
muscle from rabbits. Doses were identical to the pretreatment regimens in
the previous experiment, but 41 rabbits were used. After the dosage
schedule was completed, portions of the rabbits' aortas were removed, and
contractions of the aortic strips against a 4-g load were induced by
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exposing the strips to 1-noradrenaline at a concentration of 30 ng/ml. 
When maximum contraction at this dose was reached, increasing amounts of NG 
were added to the tissue bath. Tolerance was determined by calculating the 
dose of NG needed to produce a 50% relaxation from the maximally induced 
contraction (RD50). In rabbits pretreated for 3-5 days, greater amounts of 
NG were required to produce 50% relaxation. The average ED50 for rabbits 
pretreated until 3 hours before their aortas were removed was 776 ng/ml 
(SE=317), compared with 0.50 ng/ml (SE = 0.26) of muscle bath solution for 
controls. The author added that tolerance disappeared rapidly, although 
supporting data were not presented. Bogaert concluded that continued 
exposure to NG produced tolerance by altering the sensitivity of the smooth 
muscle to NG. The fact that this effect was obtained in isolated smooth 
muscle indicates that tolerance may result from a local component as well 
as from the adaptive changes mentioned previously in Effects on Humans.
Needleman and Johnson [83] have proposed that tolerance to organic 
nitrates in vascular smooth muscle is related to a change in the 
interaction of this class of compounds with its specific vascular receptor 
rather than to increased biotransformation or increased sympathetic 
compensatory mechanisms. In in vivo and in vitro studies, they found that 
tolerance to NG was reversed by treatment with D-l,4-dithiothreitol, a 
reducing disulfide. Needleman and Johnson suggested that NG and other 
nitroesters can oxidize a critical sulfhydryl group in the receptor, 
lowering its affinity for organic nitrates. The authors indicated that, 
after tolerance was induced, the preferred receptor conformation might 
favor the disulfide form. Changes in the affinity of the receptors 24-48
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hours after organic nitrate tolerance has been induced should be studied 
further, however.
(d) Metabolism
Many investigators have studied the transformation of lipid-soluble 
NG and EGDN to water-soluble metabolites that are excreted rapidly by the 
kidney. Using in vitro techniques, Heppel and Hilmoe [84] found that NG
reacted spontaneously with reduced glutathione to form inorganic nitrite
and oxidized glutathione and that the reaction could be catalyzed by one 
enzyme found primarily in the soluble fraction of the liver. Since reduced 
glutathione did not react spontaneously with inorganic nitrite, the authors 
proposed reduction of NG by reduced glutathione must have preceded 
hydrolysis. Because simple hydrolysis of the ester, as by strong alkali, 
will yield nitrite ions, hydrolysis and oxidation of GSH may be 
simultaneous, the electrons liberated by the formation of a disulfide 
simply adding to the nitro groups of nitrite ions.
Di Carlo et al [85] studied the absorption and excretion of NG using 
a radioactively labeled compound. A single dose of 14C-NG was administered 
to rats through a stomach tube. Absorption was rapid; within 30 minutes of 
administration, about 6.4% of the radioactivity appeared in the blood, 2.9%
in the urine, and 2.4% in carbon dioxide in expired air. The rates of
elimination in urine and exhaled air were very similar; in 4 hours, about 
20% of the administered radioactivity had appeared in each of them. 1,2- 
dinitroglycerin, 1,3-dinitroglycerin, 1-mononitroglycerin, 2-mononitro­
glycerin, glycerol, unidentified acids, and other products were detected in 
urine. Of these, glycerol was the major component followed by the acids, 
the two mononitroglycerins and the two dinitroglycerins. The intact
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compound was not found in the urine, indicating that all the NG had been 
metabolized.
Needleman and Krantz [86] reported on the pharmacologic activity of 
1,2-dinitroglycerin and 1,3-dinitroglycerin formed when NG reacts with 
reduced glutathione. They found that NG was about four times as effective 
as the dinitroglycerins in increasing coronary blood flow in isolated 
rabbit hearts and about eight times as effective in lowering systolic blood 
pressure in dogs. Thus, the pharmacologic activity of NG in rabbits and 
dogs is related primarily to the concentration of the intact compound.
Using in vivo and in vitro techniques, Clark and Litchfield [87] 
studied the metabolism of EGDN and ethylene glycol mononitrate (EGMN). In 
rat blood, EGDN was metabolized to EGMN, inorganic nitrite, and inorganic 
nitrate. Inorganic nitrite was then oxidized to the nitrate form. EGDN 
was metabolized in erythrocytes and in whole blood, but not in plasma, and 
the transformation was complete in 3 hours. In contrast, EGMN breakdown 
proceeded very slowly; only 4% of the compound was transformed within 4 
hours.
In the in vivo studies, EGDN (65 mg/kg) and EGMN (46 mg/kg) were
injected sc into rats. Blood samples taken at intervals of 0.5-96 hours 
were analyzed for EGDN, EGMN, inorganic nitrite, and inorganic nitrate
[87]. Urine collected for 24 hours was pooled and analyzed for
metabolites. Control values for inorganic nitrite and nitrate in blood and 
urine were obtained from untreated animals. In rats injected sc with EGDN, 
peak blood concentrations were reached at 30 minutes for EGDN, at 1-2 hours 
for inorganic nitrite, at 3 hours for EGMN, and at 3.5 hours for inorganic
nitrate. No EGDN was found in blood after 8 hours and none of the other
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three substances was found after 12 hours. Blood pressure decreased 
immediately after sc injection of EGDN and reached 50% of its original 
value after 30 minutes. There was a secondary fall at 2-3 hours followed 
by a steady rise. Preinjection levels were reached at 12 hours, and there 
were no changes thereafter. The initial decrease in blood pressure 
coincided with an increase in blood EGDN concentrations and the second 
decrease coincided with maximum concentrations of inorganic nitrite and 
EGMN in the blood. When blood pressure had returned to normal, there no 
longer were significant concentrations of EGDN, EGMN, inorganic nitrite, or 
inorganic nitrate in the blood. The metabolism of EGDN injected sc into 
rabbits was similar to that in rats.
In rats injected sc with EGMN, blood pressure decreased to its lowest 
value of 30% of the original value in 2 hours and returned to normal levels 
at 8 hours [87]. Inorganic nitrate was the major metabolite in the urine 
for both EGDN and EGMN, and excretion was complete after 24 hours. These 
findings indicate that although EGDN can be metabolized in erythrocytes, 
some other organ, such as the liver, is responsible for the rapid in vivo 
metabolism of EGMN. The authors injected rats sc with various 
concentrations of sodium nitrite and found that blood pressure decreased 
only slightly until blood nitrite concentrations reached 3 jug/ml. Since 
blood nitrite concentrations did not rise above 1.5 /ng/ml and since 
inorganic nitrate is generally considered to be pharmacologically inert, 
the authors concluded that EGMN causes vasodilation, although it is less 
potent than EGDN. Like NG, EGDN and EGMN appear to be denitrated by 
reduced glutathione in a reaction catalyzed by an enzyme found primarily in 
the soluble fraction of the liver. Both NG and EGDN are metabolized
118
principally in the liver, where concentrations of reduced glutathione and 
the enzyme that catalyzes the reaction are optimal, but they can be 
metabolized in other tissues such as the blood. The suggestion has been 
made that nitroesters may be metabolized also by direct hydrolysis. This 
may be a minor route for transformation of the polynitroesters but may be a 
major route for the mononitroesters [88]. For both NG and EGDN, the 
pharmacologic activity is related most closely to the concentration of 
parent compound, although their metabolites, with the exception of 
inorganic nitrate, also have some pharmacologic activity.
Reviews published by Nickerson in 1970 [89], by Litchfield in 1971
[88] and 1974 [90], by DiCarlo in 1975 [91], and by Needleman in 1976 [92]
contain more detailed information on the metabolism of various nitroesters.
The effects of NG, EGDN, and their metabolites on the intake and 
metabolism of alcohol in rats and mice were reported by Komura and 
Yoshitake [93] in 1971 and by Komura [94] in 1974. In mice, preference for 
drinking a 10% ethanol solution decreased by 48% in those injected ip with 
NG (2 g/kg) [93]. The effect of pretreatment with EGDN on the rate of 
alcohol disappearance was also assessed. Three hours after ip injection, 
blood alcohol concentrations were about 2.2% in mice treated with EGDN (0.2 
g/kg) and 0.5% in control mice injected with water. Activity of alcohol 
dehydrogenase (ADH), an enzyme in the liver that catalyzes the oxidation of 
alcohol, decreased by 56% in mice injected ip with EGDN (0.2 g/kg) and by 
28% in those injected ip with NG (0.2 g/kg).
In similar experiments, Komura [94] found that alcohol preference was
decreased in rats injected ip with NG, EGDN, EGMN, or propylene glycol
dinitrate, but not with their metabolites. Komura suggested that decreases
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in alcohol preference in mice after administration of EGDN and NG and the 
delay in the disappearance of alcohol from the blood of EGDN-treated mice 
were related to decreases in the rate of metabolism of alcohol caused by
decreases in ADH activity in the liver.
(e) Carcinogenicity
A study of the potential carcinogenicity of NG in rats was reported 
by Takayama [95] in 1975. Eight-week-old Sprague-Dawley rats, 50 males and 
48 females, were given NG as a 0.03% solution in drinking water for 10 
months. The same animals were then given plain tap water for 8 months. A
control group of 53 male and 49 female rats was given tap water for the
full 18 months. After the 10 months of continuous administration and the 
8-month withdrawal period, five males and five females were randomly 
selected from the surviving animals for necropsy, followed by biochemical 
and hematologic examinations. All survivors at 18 months were necropsied 
and examined microscopically. Five surviving males and five females 
randomly selected from each group were also examined for biochemical and 
cellular compositions of the blood.
At the end of the dosing period, rats in the control and NG groups 
had similar survival rates, and no behavioral or physical abnormalities 
were observed in either group [95]. Mammary tumors were found in 8 of 44 
(18%) of the female rats treated with NG and in 5 of 45 (11%) of the female 
rats in the control group. The difference is not statistically 
significant. All the mammary tumors were found to be fibroadenomas by 
microscopic examination. An adenoma of the pituitary gland was found in 
one of the female rats in the control group. The author concluded that NG
was not carcinogenic under the experimental conditions.
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In 1975, Suzuki et al [96] reported the results from a study of the 
potential carcinogenicity of NG administered to mice in drinking water. NG 
was dissolved in tap water to make 330, 40, and 10 mg/liter solutions. 
Four-week-old C57BL/6Jms mice, 169 males and 144 females, were exposed to 
NG at these 3 concentrations in their drinking water. About 100 mice were 
in each dosage group, and the control group consisted of 60 male and 63 
female mice.
The group drinking water containing NG at the highest concentration 
was given tap water only for drinking during weeks 52-80 [96] . This
alteration in their regimen gave to the mice of this group a time-weighted 
average concentration during the 80-week period of 214.5 mg/liter of NG in 
their drinking water. The other two groups received NG in their drinking 
water for 80 weeks. Necropsies were performed on all mice that had not 
died by the end of the experiment and on as many of those that died during 
the experiment as possible.
In macroscopic examination of 376 mice, 221 tumors were found [96]. 
There were 160 tumors in the 260 mice treated with NG and 61 tumors in the 
control group of 112 mice. With one exception, the percentages of tumors 
found were similar in the three groups exposed to NG and in the control 
group. However, tumors of the hypophysis were identified macroscopically 
in 5 of 34 female mice (15%) exposed to NG at the highest concentration; no 
tumors at this site were found by macroscopic examination in any other 
group.
The heart, liver, kidneys, spleen, and bone marrow of each animal, 
other organs with macroscopic changes, and any palpable nodules were 
examined microscopically [96] . A total of 163 tumors (69 in males, 94 in
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females) were identified by microscopic analysis; 53 were in the high- 
dosage group, 57 in the mid-dosage group, 53 in the low-dosage group, and 
52 in the control group. Enlargements of the pituitary gland, reported as 
adenomas (benign tumors), were found microscopically in 10 female mice 
exposed to NG; in 6 of 34 in the high-dosage group (18%), in 3 of 39 in the 
mid-dosage group (8%), and in 1 of 40 in the low-dosage group (3%) that 
were examined microscopically. One adenoma of the pituitary gland was 
found in the 50 females (2%) and none in the 32 males in the control group. 
No other differences between animals in the control groups and those 
administered NG were noted.
The authors [96] concluded that NG did not show any carcinogenic 
effect under the experimental conditions. Apparently the tumors of the 
pituitary gland found in female mice exposed to NG were benign, but their 
development suggests that prolonged exposure to this nitroester could
affect the human pituitary gland. Takayama [95] did not find adenomas of 
the pituitary gland in male or female rats exposed to NG. However, the
finding by Suzuki et al [96] of a high incidence of apparently benign
tumors in the pituitary glands of female mice indicates that the potential 
carcinogenicity of NG merits further study. No reports have been found in 
the literature concerning the carcinogenic potential of EGDN.
(f) Mutagenicity
In 1972, Kononova et al [97] reported from the USSR on the potential 
mutagenicity of purified NG and EGDN on extracellular bacteriophage T4B of 
Escherichia coli, as indicated by the frequency of mutations. The actions
of 10 otner organic nitro compounds on this phage were studied also.
Cultivation and inoculation of the bacteria and phage were performed by the
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Adams method. The phage was exposed to 0.084M solutions of NG and EGDN in 
0.2M carbonate buffer (pH 9.0) at 27 C. Survival of the phage and 
alterations of its UV absorption spectrum were measured, the latter effect 
being used as an index of mutagenic activity.
Survival of the bacteriophage was found to decrease with longer 
exposures to both EGDN and NG [97] . However, the survival rate of bacteria 
treated with EGDN was at least 96% below that of bacteria treated with NG. 
In untreated bacteria, the frequency of mutation was about 0.1/1,000 
organisms. The frequency ranged from 0.42 to 0.55/1,000 bacteria in those 
treated with EGDN and from 0.05 to 0.07/1,000 bacteria in those treated 
with NG. Kononova et al concluded that EGDN had some mutagenic activity 
but that NG did not. More studies are needed to determine whether EGDN and 
NG are mutagenic.
Correlation of Exposure and Effect
At present, workers who make or use dynamite are potentially exposed 
to NG:EGDN mixtures. Those who make or use double- or triple-base 
propellants for rockets or guns and those who make pharmaceuticals are 
exposed to NG but not to EGDN. Adverse health effects, nearly all of which 
are associated with changes in the circulatory system, have been reported 
in all three groups of workers.
In most of the reports, the signs and symptoms noted in dynamite
workers exposed to NG or to NG:EGDN were discussed. Dynamite workers were
exposed to NG alone before the 1930's and to both NG and EGDN after the
1930's, when EGDN began to be added to the mixture to make it safer to
manufacture and use. The ratio of EGDN:NG in dynamite has been increased
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in many plants from about 1:1 in the 1930's to about 8:2 or 9:1 at present 
[13]. Vapor pressure measurements vary for EGDN (0.038-0.050 mmHg) and 
even more for NG (0.00012-0.011 mmHg) [5-7]. From a dynamite mixture 
containing 50% EGDN and 50% NG, the concentration of airborne EGDN from the 
mixture would be 3 to 400 times greater than that of airborne NG. 
Therefore, dynamite workers employed before the 1930's were exposed to NG 
alone and those employed after that time were exposed primarily to EGDN. 
Estimates of the concentrations of airborne NG or EGDN to which workers 
were exposed were provided by some investigators, but estimates of the 
extent of absorption through the skin of workers who came into direct skin 
contact with dynamite have not been reported. Studies reported by Sundell 
et al [72] and by Gotell [73] indicated, however, that workers who had 
direct skin contact with dynamite absorbed more NG and EGDN through the 
skin than through the lungs.
There is a characteristic progression in the signs and symptoms 
associated with exposure to NG:EGDN and to NG alone. When first exposed, 
most workers developed intense, throbbing headaches. Ebright [25] 
indicated that these headaches usually began in the forehead and moved to 
the occipital region. Other symptoms associated with initial exposure 
include facial flushing, nausea, vomiting, palpitations, weakness, 
prostration, languor [22], a sense of exhilaration before developing a 
headache, diarrhea, depression, restlessness, sleeplessness [25], copious 
sweating [40], impaired vision, abdominal pain [47], tremors in the arms, 
sensations of heat on the face and limbs [41], cough, difficulty in 
breathing, pallor, and loss of consciousness [21]. The symptoms reported 
most frequently by workers during initial exposure to NG or EGDN are
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headache, dizziness, and nausea [11,22,25]. A throbbing headache is 
generally considered to be the first and the most sensitive and specific 
symptom associated with initial exposure to these compounds. Some workers 
never develop headaches, but for a group of workers as a whole, initial 
exposure to NG or to EGDN is consistently associated with the development 
of headaches. In addition to causing discomfort, these headaches may cause 
affected workers to lose some of their ability to follow the stringent 
safety precautions necessary to prevent explosions. Headaches have been 
reported in workers who make dynamite [11,22,25,38,40,41,45,46,49,68], in 
workers who use dynamite [21,47,48, and Bureau of Mines, written 
communication, November 1977], in workers who make rocket propellants [34- 
36], and in workers who make pharmaceuticals containing NG [29,30].
Trainor and Jones [49] found that six of seven workers developed 
"mild" headaches when they were exposed to NGrEGDN vapor at a mean 
concentration of 0.5 mg/cu m (range, 0.40-0.67 mg/cu m) for 25 minutes or 
less. Since the workers did not handle dynamite directly during the 
experiment, their headaches resulted only from exposure by inhalation of 
NG:EGDN vapor. Trainor and Jones [49] also noted that workers in storage 
magazines complained of headaches when exposed to NG:EGDN vapor at 
concentrations in the range of 0.10-0.53 mg/cu m. Hanlon and Fredrick [29] 
stated that pharmaceutical workers did not develop headaches when exposed 
to airborne NG at concentrations below 0.09 mg/cu m, but supporting data 
were not presented. These findings indicate that at least some workers 
will develop headaches when exposed to NGrEGDN vapor at concentrations 
above 0.1 mg/cu m.
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The most important signs associated with initial exposure to NG or 
EGDN are decreases in diastolic, systolic, and pulse pressures [11,46,57]. 
In general, diastolic pressure decreases less than systolic or pulse 
pressure [11,49]. Findings reported by Trainor and Jones [49] indicate 
that there is a dose-response relationship between pulse pressure and 
concentrations of NGrEGDN vapor; as the airborne concentrations increase, 
the pulse pressures of exposed workers decrease. In men exposed to NGrEGDN 
vapor for 25 minutes, average decreases in pulse pressure from preexposure 
levels were 9.2 mmHg in 10 men exposed at 0.7 mg/cu m and 4.5 mmHg in 7 men 
exposed at 0.5 mg/cu m. If the dose-response relationship between exposure 
to NGrEGDN vapor and the decrease in pulse pressure were linear, then pulse 
pressure would not be expected to decrease during a 25-minute exposure to 
NGrEGDN at 0.3 mg/cu m. The utility of the pulse pressure as an indicator 
of exposure is limited, however, because many other factors also affect its 
magnitude.
The signs and symptoms of initial exposure to NG or EGDN are 
indicative of a rapid and substantial shift in blood volume from the 
central to the peripheral circulatory system initiated by dilation of the 
blood vessels. After 2-4 days of workplace exposure to NG or EGDN, most 
workers do not have these signs or symptoms, ie, they have become tolerant 
to the vasodilatory activity of NG or EGDN [22,25]. Since the half-life of 
EGDN in blood, measured in vitro, was longer in dynamite workers than in 
unexposed controls [72], the development of tolerance to these compounds 
does not appear to be related to an increase in the rate of 
biotransformation in the blood. The development of tolerance is probably 
related to an increase in sympathetic compensatory activity, but it may be
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related to a decrease in the sensitivity of the vascular receptors to these 
compounds [83], to an increased ability of the liver to metabolize the 
nitroesters [98], or to a combination of these factors. Since tolerance is 
lost during periods without exposure, some workers have tried to maintain 
their tolerance to these compounds when away from work [22,25,34] by 
procedures such as placing NG or EGDN underneath their hatbands [25] or 
sucking chips of explosive material from time to time.
Blood pressure is affected by many factors other than workplace
exposure to NG or EGDN, including stress, level of activity, diet, and 
underlying disease. Changes in blood pressures therefore are difficult to 
assign categorically to any one cause. Many investigators have found that 
measurements of blood pressure in dynamite workers were within normal 
limits [25,52-54]. These findings reflect the development of tolerance in 
exposed workers, but in most instances they also reflect differences in 
activity levels before, during, and after exposure and the removal from 
exposure of workers who were less able to develop tolerance, either by 
self-selection or by the employer.
Laws [22] noted in 1910 that workers employed in dynamite plants for
a few years can develop an enlarged area of "heart dullness" as well as
labored breathing and tachycardia on exertion. Angina pectoris has been 
reported in workers who made NGrEGDN dynamite [38,43-45], in a worker who 
used NGrEGDN dynamite [48], in workers who made NG dynamite [63], and in 
workers who made rocket propellants containing NG alone [34-36] . In 
affected workers, angina usually occurred during brief periods away from 
work, eg, a weekend or early in workshifts following periods away from 
work. Reexposure to NG or EGDN, by returning to work, wearing contaminated
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clothing, or taking NG sublingually, usually relieved the pain. Angina 
pectoris is believed to result from a transient imbalance between 
myocardial needs for oxygen and the supply of oxygen in the coronary blood 
flow, and attacks in people not exposed to NGjEGDN were usually 
precipitated by exertion and relieved by rest. It was noted by Robbins 
[99] that people who have attacks of angina "almost invariably have 
atherosclerosis of the coronary arteries, usually moderately severe." In 
workers exposed to NG or EGDN, however, attacks of angina often occurred on 
a Sunday night or a Monday morning and were usually not related to exertion 
[34]. Coronary arteriograms from one worker exposed to NG:EGDN [48] and 
from two workers exposed to NG alone [34] were considered normal, ie, blood 
supply to their hearts was not restricted by atherosclerotic plaques or 
thromboses. In two instances [34,48], the workers experienced chest pains 
while the arteriograms were being taken. In both cases, spasms of the 
coronary arteries were revealed by the arteriogram, and the spasms, along 
with the pain, were relieved when they took NG sublingually. Lange et al 
[34] found that attacks of angina in affected workers generally decreased 
in frequency and severity after they terminated employment. Although most 
former dynamite workers no longer experienced chest pains, evidence of 
heart damage often persisted, including exercise intolerance, impaired left 
ventricular function, intraventricular conduction defects, and atrial 
fibrillation [34].
Sudden deaths without any apparent cause have occurred in NG:EGDN 
dynamite workers [40,49,57,58], in a NG dynamite worker [63], and in 
workers who made rocket propellants containing NG [34-36] . These deaths 
were first attributed to exposure to EGDN, but it is now apparent that
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workers exposed to NG alone also can die suddenly. Like the attacks of 
precordial pain (angina), the sudden deaths that were, reported occurred 
most frequently during brief periods away from work, and in particular, on 
Sunday nights or Monday mornings. In most cases, the worker had no 
premonitory signs or symptoms other than a history of angina during brief 
periods away from work. Some of the workers who died suddenly had never 
reported having attacks of angina, however [58] . Atherosclerotic plaques 
or thromboses were occasionally found in the coronary arteries of workers 
who were autopsied, but their coronary arteries were not occluded to the 
same extent as those of unexposed people who died suddenly [56,58,99]. 
Little information is available on the extent of exposure to NG or EGDN for 
workers who developed angina or died suddenly. Bille and Sivertssen [57] 
reported on the death of a 34-year-old man employed at a dynamite plant for 
6 years who had been exposed to NG:EGDN at concentrations ranging from 0.3 
to 1.4 mg/cu m. Information provided by the Army Environmental Hygiene 
Agency (AEHA) [36] and by Lange et al [34] suggested that at least two 
workers exposed to NG at average concentrations in the range of 1.7 to 2.7 
mg/cu m died suddenly. It should be noted, however, that these workers may 
have also absorbed considerable amounts of NG or EGDN through the skin.
The study by Lange et al [34] indicated that, in former dynamite 
workers, symptoms of heart disease, such as chest pain, had disappeared but 
that some signs of heart disease had remained. Until recently, however, no 
information was available on the health of former dynamite workers who had 
not been exposed to NG or to EGDN for long periods. By reviewing death 
certificates from a county in Sweden, Hogstedt and Axelson [75] found that 
dynamite workers were more likely to die from heart disease than were other
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men in the same county. Twenty-one deaths from cardiovascular diseases 
occurred in men who had been employed at the dynamite plant. Three of the 
deaths occurred in workers who had been actively employed, but the other 18
occurred in men who had not worked at the plant for months or years. It
appears, then, that the effects of long-term workplace exposure to NG or
EGDN may not be completely reversed after exposure is terminated and that
these changes can have severe consequences on the health of former workers.
Some authors have reported that workers who handle dynamite can 
develop numbness in the fingers, paresthesia, or Raynauds's phetnonena [38- 
40,42,62,68]. The cause of these symptoms is not known, but the suggestion 
by Jacob and Maroun [39] that they may be related to nerve damage that is 
secondary to peripheral stagnation of blood flow due to the vasodilatory 
action of nitroesters is reasonable.
It is generally recognized that workers exposed to NG or EGDN have 
less tolerance for alcohol [22,25,42], Animal studies [93,94] indicate 
that exposure to NG or EGDN decreases the activity of alcohol 
dehydrogenase, an enzyme in the liver that catalyzes the metabolism of 
alcohols. This suggests that the rate of alcohol metabolism may be 
decreased in exposed workers.
Carcinogenicity, Mutagenicity, Teratogenicity, and Effects on Reproduction
In 1898, Laws [22] noted that the wives of dynamite workers often 
experienced heavy menstrual bleeding and had fewer children than did other 
women. He added that often the children of dynamite workers were born 
prematurely, were cyanotic, or were not as strong as other children.
Additionally, however, Laws, in 1910 [24], and Ebright, in 1914 [25],
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suggested that NG was an aphrodisiac, since it appeared to them that most 
dynamite workers had large families. Other than these two impressions of 
historical interest, observations of the effects of exposure to NG or EGDN 
on reproduction in humans have not been reported and no study of the 
effects of exposure to NG or EGDN on reproduction in animals has been 
found.
The potential carcinogenicity of NG administered in the drinking 
water was recently evaluated in rats [95] and in mice [96] . No differences 
in tumor site or incidence were found in rats [95], but the study by Suzuki 
et al [96] suggested that female mice given NG in their drinking water had 
an excessive incidence of adenomas of the pituitary gland. Apparently 
these tumors were benign, but their development suggests that exposure to 
NG could affect the pituitary gland. No case reports or epidemiologic 
studies on cancer in workers exposed to NG or EGDN were found.
A study [97] of the potential mutagenicity of NG and EGDN in phage 
from Ê _ coli cannot be adequately evaluated, since the study was not 
reported in sufficient detail. More information is clearly needed to 
determine whether NG or EGDN can affect reproduction, increase the mutation 
rate, or increase the risk of developing cancer in exposed workers.
A summary of the effects on humans of exposure to NG, EGDN, or 
NG:EGDN mixtures is presented in Table III-7.
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TABLE III-7
EFFECTS OF WORKPLACE EXPOSURE TO 




0.3 -12.5* NG Headache 29,35,36
0.3 -12.5* n Blood pressure changes, rash, 
chest pain, EEG changes
36
0.1 - 14* N G :EGDN Headache 11,«3,49,
54
0.12- 0.41* n Pulse wave changes in fingertips 65
0.3 - 4.35* i i Pulse rate changes 11
0.3 -14* n Blood pressure changes 11,43,54
<1.24* n EEG changes 68
<1.24-14* n Palpitations 38,43,68
<1 .25->5* i t Chest pain 38 ,42,68




1.7 ->5* n Alcohol intolerance 38 ,42
1.7 -14* i t Dizziness and fainting 38,4 3
•Also absorbed through the skin
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IV. ENVIRONMENTAL DATA
Sampling and Analytical Methods
Safety is an issue in considering appropriate sampling and analytical 
methods for monitoring airborne NG and EGDN because these substances and 
materials made from them are highly explosive [6]. Early battery-operated 
sampling pumps were considered potential detonation hazards because of 
their electrical wiring and exposed metal surfaces, and such pumps have 
generally been avoided in the explosives industry [11,13,100]. An 
"ejector" (aspirator) sampling unit using an aerosol can containing a 
liquid fluorocarbon propellant was a feasible alternative to pumps [101]. 
This ejector apparatus was especially effective for portable sampling units 
and was used in the past in the NG and EGDN industry [13]. The propellant 
released under pressure from the aerosol can resulted in aspiration through 
the venturi. A calibrated rotometer and flow-adjusting valve were integral 
parts of the commercially available units. Even though a constant-flow 
device was available to maintain and control the flowrate at a previously 
set value for the sampling period, there was no easy way to determine how 
much propellant remained in the can [102]. These units could not be easily 
attached to the workers to be sampled, and a technician was often required 
to continuously operate the sampling unit; this posed a problem when long­
term samples were required. These "ejector" sampling units are no longer 
commercially available.
Battery-operated personal sampling pumps that can be used safely to 
monitor concentrations of airborne NG and EGDN are now available and have
been used in the industrial environment [13,102,103]. The US Department of
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the Interior and the US Department of Health, Education, and Welfare issued 
joint regulations for the approval of personal sampler units for evaluating 
exposure to coal mine dust. These regulations appeared in the Federal 
Register (35 FR 4356) on March 1, 1970, and were incorporated into the Code 
of Federal Regulations as Title 30 CFR Part 74 under authority of the 
Federal Coal Mine Health and Safety Act of 1969 [104]. These regulations 
state that NIOSH and MESA, through rigid testing programs, certify personal 
sampling pumps that meet the stated criteria to be intrinsically safe for 
use in coal mines. These pumps do not pose detonation hazards because they 
can be run for extended periods of time in atmospheres of methane gas at 
concentrations optimal for explosion. NIOSH considers pumps meeting this 
certification to be safe for sampling concentrations of airborne NG and 
EGDN if all possible safety precautions are taken during sampling. The 
most recent NIOSH-validated sampling method for NG and EGDN recommends a 
personal sampling pump [105],
Two methods have been the most effective ones examined by NIOSH for 
collecting samples of airborne NG and EGDN. One involves the use of midget 
impingers or bubblers [11,13,35,100,103,106], and the other is based on the 
use of a Tenax-GC resin adsorption tube [103,107,108]. Various collection 
liquids have been used in the midget impingers and bubblers, such as 
alcohol [11,100,103], propylene glycol [35], an aqueous solution of 0.3% 
potassium chloride [13], and distilled water [13,106]. Einert [11] 
reported "very nearly 100%" collection efficiency using 95% alcohol at a 
sampling rate of 0.5-1.0 liter/minute. In potentially explosive 
environments, the glass impinger units have been enclosed in cardboard 
containers with cellophane windows; connections are made with short Tygon
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tubing that protrudes from the cardboard container [11]. These measures 
are necessary because the static electricity that may be generated on 
exposed glass surfaces may pose a possible detonation hazard. The more 
recently developed sampling method [103,105,107,108] involves the use of 
Tenax-GC resin. A tube similar to the commonly used charcoal tube is 
filled with the resin, which serves as the adsorbing medium for both NG and 
EGDN. This sampling technique involves no liquids and the equipment is 
small, facilitating its use in the field for the collection of personal 
samples. Tenax-GC resin has been shown to be effective as a collection 
medium for NG and EGDN [103,107], and NIOSH therefore recommends its use. 
The recommended sampling method, using a Tenax GC tube and a personal 
sampling pump, is described in detail in Appendix I.
EGDN and NG have been estimated using infrared [109,110] and visible 
[11,13,35] spectrophotometry, thin-layer chromatography [111], polarography 
[112], and titrimetry [113,114]. A colorimetric technique using 
spectrophotometry has been the one most frequently used for the analysis of 
air samples collected in the liquid in midget impingers [11,13,35]. The 
sample is first hydrolyzed with alcoholic potassium hydroxide [11]. The 
nitrites formed are determined by diazotizing sulfanilic acid and coupling 
the product with 1-naphthylamine, which gives a reddish-purple colored 
product. The concentration of nitrites is then read at 525 fim. Using this 
method, Einert et al [11] reported that as little as 0.3 mg/cu m of NG or 
EGDN could be determined using a 10-liter air sample. The colorimetric 
technique is convenient, inexpensive, and relatively simple, but it is not 
specific for NG and EGDN [100]. Other nitrites and nitrates present in the 
sample will interfere in the analysis. In an explosives plant where
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dynamite is manufactured, other nitro and nitrate compounds, such as nitric 
acid, ammonium nitrate, sodium nitrate, and nitrocellulose, are generally 
present [13].
Direct-reading colorimetric tubes are available [115] that make "on- 
the-spot" monitoring of NG and EGDN feasible. These tubes, when properly 
calibrated and used in ways that take their performance characteristics and 
limitations into account, can provide approximate measurements of NG at 
concentrations as low as 1.5 ppm (13.9 mg/cu m) or of EGDN at 
concentrations as low as 0.25 ppm (1.55 mg/cu m). The disadvantages of 
this method are that it is not specific for any particular nitro-containing 
compound and that its sensitivity varies widely for different compounds, 
allowing it to provide only rough estimates of concentrations of total 
nitrates in mixed exposure situations.
The US Navy has developed a field instrument with colorimetric 
detector tubes that may be useful for monitoring airborne NG and EDGN 
[116]. The instrument, called an "Otto Fuel Detector, MK-15," was designed 
for monitoring propylene glycol dinitrate (PGDN), the major component of 
several torpedo propellants. It operates on the principle of controlled 
combustion of nitrated glycol compounds followed by colorimetric 
determination of the liberated N02. It is compact and lightweight (14 
pounds), has a 5-minute minimum response time, and has a tested sensitivity 
of 0.2 ppm (1.37 mg/cu m) for PGDN. However, the method is not specific in 
mixed atmospheres, and the detector tubes have also proved quite variable 
in response. Furthermore, the Otto Fuel Detector has not been tested 
specifically with NG and EGDN, and its safety for use in potentially 
explosive atmospheres is questionable at this time.
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Both volumetric and potentiometric titrimetry are common techniques 
for measuring NG concentrations in pharmaceutical preparations [113,114]. 
The sensitivities of these methods were not reported and, since any 
alkaline chemicals present in the sample can interfere, these methods may 
not be suitable for analysis of air samples. Infrared techniques are used 
to measure NG in drugs [110], and they are also useful in estimating NG or 
EGDN in explosives [109]. The infrared spectrum from 2 to 15 Mm shows 
nitrate absorption bands. Other nitrates commonly found in the workplace 
also absorb in this range, interfering with the accuracy of the method.
Determination of fluorescence has been recommended for qualitative 
spot tests on explosives [117]. Drops of solutions suspected of containing 
NG or EGDN are placed on filter papers and dried. These stains are 
observed in ultraviolet light both before and after the addition of a drop 
of diphenylamine. For NG and EGDN, the dried spot appears greasy and 
fluoresces yellow to blue-green after addition of diphenylamine. This 
method is rapid and may be useful to check for the presence of NG or EGDN. 
Thin layer chromatography [111] has also been recommended for separation 
and qualitative identification of various explosive powder components, 
including NG and EGDN.
Polarography is another technique used to analyze propellants [112]. 
In this method, a current-voltage curve is recorded by a dropping mercury 
cathode and a calomel anode in an electrolytic cell. The current produced 
is proportional to the concentration of the reducible substance, in this 
case NG. Samples can be analyzed quantitatively by comparing the current- 
voltage curves obtained with their solutions with calibration curves 
prepared with standard concentrations.
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Gas chromatography has been used to analyze NG and EGDN in 
propellants [118], in blood [119], and in air samples [103,105,107]. Using 
an electron-capture detector, the minimum amount of EGDN detectable in a 
single injection was "substantially smaller than 0.25 ng" [105]. The
minimum amount of NG detectable in a single injection was "smaller than 2.5 
ng" [105]. In a 10-liter air sample, these sensitivities would permit the 
detection of 0.01 mg/cu m EGDN and 0.10 mg/cu m NG.
The US Navy has also developed a method of using gas chromatography 
for monitoring PGDN that should be applicable to other nitrated glycols
[120]. A 1-ml gas syringe is used to collect a short grab sample that is 
then injected directly into a portable field gas chromatograph with an 
electron-capture detector. The method is sensitive to PGDN at
concentrations as low as 0.05 mg/cu m, but it has not been tested with NG
and EGDN. The safety of this instrument must also be determined before it 
is used in a potentially explosive atmosphere, but it could be sited in a 
safe area and have collected air samples carried to it.
Gas chromatography with an electron-capture detector has been 
validated by NIOSH [105,107] for estimation of both NG and EGDN. This is a 
convenient method for analyzing air samples collected on Tenax-GC resin, 
and it offers the advantage of easy separation and quantitative 
determination of both NG and EGDN. The recommended analytical method, 
using gas chromatography, is described in Appendix I. This method is 
adapted from NIOSH Method No. P&CAM 203 [105] which is a Class E method, 
defined by NIOSH as "Proposed: A new, unproved, or suggested method not
previously used by industrial hygiene analysts but which gives promise of 
suit-ible for th<> determination of a given substance."
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Environmental Concentrations
Most of the environmental level data available for NG and EGDN are 
from dynamite plants where both nitroesters are manufactured and used to 
produce explosives [11,13,100,103,106,121]. In 1976, Barrett et al [103] 
reported data on area sampling for NG and EGDN in a dynamite manufacturing 
plant. Samples were collected using personal sampling pumps with Tenax-GC 
or with single bubblers containing 10 ml of ethanol. The flowrate for the 
bubblers was 1.0 liter/minute, but the sampling flowrate for the sorbent 
tube method was not given. The sampling period was approximately 30 
minutes, and all samples were analyzed by gas chromatography with an 
electron-capture detector. The results are shown in Table IV-1. The 
purpose of this survey was to field test the method and to check for 
possible interferences.
Hercules Incorporated submitted data from area monitoring at its 
plant manufacturing NGrEGDN and dynamite at Carthage, Missouri, from 1975 
to 1977 and provided a description of the sampling and analytical methods 
used [13]. Area monitoring was conducted with a calibrated, battery- 
operated pump and a midget impinger containing an aqueous solution of 0.3% 
potassium chloride. The absorbed nitrate was then determined 
colorimetrically with diphenylbenzidine reagent. The sampling time was 2 
minutes, and 2-4 samples were taken at different sites within 17 buildings. 
Actual exposure concentrations were expressed as NG:EGDN and ranged from 
0.016 to 0.20 ppm. Assuming, on the basis of their relative vapor 
pressures, that these figures were for essentially 100% EGDN, the 
concentrations ranged from 0.1 to 1.24 mg/cu m.
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TABLE IV-1
CONCENTRATIONS OF EGDN AND NG IN AREA 












Dope screen Tenax GC 8.90 0.51 0.02
Oil drop II 8.10 0.57 0.01
Distributor Bubbler 48.00 0.43 -
II Tenax GC 7.81 0.77 0.05
Oil drop Bubbler 25.00 0.37 -
Distributor Tenax GC 1 1 . 0 0 1.10 0.04
Outdoors
Air intake Tenax GC 7.61 0.01 0.007
11 Bubbler 30.00 0.01 -
Slurry shed
Ground level Bubbler 35.00 0.06
If Tenax GC 9.01 0.12 0.007
Floor 2 level 11 8.62 0.04 0.005
Adapted from Barrett et al [103]
In 1959, Yee et al [100] reported atmospheric concentrations of NG 
and EGDN in an explosives plant manufacturing dynamite. Air samples were 
collected for 30 minutes in alcohol in a midget impinger and were analyzed 
colorimetrically. Since oxides of nitrogen, ammonium nitrate, sodium 
nitrate, and nitrocellulose, which interfere in the analysis, were present 
in the factory, the results were calculated as total nitrate as well as NG
and EGDN. The average concentration of nitrate ranged from 0.03 ppm in the
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maintenance building to 0.63 ppm in the dynamite mix house. The 
corresponding concentrations of NG were 0.02 ppm (0.19 mg/cu m) and 0.38 
ppm (3.52 mg/cu m) and of EGDN were 0.02 ppm (0.12 mg/cu m) and 0.31 ppm 
(1.92 mg/cu m). Analysis of exposure by occupations indicated that the 
dynamite mixer had the highest exposure, 0.63 ppm as nitrate. Atmospheric 
concentrations measured in January and March were lower than those measured 
in August. The authors attributed these findings to the fact that vapor 
pressures increase with temperature.
In April 1964, the Pennsylvania Department of Health conducted a 
survey of an explosives manufacturing plant [106]. Breathing-zone air 
samples were collected in distilled water with midget impingers. The 
analytical technique employed was not specified, but the concentrations of 
EGDN and NG combined were reported in terms of EGDN. These ranged from
"none detected" (<0.006 mg/cu m) in the nitration building and certain
areas of several other buildings to 0.06 mg/cu m in the cartridge-packing 
and mix houses. Details of the sampling procedure, such as sampling time 
and flowrate, were not reported.
In 1967, Cavagna et al [121] reported a comparison of concentrations
of airborne NG and EGDN in an Italian dynamite factory during 1955 and
1965. The results were reported as EGDN. The average concentration in the 
packing house in 1955 was 0.30 mg/cu m, with a peak concentration of 0.40 
mg/cu m. In the same location, the 1965 average value was 0.37 mg/cu m and 
the peak concentration was 0.55 mg/cu m. The highest average 
concentrations recorded were in the mix house: 1.70 mg/cu m in 1955 and
1.45 mg/cu m in 1965. However, the highest recorded peak concentrations 
occurred in the cartridge-filling house: 3.30 mg/cu m in 1955 and 1.65
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mg/cu m in 1965. Although there was not much reduction in the 
concentrations in the air between 1955 and 1965, the authors noted that 
improvement in the plant process, automation, and technical control of air 
contamination had enabled the plant to increase the percentage of EGDN in 
the dynamite without increasing the EGDN concentration in the air.
As discussed on Effects on Humans in Chapter III, Trainor and Jones 
[49] attempted to correlate the incidence of headaches in explosives 
magazine workers with the concentrations of airborne NG and EGDN. Air was 
sampled with an impinger charged with ethyl alcohol, the solution being 
analyzed colorimetrically for nitrate with phenol disulfonic acid. The
concentrations, expressed as NG, ranged from 0.10 to 0.53 mg/cu m, with a 
mean of 0.36 mg/cu m.
In 1963, Einert et al [11] reported concentrations of airborne NG and
EGDN (calculated as EGDN) in an explosives manufacturing plant. The
samples were collected in 95% alcohol in a fritted glass bubbler and 
analyzed colorimetrically. At the hand-pack house, the concentrations
ranged from 0.03 mg/cu m at a crimper operation to 4.35 mg/cu m at the bag 
closing and taping operation.
The Army Environmental Hygiene Agency [35] reported concentrations of 
airborne NG in 10 rocket propellant manufacturing installations where EGDN 
was not used. Most of the NG concentrations were between undetected and 
0.3 ppm (2.8 mg/cu m). These figures were based on 10-minute area and 
breathing zone samples segregated by the general process in which they were 
engaged, although the exact survey locations and dates were not reported. 
Air was sampled at a flowrate of 0.1 cfm (2.8 liters/minute) with glass 
midget impingers containing 10 ml of propylene glycol and were analyzed by
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colorimetric determination of the nitrate group [64]. Table 1V-2 contains
the airborne NG concentrations (range and average) for each installation,
the number of processes sampled, the number of samples taken, and the
maximum number of workers involved in the sampled processes at each
installation.
TABLE IV-2
CONCENTRATIONS OF NG IN AIR IN 10 NG 



















A 0-1.30 0.28 23 62 85
B 0-1.94 0.46 11 27 34
C 0-1.48 0.28 12 35 71
D 0-1.30 0.19 4 11 37
E 0-2.50 0.46 10 28 58
F 0-0.09 <0.09 2 4 5
G - - 6 - 44
H 1.30-2.87 1.85 6 8 120
I 0.19-1.94 0.93 4 7 28
J 0-5.56 0.46 5 18 -
K 0-12.5 1.85 27 118 -
*A concentration of 0 means that the analytical method used 
was unable to detect the chemical
Adapted from reference 35
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Installation K had by far the highest concentrations (12.5 mg/cu m); 
the reasons for this finding are not apparent [35]. Many of the workers in 
these installations were exposed at these concentrations only sporadically 
and for brief periods, but many other workers were exposed continuously for 
7-8 hours/day. For the great majority of these processes, no special 
ventilation systems were used. Workers in about half the processes also 
had skin contact with NG, and only about half of these workers used skin 
protection in the form of cotton, neoprene, or leather gloves.
Control of Exposure
Because of the severe health and explosive hazards of NG and EGDN, 
engineering controls must be instituted to control vapor and dust exposure 
in areas where the two substances are manufactured and where they are used 
to manufacture other materials. Control of exposure can best be 
accomplished by closed systems, but enclosure of materials, processes, and 
operations is effective as a control measure only when the integrity of the 
system can be maintained. Therefore, such systems must be inspected 
frequently for breakdown and promptly repaired. Special attention should 
be given to the condition of seals and joints, access ports, and similar 
places. Similarly, points of probable wear or damage should be inspected 
regularly. Local exhaust ventilation may be used in conjunction with the 
closed system to safeguard personnel involved in any part of the operation 
that requires them to handle directly NG, EGDN, or materials containing 
these compounds. Because of the toxic and explosive nature of these 
substances, effective nonsparking local exhaust ventilation systems must be
installed wherever total enclosure is not practical. The principles set
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forth in Industrial Ventilation - A Manual of Recommended Practice [122],
published by the American Conference of Governmental Industrial Hygienists, 
Fundamentals Governing the Design and Operation of Local Exhaust Systems, 
Z9.2-1971 [123], published by the American National Standards Institute, 
and NIOSH’s Recommended Industrial Ventilation Guidelines [124] should be 
applied to control workplace atmospheric concentrations of NG and EGDN. 
These ventilation systems require regular inspection and maintenance to 
ensure their effective operation. The effects of any changes or additions 
to the ventilating system or to the operations being ventilated should be 
assessed promptly after changes occur, and such assessment should include 
measurements of airflow and environmental levels of contaminants under the
new conditions. Work practices should introduce no obstructions or
interferences that would reduce the effectiveness of the ventilating 
system.
NG and EGDN are commonly manufactured in the United States by the 
Biazzi process [6], which is automated; nitration, separation, spent acid 
removal, washing, transfer, storage, and weighing are accomplished without 
the direct participation of personnel. An operator is necessary only at
the startup and shutdown points and for routine checks in the control room.
NIOSH's recommended standards for handling nitric acid [125] and sulfuric 
acid [126] should be followed when applicable.
Dynamite containing NG and EGDN is produced in a variety of
consistencies from a dry, granular type to a gel. The manufacturing
process for dynamite [11] still follows the basic pattern originally
developed by Nobel in 1867. The liquid mixture of NG and EGDN is mixed
with a batch of other material called "dope." Dope can consist of
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combinations of ammonium nitrate, sodium nitrate, and organic fillers such 
as, wood pulp, bagasse, corn starch, and rice hulls. Nitrocellulose is 
added to fora the gel type of dynamite. From the mix house, the explosive 
mixtures are transported to several different packing houses which are 
equipped to handle the specific types of dynamite. Here the cartridges are 
filled by automatic or semiautomatic equipment, packed into plastic-lined 
boxes, and moved to the magazines.
In the manufacturing and packaging processes described above, the 
danger of detonation can be minimized through the use of engineering 
controls and work practices. Engineering controls should be designed to 
prevent detonation and, in the event of accidental explosion, to minimize 
the propagation of detonation. The latter can be accomplished by the use 
of a properly designed facility made up of detached units equipped with 
explosion-venting systems, such as blow-away walls or ceilings and 
pressure-resistant walls. Whenever practical, each unit should be 
subdivided with fire- and pressure-resistant walls to restrict hazardous 
areas and to prevent direct communication with other areas. Additional 
specifications are provided in NFPA No. 63-1971 [2].
Unintentional detonation can be reduced to a minimum or its force 
minimized by controlling the concentrations of NG, EGDN, explosive dusts, 
or particles of solid materials containing these substances in the working 
environment and by removing sources of ignition. Concentrations in the air 
can be limited by the use of closed-system operations, local-exhaust 
ventilation, or combinations of the two. These systems should be 
constructed of nonsparking and noncombustible materials. For ventilation 
systems, ample clearance should be provided between fans and casings with
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dust-sealed, antifriction bearings mounted outside the fan casing. Dust 
collectors should be provided to prevent discharge of the explosives into 
the outside environment, and these collectors should be located outdoors or 
in detached rooms with adequate explosion vents for collectors and rooms. 
Collectors should be cleaned at least daily to prevent accumulation of the 
explosives. Fans should be located so as to draw air from the collector. 
Additional requirements are provided in NFPA No. 91-1973 [127].
The accumulation of explosive dust can be avoided by following the 
guidelines of NFPA No. 63-1971 [2]; for slurry or water gel explosives, the 
Industrial Safety Standard No. V [128] of the Institute of Makers of 
Explosives (IME) should be referred to. Equipment should be dust-tight 
and, where the substances are produced, processed, or handled, should be 
operated under a slight vacuum. All electrical wiring and equipment should 
conform to the requirements of NFPA No. 70-1971 [129] for hazardous
locations and must include explosion-proof fixtures and wiring. The
buildup of static electricity can be minimized by humidification, bonding, 
grounding, and the use of conductive materials. These and other 
requirements are listed in NFPA No. 77-1972 [130].
NG, EGDN, and materials containing these compounds must be stored in 
specially designed magazines. Exact specifications for the construction of 
these facilities and storage provisions are provided in NFPA No. 495-1973
[2] and the IME's Industrial Safety Standard No. 17 [131]. In brief,
magazines should be bullet-resistant, be constructed of steel, wood, 
concrete, or brick, and be used solely for the storage of explosives and 
blasting accessories.
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The siting of magazines must conform to the requirements of the 
American Table of Distances for Storage of Explosives set by the Institute 
of Makers of Explosives [1]. Adherence to these distances should minimize 
the effect of detonation on vehicles, inhabited dwellings, and passenger
4
railways and prevent propagation of an explosion.
Biologic Monitoring
As mentioned in Effects On Humans in Chapter III, a limited amount of 
work has been done on determining the concentrations of NG and EGDN in the 
blood and urine of workers exposed to these substances [71,72]. Williams 
et al [71] measured EGDN concentrations in the blood of exposed workers, 
but the concentrations in air and the amounts deposited on skin to which 
these workers were exposed were not measured. Sundell et al [72] reported 
that blood EGDN concentrations in workers were related to airborne EGDN 
exposure in the absence of skin contact, but there was no correlation 
between the concentrations in blood and urine. There is at present 
insufficient information to suggest an adequate method for biologic 
monitoring of industrial workers exposed to NG or EGDN. Additional 
research may make feasible the routine measurement of these compounds or 
their residues in blood or other body fluids.
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V. WORK PRACTICES
Control of Hazards to Health
NG and EGDN both constitute severe health and safety hazards in the 
industrial environment [11]. Adverse health effects can result from both 
inhalation and dermal contact [11,32], and they range from headaches to 
sudden death [58], Therefore, it is essential to keep worker exposure to 
these substances to a minimum. This can be achieved by effective 
engineering controls, as discussed in Chapter IV, and through a rigid 
program of work practices. The explosive characteristics of these 
substances and materials containing them are well known [6]. Many 
organizations, including state and Federal regulatory bodies, have 
presented guidelines or rules and regulations for handling these substances 
in ways that will minimize the danger of explosion. This chapter will 
therefore concentrate on work practices designed to minimize effects on 
health; safety precautions will be mentioned, but an exhaustive review of 
all appropriate safety rules and regulations is beyond the scope and 
objectives of this document.
Occupational exposure to NG and EGDN can occur during their 
manufacture [14] and during the manufacture and handling of explosives and 
munitions containing them [30,100,132]. Occupational exposure to NG can 
occur also during the manufacture of drugs used primarily to relieve angina 
pectoris [132]. NG and EGDN are both liquids, but they are mixed with 
various other liquid and solid materials to form solid or semisolid 
explosives and munitions. Although the reported vapor pressures of the two
liquids at 20 C vary [5], it is certain that the vapor pressure of NG
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(0.00012-0.011 mmHg) is much lower than that of EGDN (0.038-0.050 mmHg). 
However, work practices designed to minimize exposure to both substances by 
inhalation as well as by dermal contact should be observed because of the 
adverse health effects that can result from minimal absorption of either 
substance [11,49,57]. When the substances are in the solid or semisolid 
state, the hazard of exposure is increased because of the difficulty of 
maintaining a totally enclosed system and the possibility of particle 
dissemination.
Direct skin contact with NG and EGDN can be controlled by the use of 
protective clothing and the practice of good personal hygiene. Protective 
clothing must be worn to shield the body and face of workers from these 
chemicals. The degree of protection required will depend on the severity 
of the potential exposure [36]; however, there is no known material 
currently used in protective clothing that is completely impervious to 
these nitroesters [11,52,65,133], Clothing made of natural or synthetic 
rubbers, including neoprene, is difficult to decontaminate and does not 
provide any warning to the user of breakthrough. The lack of predictive 
sensory cue tends to prolong and promote skin contact with contaminated 
material. Cotton or cotton-lined products are preferred in industry 
because they are easily decontaminated and because breakthrough by 
contaminated liquid leads to a sensation of wetness [13,133], If plastic 
or rubber gloves are used, cotton liners must be worn underneath them 
[133]. The use of fire-retardant, disposable work coveralls and booties, 
which are commercially available [134], is another possibility; however, 
information on their effectiveness for skin protection against NG and EGDN
is needed before their use can be recommended.
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Because the materials most commonly used in protective clothing are 
pervious to NG and EGDN, the approximate breakthrough time for the clothing 
should be calculated by observing normal operating conditions to determine 
the frequency of clothing change necessary to prevent skin contact. In 
some operations, workers may have to change gloves hourly to prevent skin 
contact [133]. Care must be taken to ensure that skin contact does not
occur while contaminated clothing is being removed. In the event of 
breakthrough and skin contact, contaminated clothing must be removed and 
the affected area must be cleaned as soon as possible with soap and water 
or a waterless cleanser to minimize skin absorption.
Dynamite shells or wrappers are made of various materials, such as 
manila paper waxed or impregnated with paraffin and molded plastic [135]. 
These shells protect the explosive from moisture, but NG and EGDN in the 
explosive can permeate the casing, especially during prolonged storage, and 
pose a potential exposure hazard. Workers, such as blasters, who
frequently handle individual casings should therefore wear protective 
gloves to prevent dermal contact. Blasters and others who handle
explosives containing NG and EGDN should maintain the integrity of the
shells and wrappers, both because of the increased hazard to safety posed 
by damaged or unwrapped shells and because of the potential for adverse 
health effects caused by skin and inhalation exposure to NG and EGDN.
While extreme caution should always be used to minimize dermal
contact with these substances, this is especially important until a 
protective clothing material that is totally impervious to NG and EGDN is
available or a convenient method for testing the effectiveness of current
protective clothing is developed. Commercially available barrier or
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protective creams are not recommended at this time because none have been 
shown to provide specific protection against NG and EGDN, and their use may 
actually increase skin absorption [133].
Dermal exposure could possibly be monitored by periodically swabbing 
potentially exposed skin surfaces with a solvent, such as alcohol, and 
estimating the material recovered by gas chromatography or colorimetry. 
Swipe sampling methods are available to determine chemical concentrations 
on room and equipment surfaces [136,137]; however, these methods have not 
been applied generally to detection of contamination of skin. Another 
possible method for monitoring dermal exposure involves the periodic
analysis of the inner linings of protective clothing, such as gloves,
socks, and overalls. This method would be especially useful for 
determining breakthrough times for contaminated work shoes, which are not 
easily decontaminated.
Because these compounds can penetrate clothing, good personal hygiene 
is essential to minimize prolonged skin contact with contaminated clothing. 
NIOSH recommends that working garments, including underclothing, be cleaned 
after each workshift. Workers should be prohibited from taking soiled work 
clothing or personal articles, eg, handkerchiefs, to their homes. The
soiled clothing must be laundered either at the plant or by a cleaning
establishment. In both cases, the laundry personnel must be thoroughly
informed of the contaminants and their potential adverse health effects.
Because NG and EGDN are mixed with absorbing agents in the 
manufacture of explosives, the potential exists for exposure to these 
substances through dust contact. Therefore, work garments should not have 
cuffs or folds that can serve as points of accumulation. Pockets on outer
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garments, if any, should be equipped with securable flaps to prevent dust 
accumulation. Articles of clothing other than issued protective clothing 
should be prohibited in the production area. Care should be taken to 
minimize contamination of work shoes by NG and EGDN. If any tears, cracks, 
or other signs of unusual wear appear in the shoe material, the shoes 
should be repaired, if possible, or else discarded.
The employer should provide locker facilities for the storage of 
personal belongings of employees who have changed into clean work garments. 
A shower facility should be provided, and it should be located to eliminate 
the need for workers to enter the locker area with contaminated clothing. 
At the end of a shift, work garments, including underclothing, should be 
placed in a covered receptacle, and all workers should shower before 
entering the locker area. Employers of blasters, who handle explosives 
containing NG and EGDN, should also provide these locker and shower 
facilities to the employees when possible.
To prevent accidental ingestion of NG and EGDN, workers should be 
instructed to wash their hands before eating, smoking, or using tobacco in 
any other form, eg, snuff. They should also be instructed to avoid 
touching the face and mouth with the hands, gloves, or other contaminated 
objects. The storage, dispensing, preparation, and consumption of food and 
beverages, and the carrying of materials such as tobacco and chewing gum 
into NG or EGDN work areas must be prohibited.
Control of Hazards to if ety
The major hazarc| associated with NG and EGDN is explosion. A number 
of government agencies ’'have formulated regulations to protect workers and
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the general public from explosive materials during their manufacture, 
storage, transportation, and use. The regulations include: Bureau of
Alcohol, Tobacco, and Firearms, Title 27 CFR, Parts 178 and 181;
Occupational Safety and Health Administration, Title 29 CFR, Parts 1910 and 
1926; Environmental Protection Agency, Title 40 CFR, Parts 457 and 700; 
Office of Surface Mining Reclamation and Enforcement, Title 30 CFR Parts
700-830; Mine Safety and Health Administration, Title 30 CFR, Parts 15, 55-
57, 75, and 77; Department of Transportation, Title 49 CFR, Parts 171-178; 
and the Coast Guard, Title 49 CFR Part 176. All states and many local 
governments also have regulations concerning explosive materials [138]. In 
addition, many agencies and organizations have published guidelines for 
handling explosives. These include the Institute of Makers of Explosives 
[131,139,140], the Bureau of Mines [141], and the National Fire Protection 
Association [2] . The explosive characteristics of NG and EGDN become a 
problem during the manufacture of these substances and during the 
manufacture and use of explosives that contain them. In the pharmaceutical 
industry, where NG medications are prepared by adding alcoholic solutions 
of the ester to lactose powder [132], the danger of explosion is minimal 
because of the small amounts of NG used.
Administrative controls and work practices that regulate the amount 
of explosives within the manufacturing and packaging facilities and the 
number of people within these facilities can also effectively minimize the 
dangers of detonation and loss of life. The amounts of NG and EGDN or 
materials containing these substances that can be kept at the manufacturing 
or packaging site should be limited to prevent overstocking at the site, 
preferably to the amount needed for a single shift. Similarly, finished
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explosive products should be removed as soon as possible to a specially 
designed storage magazine. Such practices should help to reduce the 
likelihood of detonation and, should they fail to prevent detonation, 
should minimize the force of the resulting explosion.
Entry into the production area should be restricted to prevent any 
hazard to safety created by an untrained person. The number of people 
working in the area should be limited to those needed for the operation to 
reduce the possibility of accidental detonation. The amount of material 
and the number of people allowed within each facility should be posted 
outside the building. An entry log system separate from buildings 
containing explosives is a convenient method for determining whether the 
occupancy limit is being exceeded without having to enter the work area.
Work practices should be designed to eliminate sources of ignition, 
to prevent dust accumulation through housekeeping, and to minimize the 
dangers of impact detonation. Open flames, smoking, and uncovered light 
bulbs must be prohibited in production areas. Motor-driven portable 
equipment and internal combustion engines and vehicles, such as forklifts, 
should also be prohibited unless they are approved for use in an explosive 
atmosphere and correctly maintained.
Maintenance and repair work inside the buildings must be prohibited 
while the operation is in progress. Before such work is permitted inside 
the building, the operation must be shut down, all the equipment must be 
cleaned, and the work area must be inspected to ensure that there is no 
significant accumulation of liquid NG or EGDN or dust containing these 
substances. A permit system must be established to ensure that these steps 
are taken, and a responsible person, such as a shift supervisor, must sign
155
each permit before maintenance or repair work is begun. If maintenance and 
repair work is being done outside the building, the above procedure may not 
be necessary; the shift supervisor or other responsible individual must 
make this determination. In this instance also, a permit system must be 
established and a permit signed before the work is undertaken. Once the 
work is completed, the workplace must be inspected to ensure that no 
hazardous materials, such as spark-producing metals, remain. The operation 
must not be resumed until the workplace has been inspected and cleared by 
the responsible person. Before they are turned, all screws, bolts, and
nuts on equipment must be thoroughly oiled to prevent spark production. A 
machine that has been shut down for a long period of time or one that has 
been newly installed should be operated with "dummy mixes" until it has 
been proved to be in satisfactory operating condition.
A permit system should also be established to regulate entry into 
tanks that may have contained NG:EGDN. All lines should be disconnected or 
blanked off, and tanks should be emptied and cleaned with a dilute solution 
of sodium carbonate or a specific solvent. If a solvent is used for
cleaning, a water wash should follow. Then the tanks must be purged with
air. If possible, it is a good work practice to continue to blow air
through the tank at a low rate while the employee is working in it. In any 
case, the concentration of oxygen within the tank should be checked before 
an employee enters it and periodically while the tank is occupied. 
Portable, battery-operated oxygen monitors are available for this purpose 
[142]. If possible, NG and EGDN concentrations should also be checked. 
Only after all these steps have been taken and a designated representative 
of the employer, such as the shift supervisor, has signed the permit should
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an employee enter the tank. Any individual entering confined spaces should 
be furnished with appropriate personal protective equipment, such as air- 
supplied respirators, and be equipped with a lifeline harness tended by 
another worker outside the space. This second person, or "buddy," also 
should be equipped for entry into a confined space with approved personal 
protective equipment and should maintain communication by vision, voice, 
signal line, telephone, radio, or other suitable means with the employee 
inside the confined or enclosed space. A third employee, equipped to 
proceed to the aid of the other two if necessary, should have general 
surveillance of their activities.
In general, great emphasis should be placed on the explosive hazard 
associated with these substances. NG is sensitive to impact and may 
detonate. Therefore, precautions should be taken to avoid having loose 
objects in the work area. Ornaments such as metal buckles, clasps, pins, 
and buttons should be forbidden. If flashlights are used (to look into 
tanks, etc), they should be nonsparking and equipped with wrist bands so 
that they cannot fall and cause impact. Where special areas for smoking 
are provided, these areas should be far from the regulated areas. 
Furthermore, fixed lighters should be provided in those areas so that 
employees will not inadvertently carry matches or lighters to the work 
area. Any tools used in the presence of NG or EGDN must be sparkproof. 
Tools should not be left lying around in regulated areas.
At the end of each workshift, all equipment should be cleaned or 
washed. Clean rags used for wiping powder equipment should be kept in a 
covered container. Soiled or wet rags should be discarded in waste 
containers kept outside the regulated areas and should be disposed of at
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the end of the workshift. Small amounts of spilled liquids may be wiped up 
with sponges provided for this purpose. These sponges should be kept in a 
sodium carbonate solution. Large spills must be washed with water and, 
where possible, the waste water should be piped into holding tanks where 
the NG:EGDN can be separated. All dry waste, such as spilled powder and 
rags, should be burned in open grounds.
Magazines used for storing explosive materials should be clean, dry, 
well-ventilated, reasonably cool, and securely locked. Safety regulations 
governing the operation of the magazine should be posted on the interior 
side of the magazine door. All magazines containing explosive materials 
should be opened and inspected at least every 3 days to determine whether 
there has been an unauthorized entry. Except while explosive materials are 
being placed in or removed from the magazines and during inspections, 
magazine doors should be kept locked. Containers of explosive materials 
should be stored so they can be easily counted and checked. Rigid 
containers should be laid flat, and cases should be stored with the top 
side up to minimize spilling if they were to break open accidentally.
Containers of explosive materials should be unpacked and repacked 
outside the magazine, and only securely closed containers should be 
restored in the magazine. Tools used in opening these containers should be 
constructed of nonsparking material. Floors should be swept and washed 
regularly. When magazines need interior repairs, all explosive materials 
should be removed and the floors cleaned thoroughly before and after 
repairs. In making exterior magazine repairs, when there is a possibility 
of causing sparks or fire, all explosive materials should be removed from 
the magazine before these repairs are made.
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For emergency conditions,. such as sparking or rapid increases in 
temperature, a program detailing escape and entry procedures must be 
formulated, written, and made available to all employees. Practice 
evacuation drills should be held periodically, and the emergency plan 
should be recapitulated at least yearly to maintain awareness of its 
provisions. Rapid evacuation is the most important single procedure for 
ensuring safety in an emergency. The employer is responsible for providing 
necessary training to all emergency personnel.
The transporting of explosive materials should conform to the
regulations of the Department of Transporation in Title 49, Parts 171-178, 
supplemented by NFPA No. 495-1972 [2] and the Institute of Makers of
Explosives Publications No. 3 [143] and 6 [128]. Liquid NG is not
acceptable for transporation under Title 49, Part 172. For transportation 
over waterways, Title 33 CFR, Parts 6 and 126, must be followed. Users of 
explosive materials should adhere to the guidelines in the Institute of 
Makers of Explosives Publication No. 17 [131] and NFPA No. 495-1972 [2].
NG and EGDN both pose grave safety and health hazards. It is 
important, therefore, to train all employees to handle these substances 
with respect. Worker training programs, useful in many industries, are 
especially useful for reducing the risk to workers in the ammunition 
industry. Therefore, there should be a written training program for all 
employees who handle these two substances. These instructions should be 
printed both in English and in the predominant language of non-English- 
reading workers. Each new employee should be thoroughly informed about the 
process, hazards, personal protective equipment, and emergency procedures. 
In addition, the signs and symptoms of intoxication by the nitroesters,
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such as headaches, must be described to them. This information on symptoms 
of intoxication should also be made available to the worker's family in the 
event the worker becomes ill during off hours. A thorough on-the-job 
training program should be conducted for new employees, and safety meetings 
should be held regularly. Spontaneous and unannounced safety inspections 
should be made frequently, and quizzes should be given to the workers to 
ensure continuing caution on their part. Special care should be taken to 
ensure that employees unable to read the labels, signs, and instructional 
materials provided understand and know the process, the hazards of working 
with NG and EGDN, the need for, and use of, personal protective equipment, 
and the emergency procedures.
Records should be kept of maintenance schedules, written work 
practices, emergency procedures, storage locations, entries into the 
magazines, accidents, and employee exposures. These records should be 
readily accessible to employees.
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VI. DEVELOPMENT OF STANDARD
I
Basis for Previous Standards
In 1945, Cook [144] compiled a list of maximum allowable
concentrations (MAC's) based on a 40-hour workweek, of atmospheric 
industrial contaminants, including NG. He cited standards of 10-40 ppm 
recommended for NG by the Utah Department of Health and of 0.5 ppm 
recommended by the US Public Health Service. In addition, he suggested 0.5 
ppm (5 mg/cu m) as an "accepted and tentative" limit, because it had been 
found that workers exposed briefly at concentrations as low as 0.5 ppm 
experienced severe headaches after regular occupational exposure had been
discontinued for as few as 40 hours. Cook also mentioned that skin
absorption was possibly a major route of worker exposure. No limit for 
EGDN was suggested.
The American Conference of Governmental Industrial Hygienists (ACGIH) 
also proposed an MAC of 0.5 ppm for NG in 1946 [145]. No basis for this 
standard was cited. In 1949, the ACGIH changed its terminology to express 
standards as Threshold Limit Values (TLV's) [146]. The standard of 0.5 ppm 
for NG remained unchanged. According 'to the first Documentation of
Threshold Limit Values in 1962 [147], the ACGIH TLV was based on the same
findings by the US Public Health Service cited by Cook [144] and on Elkin’s 
report [148] of headache in workers exposed to NG at a concentration of 
0.04 ppm. The ACGIH stated that the 0.5-ppm limit for NG might be too high 
in view of its ability to cause vascular dilatation, with headache, and 
that poorly defined cardiovascular irregularities might follow withdrawal
from long-term exposure. The ACGIH further stated that both the cutaneous
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and inhalation routes of exposure were important, although the relative 
importance of each was not known.
In 1962, the ACGIH [149] lowered the TLV for NG to 0.2 ppm (1.9 mg/cu 
m) and added the "skin" designation to indicate that the value stated for 
the TLV could be relied upon only if absorption through the skin was 
prevented. Also in 1962, the ACGIH adopted a TLV of 0.2 ppm (1.2 mg/cu m) 
for exposure to EGDN. In 1963, the ACGIH [150] proposed a combined TLV as 
a ceiling limit of 0.2 ppm for NG and EGDN with the "skin" designation. In 
1964, however, the ACGIH [151] set separate standards of 0.2 ppm (1.2 mg/cu 
m) for EGDN and 0.2 ppm (2 mg/cu m) for NG and EGDN. Both standards were 
ceiling limits, and both carried the "skin" designation.
According to the 1966 Documentation of Threshold Limit Values [152] , 
the NG and EGDN standards were lowered to 0.2 ppm because industrial 
experience indicated that most exposures were to a mixture of NG and EGDN 
and that the previous 0.5-ppm limit might not protect against fatalities. 
Although the ACGIH noted that there were no firm toxicologic data on which 
to base the 0.2-ppm limit, industrial data were cited from companies 
reporting no serious problems when atmospheric levels of NG and EGDN 
combined were kept below about 0.25 ppm. Melville [153] mentioned that 
therapeutic doses of 0.3 mg of NG probably considerably less than the 
amount obtained from workplace exposures at the 0.5-ppm concentrations, 
produced cardiovascular effects and headache. This was cited by the ACGIH 
[152] as a basis for the lowered standard. The still unknown relative 
importance of the cutaneous and inhalation routes and Barsotti's findings 
[37] that fatalities generally resulted from withdrawal rather than from 
actual exposure were used by the ACGIH as further justification for the
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ceiling limit designation [152]. The ACGIH noted that the limit for either 
NG or EGDN alone should be the same as that for the mixed substances. In 
1966, the ACGIH announced in its list of TLV's for that year an intention 
to set a TLV with a ceiling designation for EGDN and/or NG of 0.02 ppm (0.1 
mg/cu m) "for intermittent exposure only."
In 1968 [154], the TLV for EGDN was expanded to include NG, but
remained at 0.2 ppm for either EGDN, EGDN with NG, or NG alone. The "skin" 
designation remained. This TLV was accompanied, for the first time, by a 
note that an atmospheric concentration as low as 0.02 ppm or the use of 
personal protective equipment might be necessary to prevent headache.
The TLV's and accompanying notations for NG and EGDN remained 
unchanged through 1971, and the 1971 Documentation of the Threshold Limit 
Values for Substances in Workroom Air [155] used some of the previously 
cited data [153,156] as the basis for the TLV. Additional data on 
intermittent exposures, however, were reported as a basis for the 0.02-ppm 
ceiling limit. The findings cited included those of Trainor and Jones 
[49] , who reported an immediate decrease in blood pressure and severe 
headache in workers exposed to a mixture of NG and EGDN at a concentration 
of 2 mg/cu m, and lowered blood pressure and slight headache in volunteers 
exposed to the mixture of NG:EGDN at 0.7 and 0.5 mg/cu m for 25 minutes. 
Hanlon and Fredrick's findings [29] of headache and irritation in workers 
exposed to NG and EGDN at levels of 0.03-0.11 ppm in the breathing zone and 
the subsequent disappearance of these symptoms when concentrations were 
lowered to 0.01 or less were also cited as the basis for the intermittent 
exposure ceiling [155]. The report by Morikawa et al [65] of abnormal 
pulse waves and headache in workers exposed at concentrations below 0.1 ppm
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of combined NG and EGDN were also used to develop this limit. The ACGIH
[155] stated that the intermittent exposure ceiling was primarily designed
to prevent withdrawal symptoms of headache and lowered blood pressure. 
ACGIH TLV's for both NG and EGDN have remained unchanged since 1971, except 
that the 1.2 mg/cu m equivalent for EGDN was dropped in 1972 [157].
There are no current or past ANSI standards for either NG or EGDN.
In 1960, however, the American Industrial Hygiene Association (AIHA) 
Hygienic Guide Series [158] listed a MAC of 0.5 ppm for NG for an 8-hour 
workday, based on unspecified observations of effects on humans. The AIHA 
stated, however, that the short-term exposure tolerance and the atmospheric 
concentration immediately hazardous to life were unknown. No standard for 
EGDN was recommended, although it was noted that most exposure in the 
workplace is to a mixture of NG and EGDN.
According to a 1977 report of the International Labour Office (ILO) 
[159], several foreign countries have promulgated standards for NG:EGDN, 
NG, and EGDN. The foreign standards vary considerably as shown in Table 
VI-1. No documentation for these standards was provided in the ILO report.
The present US standard (29 CFR 1910.1000(a)) for workplace exposure 
to NG is an 8-hour TWA concentration limit of 0.2 ppm (2 mg/cu m) and has a 
"skin" notation. The present US standard (29 CFR 1910.1000(a)) for 
workplace exposure to "ethylene glycol dinitrate and/or NG" is a ceiling 
concentration limit of 0.2 ppm (1 mg/cu m) and also has a "skin" notation. 
This standard has a note indicating that a concentration limit of 0.02 ppm 
or personal protective equipment may be necessary to prevent headaches in 
NG:EGDN dynamite workers. These standards are based on the TLV's for 
workplace exposure adopted by ACGIH in 1968.
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TABLE VI-1
OCCUPATIONAL NG:EGDN, NG, AND EGDN 
EXPOSURE LIMITS FOR VARIOUS FOREIGN COUNTRIES
Country NG:EGDN NG EGDN
mg/cu m ppm mg/cu m ppm mg/cu m ppm
Australia - s,c* 0.2 2 - 0.2 - - -
Belgium - II 0.2 2 s,c 0.2 - s,c 0.2
Finland 1.2 11 0.2 2 i i 0.2 1.2 f t 0.2
Federal Republic 
of Germany
— — — 5 0.5 1.6 0.25
Hungary - - - 5 s - - -
Italy - - - 1 It - 0.3 s -
Japan 1.2 S,C 0.2 - - - 1.2 II CM•O
Netherlands - II 0.2 2 s 0.2 - - -
Poland - - - 2 II - - - -
Rumania - - - 2 s,c - 1 s,c -
Sweden 1.0 s 0.1 2 s 0.2 1.0 s 0.1
Switzerland 1.2 c 0.2 2 II 0.2 1.2 II 0.2
Yugoslavia s 0.02 2 II 0.2 II 0.02
*S=skin notation;C=ceiling
Adapted from reference 159
Basis for the Recommended Standard
(a) Workplace Environmental Limits
Reports describing the effects of NG were first published over 100 
years ago [12,17,19]. At present, the reported effects of exposure to NG 
or EGDN include throbbing headaches, dizziness, nausea, and decreases in 
systolic, diastolic, and pulse pressure during initial exposure to these 
compounds [11,21,22,25,40,41,45-47,49], angina pectoris and sudden death 
without any apparent cause during brief periods away from work [34-38,43-
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45,48,63], and a greater proportion of deaths from cardiovascular diseases 
in former NG:EGDN dynamite workers than in the general population [75].
NG and EGDN are readily absorbed by inhalation and through the skin. 
A few authors have reported estimates of concentrations of airborne NG or 
EGDN to which affected workers were exposed [11,29,36,43,44,49], but 
estimates of the amount of these compounds that can be absorbed through the 
skin have not been reported in these studies. A recent study suggests, 
however, that workers who handle dynamite directly may absorb more NG:EGDN 
through the skin than through the lungs [72].
The signs and symptoms of initial exposure to NG or EGDN are
indicative of the rapid and substantial shift in blood volume from the
central to the peripheral circulatory system that is initiated by dilation 
of the blood vessels. Not all workers develop throbbing headaches or 
changes in blood pressure during initial exposure to NG or EGDN, but the 
available data indicate that these are usually the first and most
consistent effects of initial exposure. In addition to the discomfort 
caused by headaches, affected workers may be less able to follow the
stringent safety precautions necessary to prevent explosions. Headaches 
have been reported in workers who make dynamite 
[11,22,25,38,40,41,46,49,68], in workers who use dynamite [21,47,48, and 
Bureau of Mines, written communication, November 1977], in workers who make 
rocket propellants containing NG [34-36], and in workers who make NG- 
containing pharmaceuticals [29,30]. Decreases in blood pressure during 
initial exposure to NG:EGDN dynamite have also been reported [11,46,49,54],
Trainor and Jones [49] found that six of seven workers developed
"mild" headaches when exposed to NG:EGDN vapor at 0.5 mg/cu m (range 0.40-
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0.67 mg/cu m) for 25 minutes or less. Average decreases in blood pressure 
for these seven workers were 11 mmHg for systolic pressure, 6.5 mmHg for 
diastolic pressure, and 4.5 mmHg for pulse pressure. Since the experiment 
was conducted in a magazine and the subjects did not handle dynamite 
directly, these effects resulted only from exposure to NG:EGDN vapor. 
Trainor and Jones also reported that workers in a magazine developed 
headaches when exposed to NG:EGDN concentrations between 0.10 and 0.53 
mg/cu m. It is possible that some headaches developed at the lower limit 
of the range. However, since the average concentrations in the magazine 
was considerably higher, ie, about 0.36 mg/cu m, NGrEGDN concentrations 
substantially greater than 0.1 mg/cu m probably predominated in the 
magazine and produced the headaches. Hanlon and Fredrick [29] stated that 
pharmaceutical workers did not develop headaches when exposed to airborne 
NG at concentrations below 0.09 mg/cu m, but presented no data on the 
topic. Findings from the study by Trainor and Jones [49] indicated that 
there was a dose-response relationship between pulse pressure (systolic 
minus diastolic pressure) and the concentration of NG:EGDN vapor; as air 
concentrations increased from 0.5 to 2.0 mg/cu m, pulse pressures of 
exposed workers decreased.
After 2-4 days of workplace exposure to NG or EGDN, most workers no 
longer experience headache, dizziness, nausea, or decreases in diastolic, 
systolic, or pulse pressures; ie, they have become tolerant to the 
vasodilatory activity of NG or EGDN [22,56]. The development of tolerance 
is probably related to an increase in sympathetic compensatory activity, as 
indicated by the findings that administration of amphetamine, a
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sympathomimetic drug, to workers with headaches relieved the pain [32] and 
that tolerant workers without headaches would often develop severe 
headaches shortly after drinking alcohol [22,25]. The development of 
tolerance may also be related to a decrease in the sensitivity of the 
vascular receptors to these compounds [83], or to a combination of these 
effects. Since tolerance is lost during periods without exposure, workers 
have often attempted to maintain tolerance to these compounds by carrying 
the material home with them and applying it to their boaxes [22,25,34].
Many investigators have found that blood pressure measurements in 
dynamite workers were within normal limits [25,52-54]. These findings 
usually reflect the development of tolerance in exposed workers, but they 
may also reflect differences in physical activity before, during, and after 
exposure, and the removal of workers who were less able to develop 
tolerance by either administrative control or self-selection.
Angina pectoris has been reported in workers who made NG:EGDN 
dynamite [38,43-45], in a worker who used NG:EGDN dynamite [48], in workers 
who made dynamite containing NG alone [63], and in workers who made rocket 
propellants containing NG [34-36]. In affected workers, angina usually 
occurs during periods away from work, eg, on a weekend. In contrast to 
findings for most other people who develop angina, the coronary 
arteriograms of one worker exposed to NG:EGDN [48] and of two workers 
exposed to NG alone [34] were considered normal; ie, the blood supply to 
the heart was not restricted by atherosclerotic plaques or thromboses. 
Spasms of the coronary arteries were revealed by the arteriograms of two 
workers [34,48]. The spasms, along with the pain, were relieved by taking 
NG sublingually.
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Sudden deaths without any apparent cause have occurred in workers who 
made NGrEGDN dynamite [AO,49,57,58], in a worker who made NG dynamite [63], 
and in those who made rocket propellants containing NG [34-36]. These 
deaths were first attributed to exposure to EGDN, but it is now apparent 
that workers exposed to NG alone can die suddenly also. Like attacks of 
angina, the sudden deaths that were reported occurred more frequently 
during periods away from work, particularly on Sunday nights or Monday 
mornings. In most cases, workers who had died suddenly had not had any 
premonitory signs or symptoms other than a history of angina attacks during 
periods away from work [58]. Atherosclerotic plaques or thromboses were 
occasionally found in the coronary arteries of workers who were autopsied, 
but their coronary arteries were usually not occluded to the same extent as 
those of unexposed people who had died suddenly [56,58]. Unfortunately, 
little information is available on the extent of exposure to NG or EGDN for 
workers who developed angina pectoris or died suddenly. Bille and
Sivertssen [57] reported the death of a 34-year-old man employed at a
dynamite plant for 6 years who had been exposed to NGrEGDN vapor at
concentrations of 0.3-1.4 mg/cu m. Information provided by the Army 
Environmental Hygiene Agency (AEHA) [36] and by Lange et al [34] suggested 
that at least two workers exposed to airborne NG at average concentrations 
in the range 1.7-2.7 mg/cu m have died suddenly. It should be noted,
however, that these workers may have also absorbed considerable amounts of 
NG or EGDN through the skin.
The study by Lange et al [34] indicated that symptoms of heart 
disease, such as chest pain, disappeared in affected rocket propellant
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workers when they were no longer exposed to NG but that some signs of heart 
disease remained. By reviewing death certificates from a county in Sweden, 
Hogstedt and Axelson [75] found that NG:EGDN dynamite workers were more 
likely to die from heart disease than were other men in the same county. 
Twenty-one deaths from heart disease occurred in men who had been employed 
at the dynamite plant for 1 year or more; 4 occurred in workers who were 
actively employed, but the other 17 occurred in men who had not worked at 
the plant for months or years. It appears, then, that the effects of long­
term workplace exposure to NG or EGDN may not be completely reversed after 
exposure is terminated and that these changes can have severe effects on 
health.
NIOSH has concluded that workplace exposure to NG and EGDN should be 
controlled so that workers are not exposed at concentrations that will 
cause vasodilation, as indicated by the development of throbbing headaches 
or decreases in blood pressure. This standard should also protect against 
the development of angina pectoris, other signs or symptoms of cardiac 
ischemia or heart damage, and against sudden death, as a result of working 
with NG or EGDN, since all of these results seem to be related to 
compensatory vasoconstriction induced by repeated exposure to NG or EGDN 
and revealed by withdrawal to the vasodilatory activity of these substances 
during weekends or other periods of absence from regular exposure. 
Headaches appear to be the most sensitive and specific indicator of 
vasodilation ir workers initially exposed to these compounds. Apparently 
workers initially exposed at concentrations of NG:EGDN averaging 0.36 mg/cu 
m (range O.i-O.53 mg/cu m) can develop headaches [49]. Workers exposed to
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0.09 mg/cu m of NG have been said not to develop headaches [29], but 
supporting data were not provided.
In most studies of health effects in exposed workers during which 
environmental concentrations were measured, a colorimetric method was used 
that measured the concentration of total inorganic nitrites. Therefore, 
there is some information available on health effects in workers exposed to 
dynamites composed of NG and EGDN in varying proportions, but the relative 
severities of the health effects associated with exposure to each of these 
compounds cannot be adequately determined. Because equal masses of NG and 
EGDN yield very nearly equal masses of nitrite ion on hydrolysis, it is 
appropriate to recommend one standard for workplace exposure to NG, EGDN, 
or a mixture of these two compounds.
The available information indicates that when absorption of NG or 
EGDN through the skin is controlled to the greatest extent possible, 
workers exposed to concentrations of airborne NG or EGDN at or less than
0.1 mg/cu m will not experience significant changes in blood pressure as 
demonstrated by the development of throbbing headaches. Thus, it is 
recommended that exposure to NG and EGDN be controlled so that workers are 
not exposed to airborne NG, EGDN, or mixtures of these substances at 
concentrations greater than 0.1 mg/cu m, as a ceiling concentration during 
any 20-minute sampling period.
(b) Sampling and Analysis
Personal sampling with a NIOSH-certified sampling pump for coal mine 
dust and a Tenax-GC adsorption tube is recommended. This type of sampling 
pump is recommended because of the potentially explosive environments,
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similar to those in coal mines, in which NG and EGDN are to be sampled. 
The Tenax-GC adsorption tube has been shown to be an effective collection 
medium for NG and EGDN and is not affected by variations in humidity [103]. 
This sampling technique involves no liquids and the equipment is small, 
facilitating personal sampling.
Gas chromatography with an electron-capture detector is recommended 
for the analysis of NG and EGDN so that the necessary sensitivity and 
specificity can be attained. The bases for the recommended sampling and 
analytical methods are discussed in Chapter IV, and detailed directions are 
provided in Appendix I.
(c) Medical Surveillance
In view of the effects of exposure to NG and EGDN on the 
cardiovascular system, NIOSH recommends that comprehensive preplacement and 
periodic examinations be made available to all workers occupationally 
exposed to these substances. ECG's taken during rest and during exercise 
should be conducted at least annually, as these tests are indicators of 
cardiovascular damage. The worker should be informed that symptoms such as 
headaches, dizziness, or nausea (that can develop during working hours) and 
chest pains or palpitations (that can develop during periods away from 
work) may be indicative of NG or EGDN toxicity and that these symptoms 
should be immediately reported to the responsible physician. All pertinent 
medical records, with supporting documents, must be kept for at least 30 
years after termination of employment.
(d) Personal Protective Equipment and Clothing
Personal protective equipment must be used in accordance with 29 CFR 
19.10. Because of skin irritation from exposure to NG or EGDN [66,67] and
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demonstrated dermal absorption [11,63,70,76,79], proper gloves and 
protective clothing for exposed skin must be provided and used. Clothing 
that becomes spattered with NG or EGDN must be replaced immediately. 
Disposable garments may have some advantage as work clothing because of the 
ease of disposal, particularly for those made of regenerated cellulose. 
Respiratory protection, as designated in TaDia I-i, should be used to 
protect against harmful concentrations of NG or EGDN vapor, but it is not a 
substitute for ventilation and other engineering controls intended to keep 
concentrations in workplace air below the recommended environmental limit. 
Table I— 1, specifying the requirements for respiratory protection, is basea 
on the toxicologic and physical properties of NG and EGDN. Because of the 
explosive nature of both NG and EGDN and materials containing these 
compounds, nonsparking parts must be used where steel or iron is normally 
used on any respiratory equipment.
(e) Informing Employees of Hazaris
Employee awareness is important in an overall effort to reduce 
occupational injuries and illness. Therefore, employers must inform 
employees of the toxic and explosive hazaris of ^G and EGDN. Keogh [160] 
has recently written a pamphlet for workers on the health effects of 
exposure to these compounds. A continuing education program, conducted at 
least annually, should be instituted by employers. This orogram should 
include instruction for employees on the need for, and proper use of, 
personal protective equipment, emergency procedures. proper work practices, 
and sanitation.
(f) Work Practices
Exposures to NG and EGDN in occupational environments can best be 
prevented by engineering controls and good work practices. NG and EGDN are 
readily absorbed through the skin. The protective gloves currently 
available will minimize but not prevent cutaneous absorption of these 
compounds. Workers should wear rubber or plastic gloves with a cotton 
lining or plain cotton gloves. Gloves should be changed at least daily. 
Cotton gloves should be changed immediately whenever they become 
contaminated with liquid NG or EGDN.
The extreme explosiveness of NG and EGDN necessitates conformance to 
stringent work practices. Smoking, matches, open flames, spark-producing 
devices, firearms, and welding apparatus must be prohibited in areas 
containing NG or EGDN. Dynamite and pure NG or EGDN should be stored in 
clean, cool, well-ventilated, bullet- and missile-resistant areas that are 
located away from all sources of ignition. Engineering controls are 
recommended to prevent accumulation of airborne NG and EGDN in work areas. 
Employers must establish procedures for emergency situations, sanitation, 
and maintenance, and must ensure that these procedures are understood and 
followed by all occupationally exposed workers.
(g) Monitoring and Recordkeeping Requirements
Because of the toxicity of NG and EGDN, employers must determine by 
an industrial hygiene survey whether employees are exposed to these 
compounds above the action level of 0.05 mg/cu m for any sampling period. 
If this survey reveals that exposure is at or below 0.05 mg/cu m, then the 
same type of survey must be made once every 3 years and be supplemented by
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semiannual personal sampling of employees. If exposure should be found to 
be above 0.05 mg/cu m, more frequent sampling is required.
Records of such monitoring must be kept for each employee 
occupationally exposed to NG or EGDN. These records must be kept for 30 
years after the individual's employment has ended and must be made 
available upon request to the appropriate Federal agencies and to the 
employee or to the employee's authorized representatives.
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VII. RESEARCH NEEDS
Research focused on the prevention of adverse health effects in 
workers who manufacture, handle, or use NG or EGDN is needed in several 
areas. For workers who handle NG or EGDN directly, skin absorption appears 
to be the major route of exposure. Thus, investigators should develop 
processes that will minimize or prevent skin contact with these compounds.
NG and EGDN penetrate gloves made of neoprene, rubber, leather, or 
cotton that are currently worn by exposed workers. Research should be 
conducted to identify a material suitable for use in work clothing and 
gloves through which these nitroesters will not penetrate. As an interim 
measure, a safe compound that changes color when it comes in contact with 
NG or EGDN should be identified. If used on gloves and clothing, workers 
would be warned by the change in color that their clothing had become 
contaminated with nitroesters.
Compounds should be identified that will remove NG and EGDN from the 
skin and from surfaces in work areas more effectively than do soap and 
water.
Further research is needed to identify a "no effect" level for 
exposure to NG or EGDN in the workplace, and appropriate indices of both 
exposure and effect should be developed that can be used to determine 
whether workers are overexposed to these substances. Exposure by 
inhalation can be estimated from concentrations of these airborne 
compounds, but no method is currently available to assess the extent of 
exposure through the skin. Such estimates might be based on measurements 
of concentrations of NG or EGDN removed from the skin on swabs or in cotton
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gloves, glove liners, or socks. An index of exposure by both inhalation 
and akin absorption could be obtained by measuring concentrations of NG and 
EGDN in the blood or possibly the urine of exposed workers. An index of 
effect might be constructed of information on symptoms, blood pressure 
estimations, and such measurements as fingertip volume by plethysmography. 
New techniques, such as echocardiography, may provide information on the 
effects of NG or EGDN on cardiac function.
Angina pectoris, caused by an insufficient supply of oxygen to the 
heart, is usually associated with sclerosis of the coronary arteries. 
However, it does not appear that atherosclerosis is more extensive in 
workers exposed to NG or EGDN than in the general population. It has been 
suggested that spasms of the coronary arteries may ieaa to angina or sudaen 
death in exposed workers, particularly during briar periods of withdrawal 
from exposure, such as on weekends. The nechanism of causation of these 
spasms and the possibility that other factors may be associated with angina 
and sudden death in exposed workers, should be explored. Detailed 
epidemiologic studies are needed to determine the extern: of the risK of
developing heart disease in former workers who are no longer exposed to NG 
or EGDN and to identify factors, such as duration of exposure, that may be 
associated with this increased risk.
Reports, primarily from the turn of che century, suggest that 
exposure co NG alone or, especially, with aicohoi can cause psychologic 
effects. More recent reports suggest cnac vorkers ino absorb NG or EGDN 
through the skin can develop numbness in "heir fingers. Further studies 
are needed to determine whether these nitroesters act directly on the 
central or peripheral nervous systems or whether che reported effects are
secondary to the effects of these compounds on the cardiovascular system.
With the exception of one report from the late 1800's, the effects of 
NG or EGDN on the male and female reproductive systems or on the developing 
fetus have not been evaluated. The possibility that workplace exposure to 
these compounds may affect reproduction merits further attention. Well- 
designed tests are needed to determine whether NG, EGDN, or their 
metabolites are potentially mutagenic or carcinogenic by inhalation, 
ingestion, or absorption through the skin.
The US Army Medical Research and Development Command is sponsoring 
studies of the toxicity of NG. Dilley [161] is studying the effects of 
exposure to NG by inhalation and through the skin on coronary blood flow in 
dogs. Lee et al [162,163] are studying the effects of short-term and long­
term exposures to NG in rats, mice, and dogs. The potential 
carcinogenicity of NG administered orally to rats and mice is also being 
studied by Lee et al. Since these studies [161-163] are still in progress 
(1978), final results from them are not yet available.
178
VIII. REFERENCES
1. The American Table of Distances, publication No. 2. New York, 
Institute of Makers of Explosives, Safety Library, 1977, 17 pp
2. National Fire Codes— A Compilation of NFPA Codes, Standards, 
Recommended Practices, and Manuals; Combustible Solids, Dusts and 
Explosives. Boston, National Fire Protection Association, 1974, vol 
3, pp 495-1 to 415-69,63-1 to 63-16
3. Von Oettingen WF: The Effects of Aliphatic Nitrous and Nitric Acid
Esters on the Physiological Functions with Special Reference to Their 
Chemical Constitution, NIH bulletin No. 186. Federal Security 
Agency, US Public Health Service, National Institutes of Health, 
1946, 76 pp
4. Dacre JC, Tew RW: Mammalian Toxicology and Toxicity to Aquatic
Organisms of Nitroglycerin, A Waterborne Munitions Waste Pollutant— A 
Literature Evaluation. Springfield, Va, US Dept of Commerce, 
National Technical Information Service, 1974, vol 74, 37 pp (NTIS AD- 
777 902)
5. Urbanski T: Chemistry and Technology of Explosives— Vol II. Oxford,
Pergamon Press, 1965, pp 34-61,142-49.
6. Rinkenbach WN: Explosives, in Kirk-Othmer Encyclopedia of Chemical
Technology, ed 2 rev. New York, Interscience Publishers, 1965, vol 
8, pp 581-95,602-06,635-42
7. Windholz M (ed.): The Merck Index— An Encyclopedia of Chemicals and
Drugs, ed 9. Rahway, NJ, Merck and Co Inc, 1976, p 739
8. Weast RC (ed.): Handbook of Chemistry and Physics— A Ready-Reference
Book of Chemical and Physical Data, ed 55. Cleveland, CRC Press Inc, 
1974, pp C-288,C-314
9. Dean JA (ed.): Lange's Handbook of Chemistry, ed 11. New York,
McGraw-Hill Book Co, 1973, pp 7-234 to 7-237
10. Christensen HE, Fairchild EJ (eds.): Registry of Toxic Effects of
Chemical Substances, 1976 Edition, DHEW publication No. (NIOSH) 76- 
191. Rockville, Md, US Dept of Health, Education, and Welfare, 
Public Health Service, Center for Disease Control, National Institute 
for Occupational Safety and Health, 1976, pp 526,780,799
11. Einert C, Adams W, Crothers R, Moore H, Ottoboni F: Exposure to
mixtures of nitroglycerin and ethylene glycol dinitrate. Am Ind Hyg 
Assoc J 24:435-47, 1963
179
12. Holmes LC, DiCarlo FJ: Nitroglycerin— The explosive drug. J Chem 
Educ 48:573-76, 1971
13. Plant observation reports and evaluation. Menlo Park, Calif, SRI 
International, Jan 1978, 506 pp (submitted to NIOSH under Contract 
No. CDC-99-74-31)
14. Klassen HJ, Humphrys JM: Manufacture of nitroglycerine by the Biazzi 
continuous process. Chem Eng Prog 49:641-46, 1953
15. Lindner V: Propellants, in Kirk-Othmer Encyclopedia of Chemical
Technology, ed 2 rev. New York, Interscience Publishers, 1965, vol 
8, pp 659-719
16. Key MM, Henschel AF, Butler J, Ligo RN, Tabershaw IR (eds.): 
Occupational Diseases— A Guide to their Recognition, rev, DHEW 
publication No. (NIOSH) 77-181. US Dept of Health, Education, and 
Welfare, Public Health Service, Center for Disease Control, National 
Institute for Occupational Safety and Health, 1977, pp 95,160-61,282- 
84
17. Brunton TL: Use of nitrite of amyl in angina pectoris. Lancet 1:97-
93, 1867
18. Murrell W: Nitro-glycerin as a remedy for angina pectoris. Lancet
2:80-81, 113-15,151-52,225-27, 1879
19. Field AG: Nitro-glycerine or glonoine. Med Times Gaz 39:339, 1859
20. Hay M: The chemical nature and physiological action of nitro­
glycerine. Practitioner 30:422-33, 1883
21. Darlington T: The effect of the products of high explosives,
dynamite and nitro-glycerine on the human system. Med Rec 38:661-62, 
1890
22. Laws GC: The effects of nitroglycerin upon those who manufacture it.
J Am Med Assoc 31:793-94, 1898
23. Jennings JW: Cordite eating and cordite eaters. J R Army Med Corps
1:277-85, 1903
24. Laws CE: Nitroglycerin head. J Am Med Assoc 54:793, 1910
25. Ebright GE: The effects of nitroglycerin on those engaged in its
manufacture. J Am Med Assoc 62:201-02, 1914
26. Bradbury JB: The Bradshaw lecture on some new vaso-dilators. Br Med
J 2:1213-18, 1895
180
27. Haldane, J, Makgill RH, Mavrogordato AE: The action as poisons of
nitrites and other physiologically related substances. J Physiol
11:160-89, 1897
28. Oltman TV, Crandall LA Jr: The acute toxicity of glyceryl trinitrate
and sodium nitrite in rabbits. J Pharmacol Exp Ther 41:121-26, 1931
29. Hanlon JJ, Fredrick WG: Great lead controversy. Arch Environ Health
(Lett) 12:676, 1966
30. Bresler RR: Nitroglycerin reactions among pharmaceutical workers.
Ind Med 18:519-23, 1949
31. Martimor E, Cavigneaux A, Nicolas-Charles PJ: Mental disorders
caused by occupational poisoning by nitroglycerin. Arch Mai Prof Med 
Trav Secur Soc 19:574-580, 1958
32. Schwartz AM: The cause, relief and prevention of headaches arising 
from contact with dynamite. N Engl J Med 235:541-44, 1946
33. Mountcastle VB (ed.): Medical Physiology, ed 13. St. Louis, The CV 
Mosby Co, 1974, vol 1, pp 367-72
34. Lange RL, Reid MS, Tresch DD, Keelan MH, Bernhard VM, Coolidge G:
Nonatheromatous ischemic heart disease following withdrawal from 
chronic industrial nitroglycerin exposure. Circulation 46:666-78, 
1972
35. Information Concerning the Development of the Criteria Document and 
Recommended Health Standard for Nitroglycerin. Unpublished report 
submitted to NIOSH by the US Dept of the Army, US Army Environmental 
Hygiene Agency, Aberdeen Proving Ground, Md, Aug 1977, 47 pp
36. Occupational Health and Industrial Hygiene Evaluation— Nitroglycerin, 
special study No. 99-005-72. Baraboo, Wis, US Dept of the Army, Army 
Environmental Hygiene Agency, Badger Army Ammunition Plant, 1971, 62 
PP
37. Barsotti M: [Stenocardiac attacks in workers engaged in the 
manufacture of dynamites containing nitroglycol.] Med Lavoro 45:544- 
48, 1954 (Ita)
38. Bartalini E, Cavagna G, Foa V: Epidemiological and clinical features 
of occupational nitroglycol poisoning in Italy. Med Lav 58:618-23, 
1967
39. Jacob JC, Maroun FB: Peripheral neuropathy in a person sensitive to 
dynamite. Can Med Assoc J 101:102-04, 1969
40. Lanfranchi A, Beraud P: [Chronic intoxication by nitrated compounds 
in workers of explosives plants.] Presse Med 77:795-96, 1969 (Fre)
181
41. Maccherini I, Camarri E: [Nitroglycol poisoning.] Med Lav 50:193-
201, 1959 (Ita)
42. Prerovska I, Teisinger J: Clinical picture of chronic intoxication 
with dinitrodiglycol. Prac Lek 17:41-43, 1965
43. Rubino GF, Scansetti G, Crotti L: [Effects of chronic exposure to
nitroglycol in dynamite manufacture.] Minerva Med 47:1124-28, 1956
(Ita)
44. Hanova M: [Electrocardiographic changes induced by ethylene glycol
dinitrate and glyceryl trinitrate.] Bratisl Lek Listy 45:220-24, 
1965 (Slo)
45. Orlando E, Raffi GB, Miraglia G: Electrocardiographic patterns in
workers chronically exposed to nitroglycol. Lav Urn 18:455-61, 1966
46. Keogh JP, Longarini AE, Platt BB: Nonatheromatous Ischemic Heart
Disease Induced by Nitrates— Two Cases and An Epidemiological 
Investigation. Unpublished report submitted to NIOSH by Baltimore 
City Hospitals, Dept of Medicine, Baltimore, Nov 1977, 15 pp
47. Powell M, Lomax MA: The toxic effects of handling and firing
explosives in coal mines. Ann Occup Hyg 2:141-51, 1960
48. Klock JC: Nonocclusive coronary disease after chronic exposure to
nitrate— Evidence for physiologic nitrate dependence. Am Heart J 
89:510-13, 1975
49. Trainor DC, Jones RC: Headaches in explosive magazine workers. Arch
Environ Health 12:231-34, 1966
50. Oral deposition of Dr. John H. Foulger on Oct 1, 1975, in the case of 
Helen J. Stoleson vs United States of America, Civil No. 74-C-297, in 
the US District Court of the Western District of Wisconsin, 1975, 110 
PP
51. Foulger JH: Medical control of industrial exposure to toxic
chemicals. Ind Med Surg 12:214-25, 1943
52. Foulger JH: Preventive medicine in industry, in Modern Occupational
Medicine. Philadelphia, Lea and Febiger, 1954, pp 61-100
53. Hasegawa H, Sato M, Yoshikawa H, Sakabe H, Yamaguchi M, Hotta K: 
Nitroglycol poisoning in an explosives plant— 2. Bull Natl Inst Ind 
Health 8:10-20, 1962
54. Forssman S, Masreliez N, Johansson G, Sundell G, Wilander 0, Bostrom
G: Medical examination of workers engaged in the manufacture of
nitroglycerine and ethylene glycol dinitrate in the Swedish
182
explosives industry, in Proceedings of the Twelfth International 
Congress on Occupational Health, Helsinki, International Congress on 
Occupational Health, 1957, vol 3, pp 254-58
55. Kubota J: Problems of nitroglycol (Ng) poisoning in Japan, in Sangro
P, Akoun G, Beale HL (eds.): Proceedings of the International
Congress of Occupational Health, 14th, Madrid, 1963, International 
Congress Series. Amsterdam, Excerpta Medica, 1964, vol 2, pp 812-14
56. Symanski H: [Severe health injuries resulting from occupational 
exposure to nitroglycol.] Arch Hyg Bakteriol 136:139-58, 1952 (Ger)
57. Bille S, Sivertssen E: [Sudden death in an explosives worker.] Nord 
Med 70:842-43, 1963 (Nor)
58. Carmichael P, Lieben J: Sudden death in explosives workers. Arch 
Environ Health 7:424-39, 1963
59. Kannel WB, Dawber TR, Kagan A, Revotskre N, Stokes J: Factors of 
risk in the development of coronary heart disease— Six year follow-up 
experience— The Framingham study. Ann Intern Med 55:33-50, 1961
60. Hueper WC: The etiology and the causative mechanism of 
arteriosclerosis and atheromatosis. Medicine 20:397-442, 1941
61. Hueper WC: Arteriosclerosis, in Massey FC (ed.): Clinical
Cardiology. Baltimore, Williams Wilkins Co, 1953, pp 545-613
62. Yamagawa M: [Incidence of nitroglycol poisoning and its prevention 
in our country.] Kogyo Kayaku Kyokaishi 26:236-42, 1965 (Jap)
63. Lund RP, Haggendal J, Johnsson G: Withdrawal symptoms in workers 
exposed to nitroglycerine. Br J Ind Med 25:136-38, 1968
64. Yagoda H, Goldman FH: Analysis of atmospheric contaminants 
containing nitrate groupings. J Ind Hyg Toxicol 25:440-44, 1943
65. Morikawa Y, Muraki K, Ikoma Y, Honda T, Takamatsu H: Organic nitrate 
poisoning at an explosives factory— Plethysmographie study. Arch 
Environ Health 14:614-21, 1967
66. Planques J, Bazex A, Dupre A: [Cutaneous and nervous allergic 
reactions induced by dynamite.] Arch Mai Prof Med Trav Secur Soc 
20:187-88, 1959 (Fre)
67. Ryan FP: Erythroderma due to peritrate and glyceryl trinitrate. Br 
J Dermatol 87:498-500, 1972
68. Matsushita T, Tadokoro Y: An electroencephalographic study for 
chronic nitroglycol poisoning. Ind Health 13:237-41, 1975
183
69. Styblova V: [The neurotoxic effect of explosives.] Cesk Neurol
29:378-81, 1966 (Cze)
70. Gross E, Kiese M, Resag K: [Absorption of ethylene glycol dinitrate
through the skin.] Arch Toxicol 18:194-99, 1960 (Ger)
71. Williams AF, Murray WJ, Gibb BH: Determination of traces of
ethyleneglycol dinitrate (and nitroglycerine) in blood and urine. 
Nature 210:816-17, 1966
72. Sundell L, Gotell P, Axelson 0: Effects of nitroglycerin and
nitroglycol exposure, in Zenz C (ed.): Occupational Medicine—
Principles and Practical Applications. Chicago, Year Book Medical 
Publishers Inc, 1975, pp 826-32
73. Gotell P: Environmental and clinical aspects of nitroglycol and
nitroglycerin exposure. Occup Health Saf 45:50-51, 1976
74. Blumenthal HP, Fung HL, McNiff EF, Yap SK: Plasma nitroglycerin
levels after sublingual, oral, and topical administration. Br J Clin 
Pharmacol 4:241-42, 1977
75. Hogstedt C, Axelson 0: Nitroglycerine-Nitroglycol exposure and the
mortality in cardio-cerebrovascular diseases among dynamite workers. 
J Occup Med 19:675-78, 1977
76. Gross E, Bock M, Hellrung F: [Toxicology of nitroglycol as compared
to that of nitroglycerin.] Arch Exp Pathol Pharmakol 200:271-304, 
1942 (Ger)
77. Frimmer M, Gross E, Kiese M, Absag K: [Resorption of ethylene glycol
dinitrate through the lungs.] Arch Toxicol 18:200-04, 1960 (Ger)
78. Stein W: [Mechanism of the effect of continued inhalation of
nitroglycol.] Arch Gewerbepathol Gewerbehyg 15:19-36, 1956 (Ger)
79. Gross E, Kiese M, Resag K: [Absorption of glyceryl trinitrate
(nitroglycerin) through the skin.] Arch Toxicol 18:331-34, 1960
(Ger)
80. Bandelin FJ, Pankratz RE: Colorimetric determination of organic
nitro compounds used as vasodilators. Anal Chem 30:1435-37, 1958
81. Bogaert MG, De Schaepdryver AF: Tolerance towards glyceryl
trinitrate (Trinitrin) in dogs. Arch Int Pharmacodyn Ther 171:221- 
24, 1968
82. Bogaert MG: Tolerance towards glyceryltrinitrate (Trinitrin) in
rabbits. Arch Int Pharmacodyn Ther 172:228-30, 1968
83. Needleman P, Johnson EM Jr: Mechanism of tolerance development to
organic nitrates. J Pharmacol Exp Ther 184:709-15, 1973
184
84. Heppel LA, Hilmoe RJ: Metabolism of inorganic nitrite and nitrate
esters— II. The enzymatic reduction of nitroglycerin and erythritol 
tetranitrate by glutathione. J Biol Chem 183:129-38, 1956
85. DiCarlo FJ, Crew MC, Haynes LJ, Melgar MD, Gala RL: The absorption
and biotransformation of glyceryl trinitrate-1,3-C14 by rats. 
Biochem Pharmacol 17:2179-83, 1968
86. Needleman P, Krantz JC: The biotransformation of nitroglycerin.
Biochem Pharm 14:1225-30, 1965
87. Clark DG, Litchfield" MH: Metabolism of ethylene glycol dinitrate and
its influence on the blood pressure of the rat. Br J Ind Med 24:320- 
25, 1967
88. Litchfield MH: Aspects of nitrate ester metabolism. J Pharm Sei
60:1599-1607, 1971
89. Nickerson M: Vasodilator drugs, in Goodman LS, Gilman A (eds.): The
Pharmacological Basis of Therapeutics, ed 4. New York, The Macmillan 
Co, 1970, pp 745-63
90. Litchfield MH: Recent views on the mechanisms of nitrate ester
metabolism. Drug Metab Rev 2:239-64, 1973
91. DiCarlo FJ: Nitroglycerin revisited— Chemistry, Biochemistry,
Interations. Drug Metab Rev 4:1-38, 1975
92. Needleman P: Organic nitrate metabolism, in Elliott HW (ed.):
Annual Review of Pharmacology and Toxicology. Palo Alto, Calif, 
Annual Reviews Inc, 1976, vol 16, pp 81-93
93. Komura S, Yoshitake Y: Alcohol preference and nitroglycol poisoning
in C57BL mice. Jpn J Stud Alcohol 6:85-87, 1971
94. Komura S: Effects of ethyleneglycol dinitrate and related compounds
on ethanol preference and ethanol metabolism. Acta Pharmacol Toxicol 
35:145-54, 1974
95. Takayama S: Carcinogenicity of molsidomine and nitroglycerin in
rats. Pharmacometrics 9:217-28, 1975
96. Suzuki K, Sudo K, Yamamoto T, Hashimoto K: The carcinogenicity of N-
ethoxycarbonyl-3-morpholinosydnonimine (molsidomine) in comparison 
with nitroglycerin in C57BL/6Jms mice. Pharmacometrics 9:229-42, 
1975
97. Kononova SD, Korolev AM, Eremenko LT, Gumanov LL: [The mutagenic
effect of some esters of nitric acid on bacteriophage T4B.] Genetika 
8:101-08, 1972 (Rus)
185
98. Bogaert MG, Rosseel MT, DeSchaepdryver AF: Biotransformation of 
glyceryltrinitrate in rabbits. Arch Int Pharmacodyn Ther 177:487-91, 
1969
99. Robbins SL: Pathologie Basis of Disease. Philadelphia, WB Saunders 
Co, 1974, pp 648-49
100. Yee HT, Fosdick. LB, Bourne HG Jr: Nitroglycerin and nitroglycol 
exposure in an explosives plant. Am Ind Hyg Assoc J 20:45-49, 1959
101. Linch AL, Charsha RC: Development of a freeze-out technique and
constant sampling rate for the portable "Uni-Jet" air sampler. Am 
Ind Hyg Assoc J 21:325-29, 1960
102. Information Concerning the Development of the Criteria Document and 
Recommended Health Standard for Nitroglycerin. Unpublished report 
submitted to NIOSH by the Dept of the Army, Aberdeen Proving Ground, 
Md, US Army Environmental Hygiene Agency, Dec 1977, 7 pp
103. Barrett WJ, Dillon HK, James RH: Sampling and Analysis of Four
Organic Compounds Using Solid Sorbents No. 1. Unpublished report 
submitted to NIOSH by Southern Research Institute, Birmingham, Ala, 
1974, 125 pp
104. National Institute for Occupational Safety and Health: Certified
Equipment, HEW publication No. (NIOSH) 76-145. Morgantown, W Va, US
Dept Health, Education, and Welfare, Public Health Service, Center
for Disease Control, NIOSH, 1975, pp 1-2
105. Nitroglycerin and ethylene glycol dinitrate (nitroglycol) in air—  
Physical and Chemical Analysis Branch Method No. 203, in NIOSH Manual 
of Analytical Methods, ed 2, DHEW publication No. 77-157-A. 
Cincinnati, US Dept of Health, Education, and Welfare, Public Health 
Service, Center for Disease Control, NIOSH, 1977, vol 1, pp 203-1 to 
203-7
106. Sacharov K, Proctor G, Sentz F: Report of Survey— Atlas Powder
Company— Post Office Box 271— Tamaqua, Pa. Harrisburg, Pa,
Commonwealth of Pennsylvania Dept of Health, Division of Occupational 
Health, 1964, 9 pp
107. Ethylene Glycol Dinitrate and/or Nitroglycerin— Standards Completion 
Program Validated Method No. S216, in NIOSH Manual of Analytical 
Methods, ed 2, DHEW publication No. (NIOSH) 77-157-C. Cincinnati, US 
Dept of Health, Education, and Welfare, Public Health Service, Center 
for Disease Control, National Institute for Occupational Safety and 
Health, 1977, vol 3, pp S216-1 to S216-11
108. Pelliz^ari ED, Bunch JE, Berkley RE, McRae J: Collection and
analysis of trace organic vapor pollutants in ambient atmospheres—  
The performance of a Tenax GC cartridge sampler for hazardous vapors. 
Anal Lett 9:45-6J, 1976 186
109. Pristera F, Halik M, Castelli A, Fredericks W: Analysis of 
explosives using infrared spectroscopy. Anal Chem 32:495-508, 1960
110. Horwitz W (ed.): Official Methods of Analysis of the Association of 
Official Analytical Chemists, ed 11. Washington, DC, AOAC, 1970, pp 
687-88
111. Evendijk JE: [Separation and identification of explosive powder 
components by two-dimensional thin-layer chromatography.] 
Explosivstoffe 16:152-54, 1968 (Ger)
112. Frey M: [Recent methods in the analysis of propellants— Report No.
1. Polarographie analysis of propellants.] Explosivstoffe 12:149- 
57, 1964 (Ger)
113. Cannon JH, Heuermann RF: Rapid assay for nitroglycerin tablets. J 
Assoc Off Agric Chem 34:716-20, 1951
114. Dzottsoti SK: [Quantitative Potentiometrie determination of some 
nitro esters.] Azerb Khim Zh 2:81-85, 1961 (Rus)
115. Leichnitz K (ed.): Detector Tube Handbook— Air Investigations and
Technical Gas Analysis with Drager Tubes, ed 3. Lübeck, Federal
Republic of Germany, Dragerwerk AG Lübeck, 1976, pp 104-08
116. Evaluation of Operating Characteristics of Otto Fuel Detector, MK-15 
Mod 0, Environmental Chemistry Special Study No. 52-001-75/76. 
Cincinnati, Navy Environmental Health Center, Sept 1975, 37 pp
117. Coldwell BB: The application of ultra-violet light and diphenylamine 
to spot tests for explosives. Analyst 84:665-67, 1959
118. Sopranetti A, Reich HU: [Contribution to the gas chromatographic
analysis of propellants.] Explosivstoffe 20:197-202, 1972 (Ger)
119. Ehrner-Samuel H: Gas chromatographic determination of
nitroglycerine, nitroglycol and propylene glycol diniträte in blood 
with an electron capture detector, in Hygiene— Toxicology—
Occupational Diseases— 15th International Congress on Occupational 
Health, Vienna, Sept 19-24, 1946, vol 3, pp 201-05
120. Otto Fuel II Analysis. Unpublished report submitted to NIOSH by the 
US Dept of the Navy, Navy Environmental Health Center, Laboratory 
Division, Cincinnati, 3 pp
121. Cavagna G, Bartalini E, Locati G: Environmental control of health 
hazards in a dynamite factory— Past and present. Med Lav 58:501-05, 
1967
187
122. American Conference of Governmental Industrial Hygienists, Committee 
on Industrial Ventilation: Industrial Ventilation— A Manual of 
Recommended Practice, ed 15. Lansing, Mich, ACGIH, 1978, pp 1-1 to 
14-8
123. American National Standards Institute Inc: Fundamentals Governing 
the Design and Operation of Local Exhaust Systems, ANSI Z9.2-1971. 
New York, ANSI, 1971
124. Hagopian JH, Bastress EK: Recommended Industrial Ventilation
Guidelines, HEW publication No. (NIOSH) 76-162. Cincinnati, US Dept 
of Health, Education, and Welfare, Public Health Service, Center for 
Disease Control, National Institute for Occupational Safety and
Health, Division of Physical Sciences and Engineering, 1976, 330 pp
125. Criteria for a Recommended Standard....Occupational Exposure to
Nitric Acid, DHEW publication No. (NIOSH) 76-141. Rockville, Md, US 
Dept Health, Education, and Welfare, Public Health Service, Center 
for Disease Control, National Institute for Occupational Safety and 
Health, 1976, 78 pp
126. Criteria for a Recommended Standard....Occupational Exposure to
Sulfuric Acid, DHEW publication No. (NIOSH) 74-128. Rockville, Md,
US Dept Health, Education, and Welfare, Public Health Service, Center 
for Disease Control, National Institute for Occupational Safety and 
Health, 1974, 90 pp
127. National Fire Codes— A Compilation of NFPA Codes, Standards,
Recommended Practices, and Manuals; Building Construction and 
Facilities. Boston, National Fire Protection Association, 1974, vol 
4, pp 91-1 to 91-29
128. Recommended Industry Safety Standards, publication No. 6. New York, 
Institute of Makers of Explosives, Safety Library, 1977, 46 pp
129. National Fire Codes— A Compilation of NFPA Codes, Standards,
Recommended Practices, and Manuals; Electrical. Boston, National 
Fire Protection Association, 1974, vol 5, pp 70-286 to 70-316
130. National Fire Codes— A Compilation of NFPA Codes, Standards,
Recommended Practices, and Manuals; Occupancy Standards and Process 
Hazards. Boston, National Fire Protection Association, 1974, vol 9, 
pp 77-1 to 77-64
131. Safety in the Transportation, Storage, Handling, and Use of 
Explosives, publication No. 17. New York, Institute of Makers of 
Explosives, Safety Library, 1977, 61 pp
132. Shangraw RF, Contractor AM: New developments in the manufacture and 
packaging of nitroglycerin tablets. J Am Pharm Assoc 12:633-36, 1972
188
133. Medical and Industrial Hygiene Considerations for Nitroglycerin 
Operations. Aberdeen Proving Ground, US Dept of the Army, Army 
Environmental Hygiene Agency, Feb 1976, 7 pp
134. Edmont-Wilson Job-fitted Gloves and Protective Clothing. Coshocton, 
Ohio, Becton, Dickinson and Co, Edmont-Wilson, 1976, pp 14-16
135. Blasters' Handbook— A Manual Describing Explosives and Practical 
Methods of Use, ed 15. Wilmington, Del, El du Pont de Nemours and Co 
Inc, Explosives Dept, Sales Development Section, 1969, 525 pp
136. Weeks R W Jr, Dean BJ, Yasuda SK: Detection limit of chemical spot
tests toward certain carcinogens on metal, painted and concrete 
surfaces. Anal Chem 48:2227-33, 1976
137. Sansone EB, Slein MW: Application of the microbiological safety
experience to work with chemical carcinogens. Am Ind Hyg Assoc J 
37:711-19, 1976
138. Your Guide to Explosives Regulation— 1976. US Dept of the Treasury, 
Bureau of Alcohol, Tobacco, and Firearms, 1976, 203 pp
139. Do's and Dont's— Instructions and Warnings, publication No. 4. New 
York, Institute of Makers of Explosives, Safety Library, 1973, 14 pp
140. Agricultural Blasting, publication No. 11. New York, Institute of 
Makers of Explosives, Safety Library, 1976, 35 pp
141. Explosives and Blasting Safety. Unpublished report submitted to 
NIOSH by Bureau of Mines, Sept 1977, 10 pp
142. Portable Instruments. Pittsburgh, Mine Safety Appliances Co, 1976, 
section 3, pp 14-15
143. Suggested Code of Regulations for the Manufacture, Transportatipn, 
Storage, Sale, Possession, and Use of Explosive Materials, 
publication No. 3. New York, Institute of Makers of Explosives, 
Safety Library, 1974, 67 pp
144. Cook WA: Maximum allowable concentrations of industrial atmospheric
contaminants. Ind Med 14:936-46, 1945
145. Report of the Sub Committee on Threshold Limits, in Proceedings of 
the Eighth Annual Meeting of the American Conference of Governmental 
Industrial Hygienists, Chicago, Apr 7-13, 1946, pp 54-55
146. Threshold Limit Values Adopted at the Eleventh Annual Meeting of the 
American Conference of Governmental Industrial Hygienists, Detroit, 
Apr 1949, 2 pp
189
147. American Conference of Governmental Industrial Hygienists, Committee
on Threshold Limit Values: Documentation of Threshold Limit Values.
Cincinnati, ACGIH, 1962, p 77
148. Elkins HB: The Chemistry of Industrial Toxicology. New York, John
Wiley and Sons Inc, 1950, pp 160-61
149. American Conference of Governmental Industrial Hygienists: Threshold
Limit Values for 1962. Cincinnati, ACGIH, 1962, pp 6-8
150. American Conference of Governmental Industrial Hygienists: Threshold
Limit Values for 1963. Cincinnati, ACGIH, 1963, pp 5,7
151. American Conference of Governmental Industrial Hygienists: Threshold
Limit Values for 1964, Cincinnati, ACGIH, 1964, pp 8,11
152. American Conference of Governmental Industrial Hygienists, Committee
on Threshold Limit Values: Documentation of Threshold Limit Values,
rev. Cincinnati, ACGIH, 1966, p 84
153. Melville KI: Nitrites, nitrates and miscellaneous drugs, in Drill VA
(ed.): Pharmacology in Medicine— A Collaborative Textbook, ed 2.
New York, McGraw-Hill Book Co, 1958, pp 482-504
154. American Conference of Governmental Industrial Hygienists: Threshold
Limit Values of Air-borne Contaminents [sic] for 1968— Recommended 
and Intended Values. Cincinnati, ACGIH, 1968, pp 8-11
155. American Conference of Governmental Industrial Hygienists, Committee
on Threshold Limit Values: Documentation of the Threshold Limit
Values for Substances in Workroom Air, ed 3, 1971. Cincinnati, 
ACGIH, 2nd printing, 1974, pp 110-11
156. Litchfield MH: The determination of the di- and mononitrates of
ethylene glycol and 1,2-propylene glycol in blood by colorimetric and 
gas-chromatographic methods. Analyst 93:653-59, 1968
157. American Conference of Governmental Industrial Hygienists: TLV’s—
Threshold Limit Values for Substances in Workroom Air Adopted by the 
ACGIH for 1972. Cincinnati, ACGIH, 1972, pp 17,22
158. Nitroglycerin (Glycerol trinitrate), AIHA Hygienic Guide Series. 
Akron, Ohio, American Industrial Hygiene Association, 1960, 2 pp
159. Occupational Exposure Limits for Airborne Toxic Substances, 
Occupational Safety and Health Series No. 37. Geneva, International 
Labour Office, 1977, pp 112-13,160-61
160. Keogh J: Health hazards of nitroglycerin and nitroglycol,
publication No. 16. Denver, Colo, Oil, Chemical and Atomic Workers 
International Union, OCAW Health and Safety Office, 1977, 19 pp
190
161. Dilley JV: Evaluation of the occupational health hazards of
nitroglycerin using mammalian models— Final report. Menlo Park, 
Calif, SRI International, Aug 1977, 36 pp
162. Lee CC, Ellis HV, Kowalski JJ, Hodgson JR, Hwang SW, Short RD, 
Bhandari JC, Sanyer JL, Reddig TW, Minor JL, Helton DO: Mammalian 
toxicity of munition compounds— Phase II— Effects of multiple doses—  
Part I. Trinitroglycerin— Progress report No. 2. Kansas City, MO, 
Midwest Research Institute, Nov 1977, 192 pp
163. Lee CC, Dilley JV, Hodgson JR, Helton DO, Wiegand WJ, Roberts DN,
Andersen BS, Halfpap LM, Kurtz LD, West N: Mammalian toxicity of
munition compounds— Phase I. Acute oral toxicity primary skin and 
eye irritation, dermal sensitization, and disposition and 
metabolism— Final report No. 1. Kansas City, MO, Midwest Research
Institute, July 1975, 113 pp
164. Organic solvents in air— Physical and Chemical Analysis Branch Method 
No. 127, in NIOSH Manual of Analytical Methods, ed 2, DHEW 
publication No. (NIOSH) 77-157-A. Cincinnati, US Dept of Health, 
Education and Welfare, Public Health Service, Center for Disease 
Control, National Institute for Occupational Safety and Health, 1977, 
vol 1, 127-1 to 127-7
191
IX. APPENDIX I
SAMPLING AND ANALYTICAL METHOD FOR NG AND EGDN
This analytical method for NG and EGDN is adapted from NIOSH Method 
No. P&CAM 203 (classification E) [105]. A Class E method is defined by 
NIOSH as "Proposed: A new, unproved, or suggested method not previously
used by industrial hygiene analysts but which gives promise of being 
suitable for the determination of a given substance." The proposed 
validation range for NG is 0.1-100 mg/cu m in a 10-liter sample, and for 
EGDN the range is 0.01-100 mg/cu m, also in a 10-liter sample. Although 
the method has not yet been validated at the recommended action level of 
0.05 mg/cu m total NG and EGDN in a 20-liter sample, it shows promise of 
being suitable.
General Requirements
Collect breathing zone samples representative of the individual 
employee's exposure. Collect enough samples to permit calculation of a 
representative ceiling concentration for every operation or location in 
which there is exposure to NG or EGDN. At the time of the sample 
collection, record a description of the sampling location and conditions, 
equipment used, time and rate of sampling, and any other pertinent 
information.
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Principle of the Method
The nitroesters are sorbed on Tenax-GC, a porous organic polymer, as 
a known volume of air containing the analytes is drawn through a small bed 
of the sorbent in a glass tube. The nitroesters are extracted from the
sorbent with ethanol; the resulting solution is analyzed by gas
chromatography with an electron-capture detector. Areas under the
nitroester peaks from sample unknowns are compared with areas under the
peaks from nitroester standards.
Range and Sensitivity
The minimum amount of EGDN measurable in a single injection by the 
gas-chromatographic method is substantially smaller than 0.25 ng. This 
sensitivity easily permits the detection of EGDN in a 20-liter air sample 
containing 0.005 mg/cu m. The minimum amount of NG detectable in a single 
injection by the gas-chromatographic method is smaller than 2.5 ng. This 
sensitivity permits the measurement of NG in a 20-liter air sample 
containing 0.05 mg/cu m.
The capacity of the sorbent tubes is at least 1 mg of either EGDN or 
NG. Thus, it is unlikely that an excessive amount of sample will ever be 
collected even when the concentration greatly exceeds the recommended 
standard of 0.10 mg/cu m. This retention of EGDN or NG by the sorbent 
tubes is not significantly different when samples are taken from 
atmospheres of low and high relative humidities [103].
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Interferences
Ethylene glycol mononitrate, if present in a high concentration 
relative to that of EGDN, produces a gas-chromatographic peak that tails 
into the EGDN peak. This interference, although troublesome, does not 
prohibit a reasonably satisfactory analysis for EGDN. The combined 
selectivity of Tenax-GC and electron-capture detection practically
eliminates other interference. Water vapor does not interfere.
Precision and Accuracy
The coefficient of variation of the analytical method for the 
determination of EGDN is estimated to be about 0.03 at an EGDN 
concentration of 2 mg/cu m in 15-liter samples. The precision of the 
measurement of NG concentrations is approximately the same at a 
concentration of 0.27 mg/cu m.
The precision of the overall sampling and analytical method has not 
been adequately determined. The coefficient of variation for the total 
method has been estimated to be about 0.10 at an EGDN concentration of 2 
mg/cu m and an NG concentration of 0.3 mg/cu m. Since both EGDN and NG are 
sorbed on Tenax-GC at ambient temperature with 100% efficiency, it can be 
expected that the overall precision will be determined by variations in the 
measurement of sample volume.
In laboratory measurements not involving a personal sampling pump, 
the average recovery of EGDN from vapor samples at concentrations of 0.27- 
3.93 mg/cu m in 30- to 90-liter samples was 104% and that of NG was 102% at
a concentration of 0.28 mg/cu m in 60-liter samples.
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Advantages and Disadvantages of the Method
The sampling device is small and portable and involves no liquids. 
The contents of the tubes are analyzed by means of gas chromatography, a 
rapid instrumental method. Interferences in the chromatographic method are 
minimal.
The principal difficulties are those associated with the use of 
electron-capture detection. They include the limited linear range of 
electron-capture detectors and operating variables such as the effects of 
column bleed, moisture, and oxygen. The effects of these variables may be 
minimized by analyzing standards at the same time as samples. The 
electron-capture detector is about 500 times as sensitive to the 
nitroesters as a hydrogen flame ionization detector and provides a 
substantial advantage in specificity.
The precision of the method is limited by the reproducibility of the 
pressure drop across the tubes and, therefore, by the flowrate through the 
tubes. Because the pump is usually calibrated for one particular tube, 
differences in flowrates can occur when sampling through other tubes and 
can cause sample volumes to vary.
The method can be applied to a wide range of sample sizes. However, 
repeated dilutions of the ethanol extract may be necessary to bring the 
amount of sample injected into the proper range for the electron-capture 
detector.
Apparatus
(a) A properly calibrated personal sampling pump certified by 
NIOSH as intrinsically safe for use in coal mines. Calibrate the pump with
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a representative sorbent tube in the sampling line, using a wet or dry test 
meter or glass rotameter capable of measuring the appropriate flowrates (<1 
liter/minute) within an accuracy of ±5%.
(b) Sorbent tubes, 70 nun long and 5-mm internal diameter,
containing two sections of 35/60-mesh Tenax-GC separated and held in place 
by glass-wool plugs. The front section contains 100 mg of sorbent and the 
backup section contains 50 mg. Since the pressure drop must be limited to 
1 inch of mercury at 1.0 liter/minute, it is necessary to avoid overpacking 
with glass wool.
(c) Gas chromatograph equipped with an electron-capture detector.
(d) Glass column, 2.5-foot x 0.25-inch, packed with 10% of OV-17 
on 60/80-mesh Gas Chrom Q.
(e) An electronic integrator, or an equivalent means of measuring
areas under peaks.




The only reagent required is absolute ethanol for extraction of the 
sorbent. The gas chromatograph requires a supply of helium and an argon- 




(a) Cleaning of equipment. All glassware for the laboratory
analysis should be washed with detergent and thoroughly rinsed with tap and
distilled water. Particular attention should be paid to the cleaning of 
the microliter syringe with ethanol.
(b) Collection and shipping of samples.
(1) Immediately before sampling, break the ends of the tube 
to provide openings at least 2 mm in diameter.
(2) The smaller section of sorbent is used as a backup and 
should be positioned nearest the sampling pump.
(3) The sorbent tube should be placed in a vertical
position with the larger section of sorbent pointing up during sampling to
minimize channeling of EGDN and NG through the sorbent tube.
(4) Air being sampled should not be passed through any hose
or tubing before entering the sorbent tube. This is particularly important
with the nitroesters, since they are strongly sorbed on most surfaces, 
including glass.
(5) The flowrate and time (or volume) must be measured as
accurately as possible. The sample should be taken at a flowrate of 1
liter/minute or less to attain the total sample volume required (20 
liters).
(6) At the time personal samples are taken, relatively
large volumes of air should be sampled through other sorbent tubes also. 
These bulk air samples will be used by the analyst to identify possible 
interferences before the personal samples are analyzed.
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(7) The temperature and pressure of the atmosphere being 
sampled should be measured and recorded if either differs greatly from 
standard values (25 C and 760 mmHg).
(8) The Tenax-GC tubes should be capped with the supplied
plastic caps immediately after sampling. Under no circumstances should
rubber caps be used.
(9) One tube should be handled in the same manner as the 
sample tube (break, seal, and transport), except that no air is sampled 
through this tube. This tube should be labeled as a blank.
(10) Capped tubes should be packed tightly before they are
shipped to minimize tube breakage during shipping.
Analysis of Samples
(a) Preparation and desorption of samples. The sorbent tube is
scored with a file near the front end and is broken open. The first glass- 
wool plug and the front (100-mg) section of the sorbent are transferred to 
a small vial or test tube. The remaining glass-wool plug and the backup 
section of sorbent are transferred to another small vial. Two milliliters 
of ethanol are added to each vial, the vials are stoppered, and the
contents are shaken for about 1 minute. It may be necessary to-dilute the
ethanol solution before taking a sample aliquot for injection if the
concentrations of the nitrate esters are high.
(b) Gas-chromatographic conditions. Typical operating conditions 
for the gas-chromatographic analysis are:
(1) Column: 10% OV-17 on 60/80-mesh Chrom Q, 2.5-foot x
0.25-inch glass column.
(2) Helium carrier gas flow, 100 ml/minute.
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(3) Argon/methane purge gas flow, 125 ml/minute.
(4) Column temperature, 130 C.
(5) Injection port temperature, 160 C.
(6) Detector temperature, 280 C.
(c) Injection. The first step in the analysis is the injection of
the sample into the gas chromatograph. To eliminate difficulties arising
from blowback or distillation within the syringe needle, one should employ 
the solvent-flush injection technique. The lO-jul syringe is first flushed 
with solvent several times to wet the barrel and plunger. Two microliters 
of solvent are drawn into the syringe to increase the accuracy and
reproducibility of the injection sample volume. The needle is removed from 
the solvent and the plunger is pulled back about 0.4 jul to separate the
solvent flush from the sample with a pocket of air to be used as a marker.
The needle is then immersed in the sample, and a aliquot is withdrawn
to the 7.4-jul mark (2 jul solvent + 0.4 n1 air + 5 ¡il sample = 7.4 jul) . 
After the needle is removed from the sample and prior to injection, the 
plunger is pulled back a short distance to minimize evaporation of the
sample from the tip of the needle. Duplicate injections of each sample and
standard are made. No more than a 3% difference in area is to be expected. 
Automatic sampling devices may be used also.
(d) Measurement of area. The area under the sample peak is
measured by an electronic integrator or some other suitable form of area 
measurement, and preliminary results are read from a standard curve 
prepared as discussed below.
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Determination of Desorption Efficiency
Only small differences in desorption efficiency in the described 
procedure are to be expected because of differences between lots of Tenax- 
GC. If the efficiency of desorption should be questioned for some other 
reason, it can be checked by following the procedure detailed in Section 
8.5 of Analytical Method Number P&CAM 127 [164], entitled "Organic Solvents 
in Air." However, since it is not possible to accurately measure the small 
quantities of the nitrate esters that are to be added to sorbent tubes, 15- 
/i 1 aliquots of appropriate ethanol solutions are added. Ethanol is also 
the solvent used to desorb the nitrate esters from the sorbent.
Calibration and Standards
If pure NG and EGDN are available, standard solutions in ethanol may 
be prepared and analyzed under the same gas-chromatographic conditions and 
during the same time period as the unknown samples. In the course of the 
development of this method, several reference materials were obtained from 
manufacturers of nitroester products. This experience indicated that the 
following materials can be obtained for the preparation of standards.
(a) Solutions of known concentrations of NG and EGDN in ethanol 
were provided by a dynamite manufacturer.
(b) A sample of analyzed dynamite containing EGDN but no NG was 
also provided by a dynamite manufacturer. Since dynamite is a 
heterogeneous material, care must be taken to obtain a representative 
sample.
(c) Pharmaceutical-grade sublingual NG tablets may be obtained 
from wholesale drug dealers. These tablets are manufactured to meet US 
Pharmacopeia specifications, which require that the actual NG content be
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between 80 and 120% of the stated value. The actual NG content of a 
specific lot of tablets may be obtained from the manufacturer. For use, 
the tablets are weighed, crushed, and extracted with ethanol, the solution 
is filtered and diluted to a fixed volume, and aliquots are injected.
(d) An alternate standard was a material of known NG content, 
called "NG Lactose Trituration," provided by a pharmaceutical manufacturer. 
This material is used for quality control in the manufacture of NG tablets.
An experimental comparison of the NG and EGDN contents of aliquots of 
these standard materials gave coefficients of variation of 0.04 for the NG 
contents and 0.02 for the EGDN contents.
It is necessary that standards be analyzed concurrently with samples 
to minimize the effects of variations in detector response and other 
factors. Calibration curves are established by plotting concentration in 
mg/2.0 ml versus peak area.
Calculations
(a) Read the weight, in mg, corresponding to each peak area from 
the standard curve. No volume corrections are needed, because the standard 
curve is based on mg/2.0 ml and the volume of sample injected is identical 
to the volume of the standard injected.
(b) Corrections for the blank must be made for each sample.
Corrected mg = mg sample - mg blank
where:
mg sample = mg found in front section of sample tube 
mg blank = mg found in front section of blank tube
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A similar procedure is followed for the backup sections.
(c) Add the corrected amounts present in the front and backup
sections of the same sample tube to determine the total measured amount of 
EGDN or NG in the sample.
(d) The concentration of each compound in air may be expressed in
mg/cu m:
mg/cu m = corrected weight (mg)_____  x 1,000 liters/cu m
volume of air sampled (liters)
(e) The concentrations of each compound expressed in mg/cu m can
then be added together to get the total concentration of NG and EGDN 
combined.
(f) The concentration of each compound may also be expressed in
terms of ppm by volume:
ppm = mg/cu m x 24.45 x 760 x T+273
MW P 298
where:
24.45 = molar volume (liter/mole) at 25C and 760 mmHg 
MW = molecular weight 
P = pressure (mmHg) of air sampled
T = temperature (C) or air sampled
However, the concentrations expressed in ppm cannot be added together
to get the combined concentration of NG and EGDN.
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X. APPENDIX II 
MATERIAL SAFETY DATA SHEET
The following items of information which are applicable to a specific 
product or material shall be provided in the appropriate block of the 
Material Safety Data Sheet (MSDS).
The product designation is inserted in the block in the upper left 
corner of the first page to facilitate filing and retrieval. Print in 
upper case letters as large as possible. It should be printed to read
upright with the sheet turned sideways. The product designation is that 
name or code designation which appears on the label, or by which the 
product is sold or known by employees. The relative numerical hazard 
ratings and key statements are those determined by the rules in Chapter V, 
Part B, of the NIOSH publication, An Identification System for 
Occupationally Hazardous Materials. The company identification may be 
printed in the upper right corner if desired.
(a) Section I. Product Identification
The manufacturer's name, address, and regular and emergency telephone 
numbers (including area code) are inserted in the appropriate blocks of
Section I. The company listed should be a source of detailed backup
information on the hazards of the material(s) covered by the MSDS. The 
listing of suppliers or wholesale distributors is discouraged. The trade 
name should be the product designation or common name associated with the 
material. The synonyms are those commonly used for the product, especially 
formal chemical nomenclature. Every known chemical designation or 
competitor's trade name need not be listed.
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(b) Section II. Hazardous Ingredients
The "materials" listed in Section II shall be those substances which 
are part of the hazardous product covered by the MSDS and individually meet 
any of the criteria defining a hazardous material. Thus, one component of 
a multicompohent product might be listed because of its toxicity, another 
component because of its flammability, while a third component could be 
included bbth for its toxicity and its reactivity. Note that a MSDS for a 
single component product must have the name of the material repeated in 
this section to avoid giving the impression that there are no hazardous 
ingredients.
Chemical substances should be listed according to their complete name 
derived from a recognized system of nomenclature. Where possible, avoid 
using common names and general class names such as "aromatic amine," 
"safety solvent," or "aliphatic hydrocarbon" when the specific name is 
known.
The "%" may be the approximate percentage by weight or volume 
(indicate basis) which each hazardous ingredient of the mixture bears to 
the whole mixture. This may be indicated as a range or maximum amount, ie, 
"10-40% vol" or "10% max wt" to avoid disclosure of trade secrets.
Toxic hazard data shall be stated in terms of concentration, mode of
exposure or test, and animal used, eg, "100 ppm LC50-rat," "25 mg/kg LD50-
skin-rabbit," "75 ppm LC man," or "permissible exposure from 29 CFR
1910.1000," or, if not available, from other sources of publications such
as the American Conference of Governmental Industrial Hygienists or the
American National Standards Institute Inc. Flashpoint, shock sensitivity,
or similar descriptive data may be used to indicate flammability,
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reactivity, or similar hazardous properties of the material.
(c) Section III. Physical Data
The data in Section III should be for the total mixture and should 
include the boiling point and melting point in degrees Fahrenheit (Celsius 
in parentheses); vapor pressure, in conventional millimeters of mercury 
(mmHg); vapor density of gas or vapor (air = 1); solubility in water, in 
parts/hundred parts of water by weight; specific gravity (water = 1); 
percent volatiles (indicated if by weight or volume) at 70 F (21.1 C); 
evaporation rate for liquids or sublimable solids, relative to butyl 
acetate; and appearance and odor. These data are useful for the control of 
toxic substances. Boiling point, vapor density, percent volatiles, vapor 
pressure, and evaporation are useful for designing proper ventilation 
equipment. This information is also useful for design and deployment of 
adequate fire and spill containment equipment. The appearance and odor may 
facilitate identification of substances stored in improperly marked 
containers, or when spilled.
(d) Section IV. Fire and Explosion Data
Section IV should contain complete fire and explosion data for the 
product, including flashpoint and autoignition temperature in degrees 
Fahrenheit (Celsius in parentheses); flammable limits, in percent by volume 
in air; suitable extinguishing media or materials; special firefighting 
procedures; and unusual fire and explosion hazard information. If the 
product presents no fire hazard, insert "NO FIRE HAZARD" on the line 
labeled "Extinguishing Media."
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(e) Section V. Health Hazard Information
The "Health Hazard Data" should be a combined estimate of the hazard 
of the total product. This can be expressed as a TWA concentration, as a 
permissible exposure, or by some other indication of an acceptable 
standard. Other data are acceptable, such as lowest LD50 if multiple 
components are involved.
Under "Routes of Exposure," comments in each category should reflect
the potential hazard from absorption by the route in question. Comments
should indicate the severity of the effect and the basis for the statement
if possible. The basis might be animal studies, analogy with similar 
products, or human experiences. Comments such as "yes" or "possible" are 
not helpful. Typical comments might be:
Skin Contact— single short contact, no adverse effects likely;
prolonged or repeated contact, possibly mild irritation.
Eye Contact— some pain and mild transient irritation; no corneal
scarring.
"Emergency and First Aid Procedures" should be written in lay 
language and should primarily represent first-aid treatment that could be 
provided by paramedical personnel or individuals trained in first aid.
Information in the "Notes to Physician" section should include any 
special medical information which would be of assistance to an attending 
physician including required or recommended preplacement and periodic 
medical examinations, diagnostic procedures, and medical management of 
overexposed employees.
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(f) Section VI. Reactivity Data
The comments in Section VI relate to safe storage and handling of 
hazardous, unstable substances. It is particularly important to highlight 
instability or incompatibility to common substances or circumstances, such 
as water, direct sunlight, steel or copper piping, acids, alkalies, etc. 
"Hazardous Decomposition Products" shall include those products released 
under fire conditions. It must also include dangerous products produced by 
aging, such as peroxides in the case of some ethers. Where applicable, 
shelf life should also be indicated.
(g) Section VII. Spill or Leak Procedures
Detailed procedures for cleanup and disposal should be listed with 
emphasis on precautions to be taken to protect employees assigned to 
cleanup detail. Specific neutralizing chemicals or procedures should be 
described in detail. Disposal methods should be explicit including proper 
labeling of containers holding residues and ultimate disposal methods such 
as "sanitary landfill" or "incineration." Warnings such as "comply with 
local, state, and Federal antipollution ordinances" are proper but not 
sufficient. Specific procedures shall be identified.
(h) Section VIII. Special Protection Information
Section VIII requires specific information. Statements such as 
"Yes," "No," or "If necessary" are not informative. Ventilation 
requirements should be specific as to type and preferred methods. 
Respirators shall be specified as to type and NIOSH or the Mining 
Enforcement and Safety Administration (MESA) or its successor approval 
class, ie, "Supplied air," "Organic vapor canister," etc. Protective 
equipment must be specified as to type and materials of construction.
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(i) Section IX. Special Precautions
"Precautionary Statements" shall consist of the label statements 
selected for use on the container or placard. Additional information on
any aspect of safety or health not covered in other sections should be
inserted in Section IX. The lower block can contain references to
published guides or in-house procedures for handling and storage.
Department of Transportation markings and classifications and other
freight, handling, or storage requirements and environmental controls can 
be noted.
(j) Signature and Filing
Finally, the name and address of the responsible person who completed 
the MSDS and the date of completion are entered. This will facilitate 
correction of errors and identify a source of additional information.
The MSDS shall be filed in a location readily accessible to employees 
exposed to the hazardous substance. The MSDS can be used as a training aid 
and basis for discussion during safety meetings and training of new 
employees. It should assist management by directing attention to the need 
for specific control engineering, work practices, and protective measures 
to ensure safe handling and use of the material. It will aid the safety 
and health staff in planning a safe and healthful work environment and in 
suggesting appropriate emergency procedures and sources of help in the 
event of harmful exposure of employees.
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MATERIAL SAFETY DATA SHEET
1 PRODUCT IDENTIFICATION
M A N U F A C T U R E R  S N A M E
R E G U L A R  TELEPHONE NO 





M A T E R I A L  OR CO MPONENT % H A Z A R D  O AT A
III PHYSICAL DATA
B O IL IN G  POINT 7 6 0 M M  H,G M E L T IN G  P O IN '
SPECIFIC G R A V IT Y  (H20 = 1 I VAPOR PRESSURE
VAPOR DE NS IT Y  1 A l f l  - 11 SO LU0IL  IT Y IN H j O  i . 8 V W T
% V O L A T IL E S  b y  v OL E V A P O R A T IO N  RATE I f lU T Y i  ACETATE !)
APPEARANCE ANO ODOR
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IV FIRE AND EXPLOSION DATA
f l a s h  p o i n t  
(TEST METHOD)
A U T O IG N IT IO N
T E M P ER A T U R E
F L A M M A B L E  l i m i t s  i n  A IR ,  % BY VO L. LOWER UPPER





U N U S U A L  F » RE 
A N D  EXPLOSION 
H A Z A R D
_________________ V HEALTH HAZARD INFORMATION
H E A L T H  H A Z A R D  D A T A
ROUTES OF EXPOSURE





EFFECTS OF OVEREXPOSURE 
AC UTE OVEREXPOSURE
C HRONIC OVEREXPOSURE 
EMERGENCY A N D FIRST A ID  PROCEDURES 
EVES
SKtN





CO ND IT IO NS C O N T R IB U T IN G  TO IN S T A B IL IT Y
INCOMPA1 iB I L l T Y
H A Z A R D O U S  DECOMPOSITION PRODUCTS
CO ND IT IO NS C O N T R IB U T IN G  TO H A Z A R D O U S  P O L Y M E R IZ A T IO N
VII SPILL OR LEAK PROCEDURES
STEPS TO BE T A K E N  IF M A T E R I A L  IS R E L EA SE D  OR SPILLED 
N E U T R A L IZ IN G  CH EM IC ALS
WASTE DISPOSAL M ET H O D
VIII SPECIAL PROTECTION INFORMATION
V E N T I L A T IO N  R E Q U IR EM EN T S
SPECIFIC PE RSONAL PROTECTIVE EQUIPMENT 
RE SP IR AT O RY (SPECIFY IN D E T A IL !
EYE
GLOVES
OTHER CL O T H IN G  A N D  EQUIPMENT
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P R EC AU T IO N A R Y
s t a t e m e n t s
IX SPECIAL PRECAUTIONS
o t h e r  h a n d l i n g  a n d

















Vapor pressure (20 C)

























1 mg/liter =110 ppm 
1 mg/cu m = 0.110 ppm 
1 ppm =9.1 mg/cu m 
1 ppm = 9.1 /Lig/liter
















1 mg/liter = 164 ppm 
1 mg/cu m = 0.164 ppm 
1 ppm = 6.1 mg/eu m 
1 ppm =6.1 pg/liter
Adapted from references 5,7,8,9
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TABLE XI-2







































































4-Ni tro-3-hep tene 
2-Nitro-2-hexene
♦International Union of Pure and Applied Chemistry (IUPAC) common name 
★♦Department of Transportation (DOT)
Adapted from reference 10
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TABLE XI-3
OCCUPATIONS WITH POTENTIAL EXPOSURE 
TO NG AND EGDN








Rocket fuel makers 
Shell fillers 
Smokeless-powder makers 
Adapted from Key et al [16]
215 *  U.S. GOVERNMENT PRINTING OFFICE: 1978—  7 5 7 - 1 4 1 / 1 8  1 5
DEPARTMENT OF 
HEALTH, EDUCATION, AND W ELFARE
P U B L I C  H E A L T H  S E R V I C E  
C E N T E R  F O R  D I S E A S E  C O N T R O L  
N A T I O N A L  I N S T I T U T E  F O R  O C C U P A T I O N A L  S A F E T Y  A N D  H E A L T H  
R O B E R T  A.  T A F T  L A B O R A T O R I E S  
4 6 7 6  C O L U M B I A  P A R K W A Y .  C I N C I N N A T I .  O H I O  4 5 2 2 6 PO STA G E ANO FEES PAID 
U.S.  DE PAR TM EN T OF H E W. 
HEW  39 6
O F F I C I A L  B U S I N E S S  
P E N A L T Y  F O R  P R I V A T E  U S E .  $ 3 0 0
DHEW  (N IO SH ) Publication No. 78-167
